{"22085b2104670f1f6ab59352501a7ecf141af3ec": [["Numerous studies in the biomedical literature have attempted to elucidate the multifaceted functional roles of the free radical gas nitric oxide (NO) as a key signaling molecule in multiple regulatory pathways underlying vascular, metabolic, immune, and neurological function across animal phyla [1, 2] .", [["vascular", "ANATOMY", 221, 229], ["neurological", "ANATOMY", 254, 266], ["nitric oxide", "CHEMICAL", 132, 144], ["NO", "CHEMICAL", 146, 148], ["nitric oxide", "CHEMICAL", 132, 144], ["NO", "CHEMICAL", 146, 148], ["nitric oxide", "SIMPLE_CHEMICAL", 132, 144], ["NO", "SIMPLE_CHEMICAL", 146, 148], ["vascular", "MULTI-TISSUE_STRUCTURE", 221, 229], ["Numerous studies", "TEST", 0, 16], ["the free radical gas nitric oxide", "TREATMENT", 111, 144], ["a key signaling molecule", "PROBLEM", 153, 177], ["vascular", "ANATOMY", 221, 229]]], ["The widely studied biosynthetic pathway for NO production utilizes the guanidino group of L-arginine as its obligate chemical donor within a series of intermediary enzymatic steps catalyzed by 3 tissue-specific isoforms of NO synthase (NOS): endothelial (eNOS), neuronal (nNOS), and inducible (iNOS) [1] .", [["tissue", "ANATOMY", 195, 201], ["neuronal", "ANATOMY", 262, 270], ["NO", "CHEMICAL", 44, 46], ["guanidino", "CHEMICAL", 71, 80], ["L-arginine", "CHEMICAL", 90, 100], ["NO", "CHEMICAL", 223, 225], ["NO", "CHEMICAL", 44, 46], ["guanidino", "CHEMICAL", 71, 80], ["L-arginine", "CHEMICAL", 90, 100], ["NO", "CHEMICAL", 223, 225], ["NO", "SIMPLE_CHEMICAL", 44, 46], ["L-arginine", "SIMPLE_CHEMICAL", 90, 100], ["tissue", "TISSUE", 195, 201], ["NO synthase", "GENE_OR_GENE_PRODUCT", 223, 234], ["NOS", "GENE_OR_GENE_PRODUCT", 236, 239], ["endothelial (eNOS", "GENE_OR_GENE_PRODUCT", 242, 259], ["neuronal", "CELL", 262, 270], ["nNOS", "GENE_OR_GENE_PRODUCT", 272, 276], ["iNOS", "GENE_OR_GENE_PRODUCT", 294, 298], ["NO synthase", "PROTEIN", 223, 234], ["NOS", "PROTEIN", 236, 239], ["NOS", "PROTEIN", 256, 259], ["NOS", "PROTEIN", 273, 276], ["iNOS", "PROTEIN", 294, 298], ["the guanidino group of L-arginine", "TREATMENT", 67, 100], ["intermediary enzymatic steps catalyzed", "TREATMENT", 151, 189], ["endothelial (eNOS", "TREATMENT", 242, 259], ["endothelial", "ANATOMY", 242, 253]]], ["The eNOS and nNOS isoforms are constitutively expressed and strictly regulated to deliver short-lived bursts of released NO, whereas iNOS is induced following a proinflammatory/microbial challenge and is designed to deliver continuous high concentrations of NO to chemically neutralize invading pathogens via a canonical oxidative pathway [1] .", [["NO", "CHEMICAL", 121, 123], ["NO", "CHEMICAL", 258, 260], ["NO", "CHEMICAL", 121, 123], ["NO", "CHEMICAL", 258, 260], ["eNOS", "GENE_OR_GENE_PRODUCT", 4, 8], ["nNOS", "GENE_OR_GENE_PRODUCT", 13, 17], ["NO", "GENE_OR_GENE_PRODUCT", 121, 123], ["iNOS", "GENE_OR_GENE_PRODUCT", 133, 137], ["NO", "SIMPLE_CHEMICAL", 258, 260], ["eNOS and nNOS isoforms", "PROTEIN", 4, 26], ["iNOS", "PROTEIN", 133, 137], ["a proinflammatory/microbial challenge", "TREATMENT", 159, 196], ["continuous high concentrations", "TREATMENT", 224, 254], ["eNOS", "OBSERVATION", 4, 8]]], ["Historically, the chemically-mediated antibacterial and antiviral actions of NO have been attributed to the local actions of iNOS, and research has not adequately focused on more adaptive, statedependent changes in constitutively expressed NOS within integrated immune-regulatory signaling systems [3] .", [["NO", "CHEMICAL", 77, 79], ["NO", "CHEMICAL", 77, 79], ["NO", "SIMPLE_CHEMICAL", 77, 79], ["iNOS", "GENE_OR_GENE_PRODUCT", 125, 129], ["NOS", "GENE_OR_GENE_PRODUCT", 240, 243], ["iNOS", "PROTEIN", 125, 129], ["NOS", "PROTEIN", 240, 243], ["the chemically-mediated antibacterial", "TREATMENT", 14, 51], ["antiviral actions", "TREATMENT", 56, 73]]], ["We contend that despite a clear divergence in catalytic endpoints mediated by constitutive NO and iNOS, it appears that the overall goal of concerted NO production and release by multiple isoforms is to maintain homeostasis of integrated cellular and multiorgan systems in response to chemical or biological agents [2] .", [["cellular", "ANATOMY", 238, 246], ["multiorgan systems", "ANATOMY", 251, 269], ["NO", "CHEMICAL", 91, 93], ["NO", "CHEMICAL", 150, 152], ["NO", "CHEMICAL", 91, 93], ["NO", "CHEMICAL", 150, 152], ["NO", "GENE_OR_GENE_PRODUCT", 91, 93], ["iNOS", "GENE_OR_GENE_PRODUCT", 98, 102], ["NO", "SIMPLE_CHEMICAL", 150, 152], ["cellular", "CELL", 238, 246], ["iNOS", "PROTEIN", 98, 102], ["multiorgan systems", "TREATMENT", 251, 269], ["chemical or biological agents", "TREATMENT", 285, 314]]]], "99a2330d751abb5a03b0ebf32643e26e1419ff88": [["Further, modern society is highly interdependent in such a way that an adverse event occurring in any system/community have a significant impact on many other systems/communities, nations or even continents.", [["an adverse event", "PROBLEM", 68, 84]]], ["Examples of such adverse events have come to the fore in dramatic ways in recent years, i.e.: technological disruptions [1, 2] , volcanic eruptions, earthquakes & tsunamis [3] [4] [5] , Sars & Covid-19 [6] .IntroductionTo effectively respond and to mitigate the impact of to such threats, it becomes necessary for communities to have an effective emergency response plan in place.", [["eruptions", "DISEASE", 138, 147], ["earthquakes", "DISEASE", 149, 160], ["tsunamis [3] [4] [5]", "SIMPLE_CHEMICAL", 163, 183], ["such adverse events", "PROBLEM", 12, 31], ["technological disruptions", "PROBLEM", 94, 119], ["volcanic eruptions", "PROBLEM", 129, 147], ["Sars & Covid", "TEST", 186, 198]]], ["Therefore, drills are a key activity of preparedness to respond to emergencies [7] [8] [9] [10] .", [["[7] [8] [9] [10]", "SIMPLE_CHEMICAL", 79, 95]]], ["It also should be highlighted that there are two types of drills: discussion-based or desktop exercises, and operational-based exercises [10, 11] .", [["desktop exercises", "TEST", 86, 103]]], ["[9] [10] [11] .", [["[9] [10] [11]", "SIMPLE_CHEMICAL", 0, 13]]], ["It may be argued that most earthquake evacuation drills are of the announced type.IntroductionA great deal of effort has been made, by NGO (non-governmental organizations), scholars, governmental agencies in charge with civil protection, among others, to conduct and assess the effectiveness of earthquake evacuation drills [12] [13] [14] [15] [16] [17] [18] [19] [20] .", [["earthquake", "DISEASE", 27, 37], ["earthquake", "DISEASE", 295, 305], ["[12] [13] [14] [15] [16] [17] [18] [19] [20]", "CHEMICAL", 324, 368], ["[12] [13] [14] [15] [16] [17] [18] [19] [20]", "SIMPLE_CHEMICAL", 324, 368], ["earthquake evacuation drills", "TREATMENT", 27, 55], ["civil protection", "TREATMENT", 220, 236], ["earthquake evacuation drills", "TREATMENT", 295, 323]]], ["Most of the studies reported in the literature deal with drills being conducted in schools [12] [13] [14] 16] , and there are not that many on the general public [17, 18] .", [["the studies", "TEST", 8, 19]]], ["Some of the issues being address are those related to children's perception on evacuation drills [13] , protective action on CDH (\"Cover, Duck, Hold on\") [19] , degree of preparedness [12] , barriers for taking protective action [20] .IntroductionHowever, there are not that many published studies addressing explicitly what are the factors that would prompt people to participate in mass evacuation drills; the present paper intends to address this gap, at least in the context of Mexico City.", [["CDH", "DISEASE", 125, 128], ["children", "ORGANISM", 54, 62], ["people", "ORGANISM", 359, 365], ["children", "SPECIES", 54, 62], ["people", "SPECIES", 359, 365], ["evacuation drills", "TREATMENT", 79, 96], ["CDH", "PROBLEM", 125, 128], ["mass evacuation drills", "TREATMENT", 384, 406], ["this gap", "PROBLEM", 445, 453]]], ["Since then, there have been about twenty-two mass drills being conducted in the city.", [["two mass drills", "PROBLEM", 41, 56]]], ["The approach taken to the analysis has been the use of logistic regression technique.The 2017 earthquakesOn 7 September, an earthquake with a magnitude of M w \u00bc 8.2 hit Mexico City at 23:49:17 h, local time.", [["logistic regression technique", "TREATMENT", 55, 84]]], ["The epicentre of the quake was located in the Gulf of Tehuantepec, Oaxaca, Mexico, 650 km from the capital city.", [["capital", "ANATOMY_MODIFIER", 99, 106]]], ["As expected, several states of the southern region of the country were severely affected, and hundreds of people were killed; further details can be found in Ref.", [["people", "ORGANISM", 106, 112], ["people", "SPECIES", 106, 112], ["severely affected", "PROBLEM", 71, 88], ["several", "OBSERVATION_MODIFIER", 13, 20], ["severely", "OBSERVATION_MODIFIER", 71, 79], ["affected", "OBSERVATION", 80, 88]]], ["This time, the epicentre of the earthquake was located inland, 120 km from the capital city.", [["earthquake", "DISEASE", 32, 42], ["capital", "ANATOMY_MODIFIER", 79, 86]]], ["Although, the quake with a relatively lower intensity than the previous one, the consequences were severe for the residents of the city.", [["lower intensity", "OBSERVATION_MODIFIER", 38, 53]]], ["It caused the death of 370 people, 6000 were injured, and over 200 buildings were collapsed [27] .The SASMEXFollowing the devastating 1985 earthquake that struck the capital city of Mexico on September 19, 1985 [21] , an earthquake early warning (EEW) system was envisage by the mayor of the city and other organizations [24, 25] .", [["death", "DISEASE", 14, 19], ["people", "ORGANISM", 27, 33], ["people", "SPECIES", 27, 33], ["the death", "PROBLEM", 10, 19], ["devastating", "OBSERVATION_MODIFIER", 122, 133]]], ["It is believed that the SASMEX system was the first in its kind in the world and started its operation in 1991.", [["the SASMEX system", "PROBLEM", 20, 37]]], ["A detailed description of the features of the SASMEX system are given in Ref.", [["the SASMEX system", "TREATMENT", 42, 59]]], ["The SASMEX aim was to alert the residents of the city of earthquakes originating in the subduction zone along the Pacific coast of the country.", [["earthquakes", "DISEASE", 57, 68], ["subduction", "ANATOMY_MODIFIER", 88, 98], ["zone", "ANATOMY_MODIFIER", 99, 103]]], ["Further, the existing policy for issuing the alert is the following: no alert is issued for earthquakes with M b < 5.5 (M b \u00bc body-wave magnitude); relay a preventive alert if 5.5\ufffdM b < 6.0; and issue the alert when M b \ufffd 6.0 [23, p.1453 ].Evacuation drills in Mexico CityBuilding a resilient community to seismic risk is an essential component of a disaster management system.", [["earthquakes", "DISEASE", 92, 103], ["earthquakes", "PROBLEM", 92, 103], ["Evacuation drills", "TREATMENT", 240, 257], ["a disaster management system", "TREATMENT", 348, 376], ["essential", "OBSERVATION_MODIFIER", 325, 334], ["component", "OBSERVATION_MODIFIER", 335, 344]]], ["It may be argued that to be better prepared, earthquake drills may constitute a basic resource for an adequate training on what to do during an earthquake occurrence; therefore, it contributes to improving the level of preparedness of a community.", [["earthquake", "DISEASE", 45, 55], ["earthquake", "DISEASE", 144, 154], ["an adequate training", "TREATMENT", 99, 119]]], ["As mentioned in the introduction section, there are two types of evacuation drills, those with an advance notice or drills without notice.", [["evacuation drills", "TREATMENT", 65, 82], ["evacuation drills", "OBSERVATION", 65, 82]]], ["In our case study, the evacuation drills conducted in the city are of the former type.Evacuation drills in Mexico CityIn 2004, the mayor of the capital city called for what it is known as \"September, month of Civil Protection\", and since then, various preventive activities have been carried out, such as the case of drills, in order to build the \"culture of self-protection\" [24] .", [["our case study", "TEST", 3, 17], ["the evacuation drills", "TREATMENT", 19, 40]]], ["Since then, there have been earthquake mass evacuation drills in the capital city on 19 September yearly [17, 24] .", [["earthquake mass evacuation drills", "PROBLEM", 28, 61], ["earthquake", "OBSERVATION_MODIFIER", 28, 38], ["mass", "OBSERVATION", 39, 43], ["evacuation", "OBSERVATION_MODIFIER", 44, 54], ["drills", "OBSERVATION_MODIFIER", 55, 61], ["capital", "ANATOMY_MODIFIER", 69, 76]]], ["It should be mentioned that the drill participations are voluntarily and there is no punishment for non-participation.", [["no", "UNCERTAINTY", 82, 84]]], ["Overall, the idea of conducting these exercises have been well accepted by the general public.Evacuation drills in Mexico CityAs with any evacuation drill, there should be a scenario to practice.", [["Evacuation drills", "TREATMENT", 94, 111], ["any evacuation drill", "TEST", 134, 154]]], ["The following is an example of the type of information given to the public on the mass drill (an example of the 2019 drill) [17] :Evacuation drills in Mexico Citya) The evacuation drill will be held on Thursday, September 19 at 10:00 a.m. b) An earthquake of magnitude 8.6 will be taken as the hypothesis. c) You will hear the alert (issued by the SASMEX), as if it were a real earthquake. d) Once the alert is issued, all the buildings' occupiers should evacuate. e) The drills seek to improve the prevention measures and the response capacity of all the participants. f) The mass earthquake drill serves to assess the capital city's seismic emergency plan.Evacuation drills in Mexico CitySince its implementation, there have been several scenarios or hypothesises, but the one thing that never has changed is the date, i.e., 19 September.", [["participants", "SPECIES", 556, 568], ["The evacuation drill", "TREATMENT", 165, 185], ["The drills", "TREATMENT", 468, 478], ["the prevention measures", "TREATMENT", 495, 518], ["The mass earthquake drill", "PROBLEM", 573, 598], ["Evacuation drills", "TREATMENT", 658, 675], ["mass", "OBSERVATION", 82, 86], ["mass", "OBSERVATION", 577, 581], ["earthquake drill", "OBSERVATION", 582, 598], ["several", "OBSERVATION_MODIFIER", 732, 739], ["scenarios", "OBSERVATION", 740, 749]]], ["Further, in 2019, for example, about seven million participated in the drill, these included school children and the general public.", [["children", "ORGANISM", 100, 108], ["children", "SPECIES", 100, 108]]], ["The paper looks for the factors leading to the participants in the study agreeing on conducting drills on this particular date and yearly.Survey design and measuresFollowing the 2017 two earthquakes in Mexico City, a cross-sectional study was conducted by employing a survey questionnaire.", [["earthquakes", "DISEASE", 187, 198], ["participants", "SPECIES", 47, 59], ["the study", "TEST", 63, 72], ["a cross-sectional study", "TEST", 215, 238]]], ["The questionnaire was designed to assess, among other things, the Capital City's perception on the usefulness of the EEW system, the degree of residents' fear of earthquakes, the degree of preparedness, knowledge on what do during an earthquake, participation in drillings, the place they were when the earthquakes hit the capital city, etc., some other details are given in Ref.", [["earthquakes", "DISEASE", 162, 173], ["earthquakes", "PROBLEM", 162, 173]]], ["In what follows, the details of the dependent and independent variables considered in the analysis are given.", [["the dependent and independent variables", "PROBLEM", 32, 71], ["the analysis", "TEST", 86, 98]]], ["See the questionnaire included in the Appendix.Dependent variableGiven that we were interested in conducting a binary logistic regression analysis, respondents were asked the question on whether they agree on conducting mass earthquake drills in Mexico City, that is: \"Do you agree on conducting evacuation drills on 19 September every year?\"", [["earthquake", "DISEASE", 225, 235], ["Dependent variable", "PROBLEM", 47, 65], ["Appendix", "ANATOMY", 38, 46], ["variable", "OBSERVATION_MODIFIER", 57, 65]]], ["The possible answers to the question were \"Yes\" or \"No\".Explanatory variablesDemographic characteristics.", [["Explanatory variables", "PROBLEM", 56, 77]]], ["The demographic variables considered in the study were sex (1 \u00bc \"Men\", 2 \u00bc \"Women\"), age (Range \u00bc \"13-65\" years old, M \u00bc 34.5, SD \u00bc 345.67; the following two levels were considered: 1 \u00bc \"13-50\", 2 \u00bc \"51-65\" years old.", [["Women", "SPECIES", 76, 81], ["the study", "TEST", 40, 49]]], ["One of the considerations in the study was that the over 50's were regarded as one of the most vulnerable population; moreover, we assumed that this category had a direct experience on the 1985 earthquake.), occupation (1 \u00bc \"Students\", 2 \u00bc \"P&P (Public & Private organizations) Employees\", 3 \u00bc \"ES (Education Sector) Employees\", 4 \u00bc \"Other\" (Retirees, etc)), and education level (1 \u00bc \"Primary/Secondary\", 2 \u00bc \"High school\", 3 \u00bc \"Undergraduate\", 4 \u00bc \"Postgraduate\").", [["the study", "TEST", 29, 38]]], ["In the subsequent process of the analysis, it was necessary to collapse the variable related to occupation into two levels (1 \u00bc \"Students\", 2 \u00bc \"Employees\"); in all cases dummy variables were created to perform the logistic regression analysis.Explanatory variablesLocation.", [["the analysis", "TEST", 29, 41], ["the logistic regression analysis", "TEST", 211, 243], ["Explanatory variablesLocation", "PROBLEM", 244, 273], ["collapse", "OBSERVATION", 63, 71]]], ["The respondents of the study came from the capital city and the metropolitan area (1 \u00bc \"CDMX\", 2 \u00bc \"EDOMX\").Explanatory variablesEarthquake experience.", [["Earthquake", "DISEASE", 129, 139], ["the study", "TEST", 19, 28], ["Explanatory variables", "PROBLEM", 108, 129], ["capital", "ANATOMY_MODIFIER", 43, 50]]], ["A question was included in the questionnaire regarding the respondents' experience on the 1985 earthquake [21] ; that is, people who had a 'direct' experience on it; however, it should be mentioned that the approaches taken in the analysis of 'direct' and 'indirect' past experiences in Refs.", [["people", "ORGANISM", 122, 128], ["people", "SPECIES", 122, 128]]], ["Again, dummy variables were created to perform the analysis.Explanatory variablesEarthquake knowledge.", [["Earthquake", "DISEASE", 81, 91], ["dummy variables", "PROBLEM", 7, 22], ["the analysis", "TEST", 47, 59], ["Explanatory variables", "PROBLEM", 60, 81]]], ["There is evidence that those with more earthquake knowledge are more likely to prepare for earthquakes [30] [31] [32] .", [["earthquake", "DISEASE", 39, 49], ["earthquakes", "DISEASE", 91, 102]]], ["Finally, as mentioned in section 2, when conducting evacuation drills, the SASMEX (or any other EEW system) is an important element in this process; further, knowing the warning time is crucial in order to have a better response to earthquakes [26, 33] (warning time means the time between the moment the alarm goes-off and the actual ground shaking); an item regarding whether respondents knew the warning time once the alert is issued until the actual ground shaking was included in the questionnaire.", [["earthquakes", "DISEASE", 232, 243], ["conducting evacuation drills", "TEST", 41, 69]]], ["[26] , before the 2017 earthquakes, there was the general belief among the residents of the capital city that 60 s was the warning time before the ground shaking.", [["earthquakes", "DISEASE", 23, 34]]], ["As mentioned in subsection 2.3, earthquake drills have been organised by local decision-makers since 2004 and held every 19 September yearly; further, in some instances, there have been drills in schools and other organizations which are held not necessarily in the mentioned date, but at local level.", [["earthquake", "DISEASE", 32, 42]]], ["Moreover, a question was included in relation to the participants' perceptions on the frequency of earthquake evacuation drills they would like it to be (1 \u00bc \"None\", 2 \u00bc \"1-drill/year\", 2 \u00bc \"2-drills/year\", 3 \u00bc \"3-drills/year\", 4 \u00bc \"4-drills/year\", 5 \u00bc \"6-drills/year\", 6 \u00bc \"12-drills per year\").", [["earthquake", "DISEASE", 99, 109], ["participants", "SPECIES", 53, 65], ["earthquake evacuation drills", "TREATMENT", 99, 127]]], ["Finally, respondents were asked the following question: Do you think that having a good knowledge on what to do during an earthquake, mass drillings are not necessary?", [["mass drillings", "PROBLEM", 134, 148]]], ["Similarly, in all cases dummy variables were created to perform the analysis.Explanatory variablesEarthquake early warning (the SASMEX).", [["Earthquake", "DISEASE", 98, 108], ["the analysis", "TEST", 64, 76], ["Explanatory variables", "PROBLEM", 77, 98]]], ["A question related to the usefulness of the existing earthquake early warning (SASMEX) system was included in the questionnaire; the participants of the study were asked to assess this by responding with the following options: 1 \u00bc \"Yes\", 2 \u00bc \"No\".", [["participants", "SPECIES", 133, 145], ["the study", "TEST", 149, 158]]], ["It should be highlighted that there have been several false alarms in the past, however, there is not data to assess people's perceptions on this.", [["people", "ORGANISM", 117, 123], ["people", "SPECIES", 117, 123], ["several", "OBSERVATION_MODIFIER", 46, 53], ["false alarms", "OBSERVATION", 54, 66]]], ["Nevertheless, a detailed discussion of the SASMEX's performance during the two 2017 earthquakes is given in Ref.", [["earthquakes", "DISEASE", 84, 95], ["the SASMEX's performance", "TEST", 39, 63]]], ["[26] .Explanatory variablesPerception of seismic risk.", [["Explanatory variables", "PROBLEM", 6, 27], ["seismic risk", "PROBLEM", 41, 53], ["seismic risk", "OBSERVATION", 41, 53]]], ["Risk judgement includes an individual's estimate of the likelihood of harm to self, and his/her perception of the potential severity of that harm [34] ; the likelihood of harm and the severity of it were measured on a scale ranging from 0-10, i.e.: (0 \u00bc \"Absolutely no chance\", 10 \u00bc \"Absolutely certain\") and (0 \u00bc \"Not serious at all\", 10 \u00bc \"Severe\"), respectively.", [["harm", "PROBLEM", 171, 175]]], ["Finally, the perception of the vulnerability of the city was measured with two sets of items representing a likelihood of a future big earthquake occurrence and its devastating consequences in the capital city.", [["earthquake", "DISEASE", 135, 145], ["a future big earthquake occurrence", "PROBLEM", 122, 156], ["devastating", "OBSERVATION_MODIFIER", 165, 176], ["capital", "ANATOMY_MODIFIER", 197, 204]]], ["These two items were combined into a compound measure related to what it will be referred to as 'Perception vulnerability city' (\u03b1 \u00bc 0.67).Explanatory variablesPsychological reaction.", [["Explanatory variables", "PROBLEM", 139, 160], ["Psychological reaction", "PROBLEM", 160, 182]]], ["In the present case study, negative emotions are considered, and five items were considered to measure it (\u03b1 \u00bc 0.75) (see the Appendix for details about these).", [["Appendix", "ANATOMY", 126, 134]]], ["Further, the level of fear of the 19 September earthquake was measured at two levels (1 \u00bc \"High\", 2 \u00bc \"Low\"); finally, the level of fear of the 07 September earthquake was measured on a scale (0 \u00bc \"No at all\", 10 \u00bc \"A lot\").Data collectionThe study was for convenience.", [["Data collection", "TEST", 224, 239], ["The study", "TEST", 239, 248]]], ["The survey was conducted a few weeks after the occurrences of the two earthquakes in the capital city, i. e., 4 October -20 November 2017.", [["earthquakes", "DISEASE", 70, 81]]], ["A team comprising mainly postgraduate students administered the questionnaires to a sample of 2400 participants.", [["participants", "SPECIES", 99, 111]]], ["Overall, the approach was to go and ask personnel from different organizations to participate in the study, such as shopping malls, public libraries, restaurants, and high rising buildings.", [["the study", "TEST", 97, 106]]], ["We also visited schools, universities, and research centres; further, we randomly selected households located throughout the sixteen city councils that comprise the capital city.", [["capital", "OBSERVATION_MODIFIER", 165, 172]]], ["[26] , participants completed the questionnaires anonymously and were assured of the confidentiality of their answers.", [["participants", "ORGANISM", 7, 19], ["participants", "SPECIES", 7, 19]]], ["The response rate (RR) was 95%, given the fact that people were very proactive and willing to participate at the time.Statistical analysisData were analysed using the Statistical Package for the Social Sciences software (SPSS 25.0, IBM Corp., Armonk, NY, USA).", [["people", "ORGANISM", 52, 58], ["people", "SPECIES", 52, 58], ["The response rate", "TEST", 0, 17], ["RR", "TEST", 19, 21]]], ["Descriptive analysis was conducted by frequency tables.", [["Descriptive analysis", "TEST", 0, 20]]], ["For continuous variables, an unpaired t-test was conducted.", [["an unpaired t-test", "TEST", 26, 44]]], ["In some instances, it was necessary to convert discrete items into a continuous variable by reporting the relevant Cronbach's alpha of internal consistency.Statistical analysisThe independent variables were selected by conducting a univariate analysis; the results of such analysis are expressed as odds ratios (OR) and their 95% confidence intervals (CI).", [["Statistical analysis", "TEST", 156, 176], ["a univariate analysis", "TEST", 230, 251], ["such analysis", "TEST", 268, 281], ["CI", "TEST", 352, 354]]], ["The explanatory candidate variables for a first multivariate model were those whose univariable test had a p < .25 [36] [37] [38] [39] .", [["univariable test", "TEST", 84, 100]]], ["These authors argued that the use of the traditional p < 05 often fail to identify important variables that should be considered in the analysis.", [["the analysis", "TEST", 132, 144]]], ["Finally, a multivariate logistic regression was conducted; this time, all significant variables with a p < .05 were entered into the multivariate analysis ( Table 3 presents the details of the final model).Descriptive analysisWe begin the analysis by employing basic descriptive statistics to provide initial insights into the structure of the data.", [["a multivariate logistic regression", "PROBLEM", 9, 43], ["a p < .05", "TREATMENT", 101, 110], ["the multivariate analysis", "TEST", 129, 154], ["the analysis", "TEST", 235, 247]]], ["For example, in relation to the dependent variable (i.e., agreeing to earthquake mass evacuation drills on 19 September yearly), the results showed that 53.5% of respondents considered \"Yes\" and 46.9% responded \"No\" to the question.", [["earthquake", "DISEASE", 70, 80], ["earthquake mass evacuation drills", "TREATMENT", 70, 103], ["dependent", "OBSERVATION_MODIFIER", 32, 41], ["variable", "OBSERVATION_MODIFIER", 42, 50]]], ["As described in section 3.1.2, these are organised under the following eight categories: demographics, location, earthquake experience, earthquake knowledge, drills, the SAMEX, perception of seismic risk, and psychological reactions to earthquakes.", [["earthquake", "DISEASE", 113, 123], ["earthquake", "DISEASE", 136, 146], ["earthquakes", "DISEASE", 236, 247], ["seismic risk", "PROBLEM", 191, 203], ["psychological reactions", "PROBLEM", 209, 232]]], ["The results showed that in the sample of 2400 participants of the study, the proportion of participants agreeing to mass evacuation drills were: a) higher for women than men; b) lower for over 50's; c) highest for those participants that considered the frequency of conducting mass drills once a month; d) interestingly, higher for those participants that considered that the earthquake early warning (i.e., SASMEX) was useless during the 19 September 2017 earthquake; e) lower for respondents that experienced the 1985 earthquake than those that did not; and f) as expected, respondents experienced a considerable level of fear during the 19 September earthquake.", [["earthquake", "DISEASE", 376, 386], ["earthquake", "DISEASE", 457, 467], ["earthquake", "DISEASE", 520, 530], ["participants", "ORGANISM", 91, 103], ["women", "ORGANISM", 159, 164], ["men", "ORGANISM", 170, 173], ["participants", "SPECIES", 46, 58], ["participants", "SPECIES", 91, 103], ["women", "SPECIES", 159, 164], ["men", "SPECIES", 170, 173], ["participants", "SPECIES", 220, 232], ["participants", "SPECIES", 338, 350], ["the study", "TEST", 62, 71], ["mass evacuation drills", "TREATMENT", 116, 138]]], ["These are examples of some of the most relevant aspects of the frequency data.Descriptive analysisFinally, it should be mentioned that in Table 1 there is not a cell with a zero frequency that could lead to problems associated with having odds ratios of either zero or infinity.", [["cell", "ANATOMY", 161, 165], ["cell", "CELL", 161, 165], ["a cell", "PROBLEM", 159, 165], ["a zero frequency", "PROBLEM", 171, 187]]], ["Table 1 also shows some descriptive statistics such as the group means, standard deviations and the p-values of the continuous variables considered in the analysis.", [["standard deviations and the p-values", "PROBLEM", 72, 108], ["the analysis", "TEST", 151, 163]]], ["In general, it was found that there is no significant difference between the means of the two groups (if p<.05).", [["no", "UNCERTAINTY", 39, 41], ["significant", "OBSERVATION_MODIFIER", 42, 53], ["difference", "OBSERVATION", 54, 64]]], ["However, as mentioned in section 3.3, the adopted criterion in the present analysis (p<.25), the variables related to 'Perception vulnerability city' (p \u00bc .165) and 'Current knowledge' (p \u00bc .127) were considered as candidates in the initial process of the analysis as demonstrated in the univariate analysis (see Table 2 ).Factors that motivate respondents to agree on conducting evacuation drills 4.2.1.", [["the analysis", "TEST", 252, 264], ["the univariate analysis", "TEST", 284, 307], ["conducting evacuation drills", "TEST", 369, 397]]], ["Table 2 shows the results when fitting a univariable logistic regression model for each explanatory variable.Factors that motivate respondents to agree on conducting evacuation drills 4.2.1.", [["a univariable logistic regression model", "TREATMENT", 39, 78], ["conducting evacuation drills", "TEST", 155, 183]]], ["Univariate analysisThe results showed that the independent variables related to the demographics of the participants of the study, only age was significantly associated with the outcome (\u03c7 2 (1, n \u00bc 2368) \u00bc 4.337, p < .05).", [["participants", "SPECIES", 104, 116], ["Univariate analysis", "TEST", 0, 19], ["the study", "TEST", 120, 129]]], ["Regarding the location of where the participants reside, it was found that there was not association with the outcome.", [["participants", "ORGANISM", 36, 48], ["participants", "SPECIES", 36, 48]]], ["Similarly, the variable related to knowledge on the warning time had a significant effect (\u03c7 2 (1, n \u00bc 2368)Factors that motivate respondents to agree on conducting evacuation drills 4.2.1.", [["conducting evacuation drills", "TEST", 154, 182], ["significant", "OBSERVATION_MODIFIER", 71, 82]]], ["Univariate analysisHowever, the first multivariable model (Model 1, Table 3 ) was fitted by considering the explanatory variables that were significant in the univariate analysis at p < .25.", [["Univariate analysisHowever", "TEST", 0, 26]]], ["It should be mentioned that a significance level of 0.20 or 0.25 as a screening criterion for initial variable selection have been proposed by Refs.", [["a screening criterion", "TEST", 68, 89], ["initial variable selection", "TREATMENT", 94, 120]]], ["[36] [37] [38] [39] .", [["[36] [37] [38] [39]", "SIMPLE_CHEMICAL", 0, 19]]], ["As a result of this process, eleven variables have been selected by employing the criterion of p < .25.Factors that motivate respondents to agree on conducting evacuation drills 4.2.1.", [["conducting evacuation drills", "TEST", 149, 177]]], ["Univariate analysisEach variable of Model 1 was analysed at the traditional level of significance (p < .05).", [["Univariate analysisEach", "TEST", 0, 23]]], ["The results showed that sex (demographics), drill participation (drills), current knowledge (earthquake knowledge), and the variable related to fear of the 19 September earthquake (Psychological reactions) were not significant and therefore removed.", [["earthquake", "DISEASE", 169, 179], ["Psychological reactions", "PROBLEM", 181, 204]]], ["Model 2 is the result of this process; moreover, these variables were checked whether they confound or are needed to adjust the effects of the independent variables remaining in the model.", [["this process", "PROBLEM", 25, 37]]], ["The results showed that the variables' coefficients did not become significant.", [["the variables' coefficients", "TEST", 24, 51]]], ["Table 3 shows the final fitted model (Model 3) when considering an interaction term (i.e., \"Perception vulnerability city\" x \"Occupation\").Factors that motivate respondents to agree on conducting evacuation drills 4.2.1.", [["conducting evacuation drills", "TEST", 185, 213]]], ["Univariate analysisIt should be highlighted that there are several strategies that might be applied to selecting a final model.", [["Univariate analysis", "TEST", 0, 19]]], ["In the present case study, it was opted for a two-way approach to interactions of model terms that had each been demonstrated to have a significant main effect on the agreement to the outcome variable.", [["significant", "OBSERVATION_MODIFIER", 136, 147], ["main", "OBSERVATION_MODIFIER", 148, 152]]], ["Fig. 1 shows the interaction graphically (see section 4.4. for the limitations of the study).The multivariate analysisAs described in the previous section, the explanatory variables that have a significant effect on the outcome were those related to age, occupation, frequency of drills, warning time, usefulness of the SASMEX, knowledge vs drills, 'perception vulnerability city' (Table 3) .", [["the study", "TEST", 82, 91], ["The multivariate analysisAs", "TEST", 93, 120]]], ["For example, respondents whose age ranged from 13-49 years old have 1.366 times the odds of agreeing on conducting mass earthquake drills on 19 September yearly compared to older participants (50-65 years old) (95% CI 1.039 -1.795).", [["earthquake", "DISEASE", 120, 130], ["participants", "SPECIES", 179, 191], ["conducting mass earthquake drills", "PROBLEM", 104, 137], ["CI", "TEST", 215, 217]]], ["All those employees that participated in the study have 3.378 times the odds of agreeing on conducting mass earthquake drills compared to students (95% CI 1.457 -7.830).The multivariate analysisThe results also highlighted that the two most influential factors to the outcome variable were those related to the frequency of drills and knowledge vs drills.", [["earthquake", "DISEASE", 108, 118], ["the study", "TEST", 41, 50], ["CI", "TEST", 152, 154], ["The multivariate analysis", "TEST", 169, 194]]], ["That is, respondents considering one and three evacuation drills per year have 2.128 and 1.708 times the odds of agreeing on conducting drills yearly compared to those considering one per month (95% CI 1.610 -2.812 & 95% CI 1.006 -3.151, respectively).", [["CI", "TEST", 199, 201], ["CI", "TEST", 221, 223]]], ["To find out whether this was the case, we rerun the model by setting the frequency of drills \"1/year\" as the base or reference category.", [["base", "ANATOMY_MODIFIER", 109, 113]]], ["The results showed that effectively, the frequency of \"3/year\" does not contribute significantly to explaining the outcome variable (Wald:The multivariate analysisOn the other hand, the odds of agreeing on conducting mass evacuation drills are 1.394 times higher for participants that considered that an adequate knowledge on what actions to take during the ground shaking, respondents feel that it is not necessary to participate in drills compared to those that responded \"No\" to the question (95% CI 1.172 -1.658).The multivariate analysisThe odds of agreeing on conducting drills are 1.266 higher for those that consider that the warning time (which is issued by the SASMEX) varies before the ground shaking to those that answer \"Other\" (e.g., 50 min, 2 min, see the Appendix) (95% CI 1.036 -1.548).", [["participants", "SPECIES", 267, 279], ["conducting mass evacuation drills", "TREATMENT", 206, 239], ["CI", "TEST", 500, 502], ["The multivariate analysis", "TEST", 517, 542], ["conducting drills", "TREATMENT", 566, 583], ["CI", "TEST", 786, 788], ["Appendix", "ANATOMY", 771, 779]]], ["Further, the odds of agreeing on conducting mass earthquake drills yearly are 0.783 times higher for participants that consider the usefulness of the SASMEX compared to those that considered it useless (95% CI 0.615 -0.998).The multivariate analysisFinally, when considering the 'perception vulnerability city' by occupation interaction, the results showed that conducting mass earthquake drills of students are predicted to be increasing gradually with higher degree of agreement on the vulnerability of the city to a big earthquake, while the opposite was observed for employees (95% CI 0.643 -0.961) (Fig. 1) .", [["earthquake", "DISEASE", 523, 533], ["participants", "SPECIES", 101, 113], ["CI", "TEST", 207, 209], ["conducting mass earthquake drills", "PROBLEM", 362, 395], ["CI", "TEST", 586, 588], ["mass", "OBSERVATION", 373, 377]]], ["Thus, it may be argued that if students were more pessimistic (or aware of the importance of the need to be better prepared to earthquakes) than employees and therefore were more likely to agree on conducting drills every year on 19 September.", [["earthquakes", "DISEASE", 127, 138]]], ["However, this tendency was not observed in employees.DiscussionEarthquake evacuation drills may be regarded as a key activity .208 a a The selected variables at significance criterion p < .25 [36] [37] [38] [39] .Discussionwithin the emergency preparedness process.", [["Earthquake evacuation drills", "TREATMENT", 63, 91]]], ["Since 2004, mass drills have been conducted on 19 September every year in the capital city of the country.", [["mass drills", "PROBLEM", 12, 23]]], ["The aim of the present study was to address the following research question: What factors predict the likelihood that respondents would report that they agree on conducting mass evacuation drills yearly?", [["conducting mass evacuation drills", "TREATMENT", 162, 195]]], ["Logistic regression was employed to identify these factors.", [["Logistic regression", "TREATMENT", 0, 19]]], ["Finally, we considered the possibility of interaction effects between some of the variables.", [["interaction effects", "PROBLEM", 42, 61], ["considered the possibility of", "UNCERTAINTY", 12, 41], ["interaction", "OBSERVATION", 42, 53]]], ["However, these findings are consistent with those reported in Refs.", [["consistent with", "UNCERTAINTY", 28, 43]]], ["[7] [8] [9] [10] in the sense that earthquake drills are important in building a resilient community to seismic risk.", [["earthquake", "DISEASE", 35, 45], ["[7] [8] [9] [10]", "SIMPLE_CHEMICAL", 0, 16]]], ["For example, it is believed that more than 57 million people participated in drills across 56 countries and most of the US (this is according to the ShakeOut.org as cited in Ref.", [["people", "ORGANISM", 54, 60], ["people", "SPECIES", 54, 60], ["the US", "TEST", 116, 122]]], ["Similarly, in New Zealand, in 2012 about 1.3 million people registered to participate in \"ShakeOut\" drill [20] .", [["people", "ORGANISM", 53, 59], ["people", "SPECIES", 53, 59], ["New", "OBSERVATION_MODIFIER", 14, 17], ["Zealand", "OBSERVATION_MODIFIER", 18, 25]]], ["Further, by participating in drills, people will act if they believe that by doing this (i. e. drill participation) will increase their chance of survival and recovery; therefore, they will be more likely to undertake that action [20, 40, 41] .", [["people", "ORGANISM", 37, 43], ["people", "SPECIES", 37, 43]]], ["However, there is evidence that drill participation in some countries are low, for example, the 2005 evacuation drill participation in Japan was 19% [18] ; similarly, the participation rate in the 2014 evacuation drill that took place in the city of Ishinomaki (Japan) was only 7.3% [18] .", [["the 2014 evacuation drill", "TREATMENT", 193, 218], ["drill", "OBSERVATION_MODIFIER", 32, 37]]], ["The low participation is attributed, among other things, to embarrassment [20] , lack of motivation value of such drills [18] .", [["low participation", "OBSERVATION_MODIFIER", 4, 21]]], ["Similar studies on the effectiveness of evacuation drills should be investigated in the context of our case study.", [["Similar studies", "TEST", 0, 15], ["evacuation drills", "TREATMENT", 40, 57], ["our case study", "TEST", 99, 113]]], ["In our study, the frequency of drills was one of the most important contributors to the outcome variable.", [["our study", "TEST", 3, 12]]], ["In short, respondents in our study considered that one drill per year may be enough (section 4.4.2).", [["our study", "TEST", 25, 34]]], ["Further research is needed to explain this difference; for example, by conducting a similar analysis in relation to the two questions that have not been addressed here, i.e., those related to whether respondents agree on conducting mass evacuation drills anytime during the day and night (see the Appendix).DiscussionThe variable related to knowledge vs drills, on the other hand, was the other most important contributor to the outcome variable in our study.", [["conducting mass evacuation drills", "TREATMENT", 221, 254], ["our study", "TEST", 449, 458], ["Appendix", "ANATOMY", 297, 305]]], ["In general, this finding is consistent with those reported in Refs.", [["consistent with", "UNCERTAINTY", 28, 43]]], ["[30, 42] ; for example, it has been found that those with more knowledge about earthquakes were more likely to prepare for one [30] .", [["earthquakes", "DISEASE", 79, 90]]], ["However, what is less clear is, why those participants that do not have adequate knowledge, were also not interested in participating in drills.", [["participants", "SPECIES", 42, 54], ["less clear", "OBSERVATION_MODIFIER", 17, 27]]], ["It may be argued that there are other precursors outside their personal control besides drills, e.g., the quality of the drill exercises, among others; for example, in Ref.", [["the drill exercises", "TREATMENT", 117, 136]]], ["[18] , it was reported that drills have become increasingly stereotypical and boring.", [["increasingly", "OBSERVATION_MODIFIER", 47, 59], ["stereotypical", "OBSERVATION", 60, 73]]], ["More research is needed to better understand why this kind of people's behaviour in relation to mass evacuation drills.DiscussionAs mentioned in section 2, a key component of the Mexican earthquake disaster management system is the earthquake early warning system (the SASMEX).", [["people", "ORGANISM", 62, 68], ["people", "SPECIES", 62, 68], ["mass evacuation drills", "PROBLEM", 96, 118]]], ["In general, the aim of an EEW system is to alert people by proving a few seconds/minutes to take some sort of action before the actual ground shaking [22, 23, 26] .", [["people", "ORGANISM", 49, 55], ["people", "SPECIES", 49, 55]]], ["The results showed that the variable warning time was significantly associated with the dependent variable.", [["the dependent variable", "PROBLEM", 84, 106], ["dependent", "OBSERVATION_MODIFIER", 88, 97], ["variable", "OBSERVATION_MODIFIER", 98, 106]]], ["This may be explained given the fact that during the 07 September 2017 earthquake, the warning was issued in time (i.e., about 2 min before the actual shaking).", [["earthquake", "DISEASE", 71, 81]]], ["However, the 19 September earthquake (the earthquake that occurred twelve days after the first one), the warning was issued almost simultaneously with the ground shaking.", [["earthquake", "DISEASE", 26, 36], ["earthquake", "DISEASE", 42, 52]]], ["Because of this, respondents may have perceived the need for drills in order to enhance their response capabilities during the emergency.", [["drills", "TREATMENT", 61, 67]]], ["Again, a detailed analysis of the performance of the SAMEX during the two earthquakes is presented in Ref.", [["earthquakes", "DISEASE", 74, 85], ["SAMEX", "DNA", 53, 58], ["a detailed analysis", "TEST", 7, 26]]], ["The importance of knowing the warning time before the shaking is consistent with similar studies [19, 20, 26, [43] [44] [45] [46] .DiscussionSimilarly, respondents that considered the SAMEX as useful were more likely to agree on conducting drills than those that considered it useless.", [["[43] [44] [45] [46]", "SIMPLE_CHEMICAL", 110, 129], ["the shaking", "PROBLEM", 50, 61]]], ["As mentioned above, respondents were very surprised to know that the SASMEX was not very useful during the 19 September earthquake, but afterwards respondents may have understood that the warning system was not functional for cases where the earthquake epicentre was located only 120 km from the capital city [26] .", [["earthquake", "DISEASE", 242, 252]]], ["Given the fact that earthquakes cannot be predicted, earthquake early warning systems are essential in alerting people to take actions and prevent fatalities [22, 23, 26, 33, 47] , but people should be educated on their features, warning time, etc; in other words, EEW systems should be people-centred [26] .DiscussionWhen considering the 'perception vulnerability city' by occupation interaction, the results showed that students were more pessimistic than employees and therefore were more likely to agree on conducting drills every year on 19 September.", [["earthquakes", "DISEASE", 20, 31], ["fatalities", "DISEASE", 147, 157], ["people", "ORGANISM", 112, 118], ["people", "ORGANISM", 185, 191], ["people", "SPECIES", 112, 118], ["people", "SPECIES", 185, 191], ["people", "SPECIES", 287, 293]]], ["These results may be consistent with those reported in Ref.", [["may be consistent with", "UNCERTAINTY", 14, 36]]], ["Effectively, more research may be needed to better understand why people do not participate in drills.", [["people", "ORGANISM", 66, 72], ["people", "SPECIES", 66, 72]]], ["Finally, when considering the variable age, it has been found that respondents whose age ranged from 13-49 years old were more likely to agree on conducting drills yearly than those over 50's.DiscussionSeveral questions have arisen from the study, for example, the following in the context of the case study: why conducting earthquake drills on 19 September yearly?", [["earthquake", "DISEASE", 324, 334], ["the study", "TEST", 237, 246]]], ["Why not evacuation drills in other dates?", [["evacuation", "OBSERVATION", 8, 18]]], ["More generally, should earthquake evacuation drills be unannounced?", [["evacuation drills", "TREATMENT", 34, 51]]], ["These questions need to be addressed because of their implications in the way people may respond to the emergency [47] .", [["people", "ORGANISM", 78, 84], ["people", "SPECIES", 78, 84]]], ["That is, historical data shows that earthquakes have occurred anytime during the day and night and with devastating consequences.", [["earthquakes", "DISEASE", 36, 47], ["historical data", "TEST", 9, 24]]], ["For example, the 07 September that hit Mexico City in 2017 occurred at 23.49 h local time, where most people were about to go to bed (or some were sleeping already); it may be argued that people's reaction to earthquakes at night may be different than during daylight, for example, the evacuation from high rising buildings [48] .", [["earthquakes", "DISEASE", 209, 220], ["people", "ORGANISM", 102, 108], ["people", "ORGANISM", 188, 194], ["people", "SPECIES", 102, 108], ["people", "SPECIES", 188, 194], ["the evacuation", "TEST", 282, 296]]], ["More research should be conducted on these issues to gain a better understanding on peoples' response under these (or any other) scenarios.Some limitationsAs with any analysis such as the presented in here, is not without limitations.", [["Some limitations", "PROBLEM", 139, 155], ["any analysis", "TEST", 163, 175], ["not without", "UNCERTAINTY", 210, 221]]], ["Most of the weaknesses in this study stem from the participants sample that was gathered.", [["participants", "SPECIES", 51, 63], ["the weaknesses", "PROBLEM", 8, 22], ["this study stem", "TEST", 26, 41], ["weaknesses", "OBSERVATION", 12, 22]]], ["Further research may be needed to further explore this.ConclusionsEarthquake evacuation drills may constitute a key process for preparing for a seismic emergency.", [["Earthquake evacuation drills", "TREATMENT", 66, 94]]], ["The paper has presented the results of an analysis of participants' perceptions on the factors leading to conducting drills for the case of Mexico City.", [["participants", "SPECIES", 54, 66]]], ["The sample size considered for the analysis was N \u00bc 2400.", [["The sample size", "TEST", 0, 15], ["the analysis", "TEST", 31, 43], ["size", "OBSERVATION_MODIFIER", 11, 15]]], ["The approach has been the application of logistic regression to identify these factors.", [["logistic regression", "TREATMENT", 41, 60], ["these factors", "PROBLEM", 73, 86]]], ["Of the 19 initial explanatory variables, in the final model, only seven variables were significantly associated with the outcome variable; i.e.: age & occupation (Demographics), frequency of drills (Drills), knowledge vs drills (Earthquake knowledge), 'perception vulnerability city' (Perception of seismic risk), warning time & usefulness of SASMEX (EEW), and the 'perception vulnerability city' by occupation interaction.ConclusionsFurther research may be needed to gain a better understanding of people's motivations on evacuation drills taking place anytime during the day or at night, and whether evacuation drills should be unannounced.ConclusionsFinally, it is hoped that the results presented here may contribute to further discussion on the need for implementing EEW systems to those regions lacking them; moreover, the need to conduct earthquake drills to better prepare to earthquakes.Declaration of competing interestThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.", [["earthquakes", "DISEASE", 884, 895], ["people", "ORGANISM", 499, 505], ["people", "SPECIES", 499, 505], ["evacuation drills", "TREATMENT", 523, 540], ["evacuation drills", "TREATMENT", 602, 619], ["implementing EEW systems", "TREATMENT", 759, 783], ["earthquake drills", "TREATMENT", 845, 862]]]], "13acba5c07595b6d9a8cabbe72d7e67bca3b4b30": [["one of the nine babies was subsequently confirmed as COVID-19 positive (patient 1) based on nasopharyngeal RT-PCR.", [["nasopharyngeal", "ANATOMY", 92, 106], ["babies", "ORGANISM", 16, 22], ["patient", "ORGANISM", 72, 79], ["patient", "SPECIES", 72, 79], ["COVID", "TEST", 53, 58], ["nasopharyngeal RT-PCR", "TREATMENT", 92, 113], ["nasopharyngeal RT", "ANATOMY", 92, 109]]]], "PMC7252162": [["IntroductionThe new Coronavirus (COVID-19) is an emerging disease responsible for infecting millions of people and killing thousands worldwide since the first notification until nowadays, according to the World Health Organization (WHO) [1], [2].", [["COVID-19", "CHEMICAL", 33, 41], ["COVID-19", "ORGANISM", 33, 41], ["people", "ORGANISM", 104, 110], ["people", "SPECIES", 104, 110], ["The new Coronavirus (COVID", "TREATMENT", 12, 38], ["an emerging disease", "PROBLEM", 46, 65], ["new", "OBSERVATION_MODIFIER", 16, 19], ["Coronavirus", "OBSERVATION", 20, 31], ["disease", "OBSERVATION", 58, 65]]], ["Also according to WHO, Brazil registered 40.581 confirmed cases until April 22nd 2020, holding the 12th position in the world ranking in the number of confirmed cases of COVID-19, and 2nd position in the Americas (behind the United States of America).IntroductionDue to the impacts of the COVID-19 pandemic in people\u2019s lives and the world\u2019s economy, the governments and population are most concerned with (i) when the COVID-19 outbreak will peak; (ii) how long the outbreak will last and (iii) how many people will eventually be infected [3].", [["people", "ORGANISM", 310, 316], ["people", "ORGANISM", 503, 509], ["people", "SPECIES", 310, 316], ["people", "SPECIES", 503, 509], ["COVID", "TEST", 170, 175]]], ["Further, Boccaletti et al. [4] have identified at least three scientific communities that may cooperate in the effort to deal with the current pandemic: (i) the community of applied mathematicians, virologists and epidemiologists, developing sophisticated diffusion models to the specific properties of a given pathogen; (ii) the community of complex systems scientists who study the spread of infections using compartmental models, using methods and principles from statistical mechanics and nonlinear dynamics; and (iii) the community of scientists who incorporate artificial intelligence (AI) and most specifically deep learning approaches to produce accurate predictive models.", [["infections", "DISEASE", 394, 404], ["sophisticated diffusion models", "PROBLEM", 242, 272], ["infections", "PROBLEM", 394, 404], ["compartmental models", "TREATMENT", 411, 431], ["methods", "TREATMENT", 439, 446], ["infections", "OBSERVATION", 394, 404]]], ["Also, different studies are evaluating the impacts of COVID-19 on society, whether through predictions of future cases, as well as variables capable of helping to understand the spread of this disease [5], [6], [7], [8], [9].IntroductionMoreover, epidemiological time series forecasting plays an important role in health public system, once it allows the managers to develop strategic planning to avoid possible epidemics.", [["different studies", "TEST", 6, 23], ["COVID", "TEST", 54, 59], ["strategic planning", "TREATMENT", 375, 393], ["epidemics", "PROBLEM", 412, 421]]], ["Forecasting diseases as accurate as possible is important due to their impact on the public health system.", [["Forecasting diseases", "PROBLEM", 0, 20], ["diseases", "OBSERVATION", 12, 20]]], ["To ensure this accuracy, AI models have been widely used to forecast epidemiological time series over the years [10], [11], [12].", [["this accuracy", "TEST", 10, 23]]], ["Moreover, in the AI context, Vaishya et al. [13] presented a review of trends in COVID-19 data analysis.IntroductionRegarding this context, the objective of this paper is to explore and compare the predictive capacity of machine learning regression and statistical models, in the task of forecasting one, three, and six-days-ahead COVID-19 cumulative cases in Brazil.", [["COVID", "TEST", 81, 86], ["data analysis", "TEST", 90, 103]]], ["In this respect, datasets of ten Brazilian states some with a high incidence of COVID-19 until now, like Sao Paulo and Rio de Janeiro, are adopted to evaluates the forecasting efficiency through of the autoregressive integrated moving average (ARIMA), cubist regression (CUBIST), random forest (RF), ridge regression (RIDGE), support vector regression (SVR), and stacking-ensemble learning models.", [["COVID", "TEST", 80, 85], ["random forest (RF)", "TREATMENT", 280, 298], ["ridge regression (RIDGE)", "TREATMENT", 300, 324], ["support vector regression", "TREATMENT", 326, 351], ["SVR", "TEST", 353, 356]]], ["In the stacking-ensemble learning modelling, which is an effective ensemble learning approach [14], [15], CUBIST, RF, RIDGE, and SVR are used as base-learners (weak models), and Gaussian process (GP) as meta-learner (strong model).", [["RIDGE", "TREATMENT", 118, 123], ["SVR", "TREATMENT", 129, 132]]], ["The out-of-sample forecasting accuracy of each model is compared by some performance metrics such as the improvement percentage index (IP), mean absolute errors (MAE), and symmetric mean absolute percentage error (sMAPE).IntroductionThe contributions of this paper can be summarized as follows:\u2022The first contribution is related to the presentation of a novel analysis of the forecast model for cumulative confirmed cases of COVID-19 in Brazil, whose accuracy of the models assists governors in decision-making to contain the pandemic and strategies concerning the health system;\u2022The second contribution, we can highlight the use of heterogeneous machine learning models, as well as the stacking-ensemble learning approach to forecast the Brazilian cumulative confirmed cases of COVID-19;\u2022Also, this paper evaluates models forecasting in a multi-day-ahead forecasting strategy.", [["COVID-19", "CHEMICAL", 779, 787], ["mean absolute errors", "PROBLEM", 140, 160], ["COVID", "TEST", 425, 430], ["COVID", "TEST", 779, 784], ["improvement", "OBSERVATION_MODIFIER", 105, 116], ["percentage", "OBSERVATION_MODIFIER", 117, 127], ["index", "OBSERVATION_MODIFIER", 128, 133], ["absolute errors", "OBSERVATION", 145, 160], ["symmetric", "OBSERVATION_MODIFIER", 172, 181], ["mean absolute", "OBSERVATION", 182, 195], ["percentage error", "OBSERVATION", 196, 212]]]], "c167d27c2b3ad646db23aca0a505198d31d7c508": [["Coagulopathy (Tang, et al 2020) and a prothrombotic diathesis with high D-dimer and fibrinogen levels 3", [["Coagulopathy", "DISEASE", 0, 12], ["prothrombotic diathesis", "DISEASE", 38, 61], ["D-dimer", "GENE_OR_GENE_PRODUCT", 72, 79], ["fibrinogen", "GENE_OR_GENE_PRODUCT", 84, 94], ["D-dimer", "PROTEIN", 72, 79], ["fibrinogen", "PROTEIN", 84, 94], ["Coagulopathy", "PROBLEM", 0, 12], ["a prothrombotic diathesis", "PROBLEM", 36, 61], ["high D-dimer", "PROBLEM", 67, 79], ["fibrinogen levels", "TEST", 84, 101], ["prothrombotic", "OBSERVATION_MODIFIER", 38, 51], ["diathesis", "OBSERVATION", 52, 61], ["high D-dimer", "OBSERVATION_MODIFIER", 67, 79]]]], "ebe1933a339b9ae019453bbf059664ceeb0d96ad": [["Infectious bronchitis virus (IBV) is a prototype of theCoronaviridae family (Collisson et al., 1992; Siddell et al., 1983) .", [["Infectious bronchitis virus", "DISEASE", 0, 27], ["Infectious bronchitis virus", "ORGANISM", 0, 27], ["IBV", "ORGANISM", 29, 32], ["Infectious bronchitis virus", "SPECIES", 0, 27], ["Infectious bronchitis virus", "SPECIES", 0, 27], ["IBV", "SPECIES", 29, 32], ["Infectious bronchitis virus", "PROBLEM", 0, 27]]], ["Infection with IBV causes a highly contagious, respiratory disease in chickens with high mortality in young chicks (Alexander et al., 1978; Crinion and Hofstad, 1972; Hofstad, 1984) .", [["respiratory", "ANATOMY", 47, 58], ["IBV", "DISEASE", 15, 18], ["respiratory disease", "DISEASE", 47, 66], ["IBV", "ORGANISM", 15, 18], ["chickens", "ORGANISM", 70, 78], ["chickens", "SPECIES", 70, 78], ["chicks", "SPECIES", 108, 114], ["IBV", "SPECIES", 15, 18], ["chickens", "SPECIES", 70, 78], ["Infection", "PROBLEM", 0, 9], ["IBV", "PROBLEM", 15, 18], ["respiratory disease", "PROBLEM", 47, 66], ["IBV", "OBSERVATION", 15, 18], ["highly", "OBSERVATION_MODIFIER", 28, 34], ["contagious", "OBSERVATION_MODIFIER", 35, 45], ["respiratory disease", "OBSERVATION", 47, 66], ["high mortality", "OBSERVATION_MODIFIER", 84, 98]]], ["In addition to the upper and lower respiratory tract, IBV affects the genital and urinary systems and has been isolated from many tissues, including the lung, trachea, cecal tonsils, kidneys, Harderian (paraocular) glands, and spleen (Alexander et al., 1978; Crinion and Hofstad, 1972; Hofstad, 1984) .", [["lower respiratory tract", "ANATOMY", 29, 52], ["genital", "ANATOMY", 70, 77], ["urinary systems", "ANATOMY", 82, 97], ["tissues", "ANATOMY", 130, 137], ["lung", "ANATOMY", 153, 157], ["trachea", "ANATOMY", 159, 166], ["cecal tonsils", "ANATOMY", 168, 181], ["kidneys", "ANATOMY", 183, 190], ["Harderian", "ANATOMY", 192, 201], ["paraocular) glands", "ANATOMY", 203, 221], ["spleen", "ANATOMY", 227, 233], ["upper", "ORGANISM_SUBDIVISION", 19, 24], ["lower", "ORGANISM_SUBDIVISION", 29, 34], ["respiratory tract", "ORGANISM_SUBDIVISION", 35, 52], ["IBV", "ORGANISM", 54, 57], ["genital", "ORGANISM_SUBDIVISION", 70, 77], ["urinary", "ORGANISM_SUBDIVISION", 82, 89], ["tissues", "TISSUE", 130, 137], ["lung", "ORGAN", 153, 157], ["trachea", "MULTI-TISSUE_STRUCTURE", 159, 166], ["cecal tonsils", "MULTI-TISSUE_STRUCTURE", 168, 181], ["kidneys", "ORGAN", 183, 190], ["Harderian", "ORGAN", 192, 201], ["glands", "ORGAN", 215, 221], ["spleen", "ORGAN", 227, 233], ["IBV", "SPECIES", 54, 57], ["the upper and lower respiratory tract", "PROBLEM", 15, 52], ["IBV affects the genital and urinary systems", "PROBLEM", 54, 97], ["the lung, trachea, cecal tonsils, kidneys, Harderian (paraocular) glands", "PROBLEM", 149, 221], ["upper", "ANATOMY_MODIFIER", 19, 24], ["lower", "ANATOMY_MODIFIER", 29, 34], ["respiratory tract", "ANATOMY", 35, 52], ["IBV", "OBSERVATION", 54, 57], ["genital", "ANATOMY", 70, 77], ["urinary systems", "ANATOMY", 82, 97], ["many tissues", "OBSERVATION", 125, 137], ["lung", "ANATOMY", 153, 157], ["trachea", "ANATOMY", 159, 166], ["cecal tonsils", "ANATOMY", 168, 181], ["kidneys", "ANATOMY", 183, 190], ["Harderian", "ANATOMY", 192, 201], ["glands", "ANATOMY", 215, 221], ["spleen", "ANATOMY", 227, 233]]], ["In laying flocks, IBV infection can cause complete cessation of egg production or production of thin-shelled, rough, and misshapen eggs, and in broilers, infection can result in decreases in feed consumption.Infectious bronchitis virus (IBV) is a prototype of theCytotoxic T lymphocytes (CTL) specific for IBV, associated with the control of acute infection in chicks, have been shown in vitro to be MHC restricted and mediated primarily by cells with the CD8 phenotype Collisson, 1997, 1998) .", [["egg", "ANATOMY", 64, 67], ["eggs", "ANATOMY", 131, 135], ["theCytotoxic T lymphocytes", "ANATOMY", 260, 286], ["CTL", "ANATOMY", 288, 291], ["cells", "ANATOMY", 441, 446], ["IBV infection", "DISEASE", 18, 31], ["infection", "DISEASE", 154, 163], ["Infectious bronchitis virus", "DISEASE", 208, 235], ["infection", "DISEASE", 348, 357], ["IBV", "ORGANISM", 18, 21], ["egg", "ORGANISM_SUBSTANCE", 64, 67], ["broilers", "ORGANISM_SUBDIVISION", 144, 152], ["Infectious bronchitis virus", "ORGANISM", 208, 235], ["IBV", "ORGANISM", 237, 240], ["theCytotoxic T lymphocytes", "CELL", 260, 286], ["CTL", "CELL", 288, 291], ["IBV", "ORGANISM", 306, 309], ["chicks", "ORGANISM", 361, 367], ["cells", "CELL", 441, 446], ["CD8", "GENE_OR_GENE_PRODUCT", 456, 459], ["theCytotoxic T lymphocytes", "CELL_TYPE", 260, 286], ["CTL", "CELL_TYPE", 288, 291], ["MHC", "PROTEIN", 400, 403], ["CD8", "PROTEIN", 456, 459], ["broilers", "SPECIES", 144, 152], ["Infectious bronchitis virus", "SPECIES", 208, 235], ["chicks", "SPECIES", 361, 367], ["IBV", "SPECIES", 18, 21], ["Infectious bronchitis virus", "SPECIES", 208, 235], ["IBV", "SPECIES", 237, 240], ["IBV", "SPECIES", 306, 309], ["IBV infection", "PROBLEM", 18, 31], ["egg production", "PROBLEM", 64, 78], ["production of thin-shelled", "PROBLEM", 82, 108], ["infection", "PROBLEM", 154, 163], ["Infectious bronchitis virus", "PROBLEM", 208, 235], ["theCytotoxic T lymphocytes", "PROBLEM", 260, 286], ["IBV", "PROBLEM", 306, 309], ["acute infection in chicks", "PROBLEM", 342, 367], ["infection", "OBSERVATION", 22, 31], ["infection", "OBSERVATION", 154, 163], ["decreases", "OBSERVATION_MODIFIER", 178, 187], ["acute", "OBSERVATION_MODIFIER", 342, 347], ["infection", "OBSERVATION", 348, 357]]], ["Initial elimination of virus following infection has been associated with this CTL response .", [["infection", "DISEASE", 39, 48], ["CTL", "CANCER", 79, 82], ["virus", "PROBLEM", 23, 28], ["infection", "PROBLEM", 39, 48], ["virus", "OBSERVATION", 23, 28], ["infection", "OBSERVATION", 39, 48]]], ["Furthermore, the nucleocapsid polypeptide, known to induce CTL activity, could protect chicks from IBV challenge, when expressed in vivo by a eukaryotic expression plasmid .", [["plasmid", "ANATOMY", 164, 171], ["CTL", "GENE_OR_GENE_PRODUCT", 59, 62], ["chicks", "ORGANISM", 87, 93], ["IBV", "ORGANISM", 99, 102], ["nucleocapsid polypeptide", "PROTEIN", 17, 41], ["eukaryotic expression plasmid", "DNA", 142, 171], ["chicks", "SPECIES", 87, 93], ["IBV", "SPECIES", 99, 102], ["the nucleocapsid polypeptide", "TREATMENT", 13, 41], ["IBV challenge", "TREATMENT", 99, 112], ["a eukaryotic expression plasmid", "TREATMENT", 140, 171], ["CTL activity", "OBSERVATION", 59, 71]]], ["Protection occurred in the absence of neutralizing antibody, which is induced later during a viral infection by the spike, not the nucleocapsid, protein (Ignjatovic and Galli, 1994) .Infectious bronchitis virus (IBV) is a prototype of theAdoptive transfer of immune lymphocytes has been used to evaluate their role in protecting mice from severe viral infections (Offit and Dudzik, 1990; Cannon et al., 1987; Klavinskis et al., 1989) .", [["immune lymphocytes", "ANATOMY", 259, 277], ["infection", "DISEASE", 99, 108], ["Infectious bronchitis virus", "DISEASE", 183, 210], ["viral infections", "DISEASE", 346, 362], ["Infectious bronchitis virus", "ORGANISM", 183, 210], ["IBV", "ORGANISM", 212, 215], ["immune lymphocytes", "CELL", 259, 277], ["mice", "ORGANISM", 329, 333], ["neutralizing antibody", "PROTEIN", 38, 59], ["nucleocapsid, protein", "PROTEIN", 131, 152], ["immune lymphocytes", "CELL_TYPE", 259, 277], ["Infectious bronchitis virus", "SPECIES", 183, 210], ["mice", "SPECIES", 329, 333], ["Infectious bronchitis virus", "SPECIES", 183, 210], ["IBV", "SPECIES", 212, 215], ["mice", "SPECIES", 329, 333], ["Protection", "TREATMENT", 0, 10], ["neutralizing antibody", "PROBLEM", 38, 59], ["a viral infection", "PROBLEM", 91, 108], ["Infectious bronchitis virus", "PROBLEM", 183, 210], ["immune lymphocytes", "PROBLEM", 259, 277], ["severe viral infections", "PROBLEM", 339, 362], ["neutralizing antibody", "OBSERVATION", 38, 59], ["viral", "OBSERVATION_MODIFIER", 93, 98], ["infection", "OBSERVATION", 99, 108], ["Galli", "ANATOMY", 169, 174], ["immune lymphocytes", "OBSERVATION", 259, 277], ["severe", "OBSERVATION_MODIFIER", 339, 345], ["viral", "OBSERVATION_MODIFIER", 346, 351], ["infections", "OBSERVATION", 352, 362]]], ["For example, suckling mice were protected from murine rotavirus-induced gastroenteritis after adoptive transfer of splenic lymphocytes from immunized animals.", [["splenic lymphocytes", "ANATOMY", 115, 134], ["gastroenteritis", "DISEASE", 72, 87], ["suckling mice", "ORGANISM", 13, 26], ["murine", "ORGANISM", 47, 53], ["rotavirus", "ORGANISM", 54, 63], ["splenic lymphocytes", "CELL", 115, 134], ["splenic lymphocytes", "CELL_TYPE", 115, 134], ["mice", "SPECIES", 22, 26], ["murine", "SPECIES", 47, 53], ["mice", "SPECIES", 22, 26], ["rotavirus", "SPECIES", 54, 63], ["murine rotavirus", "PROBLEM", 47, 63], ["gastroenteritis", "PROBLEM", 72, 87], ["splenic lymphocytes", "PROBLEM", 115, 134], ["immunized animals", "PROBLEM", 140, 157], ["gastroenteritis", "OBSERVATION", 72, 87], ["splenic", "ANATOMY", 115, 122], ["lymphocytes", "OBSERVATION", 123, 134]]], ["Protection against disease occurred in the absence of rotavirus-specific neutralizing antibodies in the sera of suckling mice (Offit and Dudzik, 1990) .", [["sera", "ANATOMY", 104, 108], ["rotavirus", "ORGANISM", 54, 63], ["sera", "ORGANISM_SUBSTANCE", 104, 108], ["suckling mice", "ORGANISM", 112, 125], ["rotavirus-specific neutralizing antibodies", "PROTEIN", 54, 96], ["mice", "SPECIES", 121, 125], ["rotavirus", "SPECIES", 54, 63], ["mice", "SPECIES", 121, 125], ["Protection", "TREATMENT", 0, 10], ["disease", "PROBLEM", 19, 26], ["rotavirus", "PROBLEM", 54, 63]]], ["In a study with respiratory syncytial virus (RSV), primed RSV-specific immune T cells collected between days 5 and 8 of infection cleared the lungs of nude and irradiated mice of RSV within 10 days of transfer (Cannon et al., 1987) .", [["immune T cells", "ANATOMY", 71, 85], ["lungs", "ANATOMY", 142, 147], ["respiratory syncytial virus", "DISEASE", 16, 43], ["infection", "DISEASE", 120, 129], ["RSV", "DISEASE", 179, 182], ["respiratory syncytial virus", "ORGANISM", 16, 43], ["RSV", "ORGANISM", 45, 48], ["RSV", "ORGANISM", 58, 61], ["immune T cells", "CELL", 71, 85], ["lungs", "ORGAN", 142, 147], ["nude", "ORGANISM", 151, 155], ["mice", "ORGANISM", 171, 175], ["RSV", "ORGANISM", 179, 182], ["immune T cells", "CELL_TYPE", 71, 85], ["respiratory syncytial virus", "SPECIES", 16, 43], ["mice", "SPECIES", 171, 175], ["respiratory syncytial virus", "SPECIES", 16, 43], ["RSV", "SPECIES", 45, 48], ["RSV", "SPECIES", 58, 61], ["mice", "SPECIES", 171, 175], ["RSV", "SPECIES", 179, 182], ["a study", "TEST", 3, 10], ["respiratory syncytial virus", "PROBLEM", 16, 43], ["primed RSV", "TEST", 51, 61], ["infection", "PROBLEM", 120, 129], ["RSV", "PROBLEM", 179, 182], ["respiratory syncytial", "ANATOMY", 16, 37], ["infection", "OBSERVATION", 120, 129], ["lungs", "ANATOMY", 142, 147]]], ["When adoptively transferred at the time of infection, MHC Class I restricted CTL protected mice from lymphocytic choriomeningitis virus infection (Klavinskis et al., 1989) .Infectious bronchitis virus (IBV) is a prototype of theThe chicken is an especially appealing model for doing adoptive transfer studies.", [["infection", "DISEASE", 43, 52], ["lymphocytic choriomeningitis virus infection", "DISEASE", 101, 145], ["Infectious bronchitis virus", "DISEASE", 173, 200], ["MHC Class I", "GENE_OR_GENE_PRODUCT", 54, 65], ["CTL", "GENE_OR_GENE_PRODUCT", 77, 80], ["mice", "ORGANISM", 91, 95], ["lymphocytic choriomeningitis virus", "ORGANISM", 101, 135], ["Infectious bronchitis virus", "ORGANISM", 173, 200], ["IBV", "ORGANISM", 202, 205], ["chicken", "ORGANISM", 232, 239], ["MHC Class I", "PROTEIN", 54, 65], ["CTL", "CELL_TYPE", 77, 80], ["mice", "SPECIES", 91, 95], ["lymphocytic choriomeningitis virus", "SPECIES", 101, 135], ["Infectious bronchitis virus", "SPECIES", 173, 200], ["chicken", "SPECIES", 232, 239], ["mice", "SPECIES", 91, 95], ["lymphocytic choriomeningitis virus", "SPECIES", 101, 135], ["Infectious bronchitis virus", "SPECIES", 173, 200], ["IBV", "SPECIES", 202, 205], ["chicken", "SPECIES", 232, 239], ["infection", "PROBLEM", 43, 52], ["lymphocytic choriomeningitis virus infection", "PROBLEM", 101, 145], ["Infectious bronchitis virus", "PROBLEM", 173, 200], ["infection", "OBSERVATION", 43, 52], ["lymphocytic choriomeningitis", "OBSERVATION", 101, 129]]], ["In addition to the ease of synchronizing hatching and maintaining these animals, a number of stocks are available with well-defined MHC haplotypes Briles, 1982, 1987) and recombinants within the MHC chromosomal region (Miller et al., 1988; Aeed et al., 1993; Golemboski et al., 1995) .", [["MHC", "PROTEIN", 132, 135], ["MHC chromosomal region", "DNA", 195, 217], ["synchronizing hatching", "TREATMENT", 27, 49]]], ["In this article, the role of T lymphocytes with CTL activity in protecting chicks against acute IBV infection was confirmed through the adoptive transfer of immune cells to naive syngeneic chicks prior to challenge.", [["T lymphocytes", "ANATOMY", 29, 42], ["immune cells", "ANATOMY", 157, 169], ["IBV infection", "DISEASE", 96, 109], ["T lymphocytes", "CELL", 29, 42], ["CTL", "CELL", 48, 51], ["chicks", "ORGANISM", 75, 81], ["IBV", "ORGANISM", 96, 99], ["immune cells", "CELL", 157, 169], ["syngeneic chicks", "ORGANISM", 179, 195], ["T lymphocytes", "CELL_TYPE", 29, 42], ["immune cells", "CELL_TYPE", 157, 169], ["chicks", "SPECIES", 75, 81], ["IBV", "SPECIES", 96, 99], ["CTL activity", "TREATMENT", 48, 60], ["acute IBV infection", "PROBLEM", 90, 109], ["immune cells", "TREATMENT", 157, 169], ["naive syngeneic chicks", "TREATMENT", 173, 195], ["acute", "OBSERVATION_MODIFIER", 90, 95], ["IBV", "OBSERVATION_MODIFIER", 96, 99], ["infection", "OBSERVATION", 100, 109]]], ["The present study also investigated the in vivo role of subtypes of T lymphocytes in protecting chicks from IBV infection.", [["T lymphocytes", "ANATOMY", 68, 81], ["IBV infection", "DISEASE", 108, 121], ["T lymphocytes", "CELL", 68, 81], ["chicks", "ORGANISM", 96, 102], ["IBV", "ORGANISM", 108, 111], ["T lymphocytes", "CELL_TYPE", 68, 81], ["chicks", "SPECIES", 96, 102], ["IBV", "SPECIES", 108, 111], ["The present study", "TEST", 0, 17], ["T lymphocytes", "PROBLEM", 68, 81], ["IBV infection", "PROBLEM", 108, 121], ["T lymphocytes", "OBSERVATION", 68, 81], ["IBV", "OBSERVATION_MODIFIER", 108, 111], ["infection", "OBSERVATION", 112, 121]]], ["The transfer of \u2423\u2424 T lymphocytes bearing CD8 antigens protected chicks from acute IBV infection.Adoptive transfer of immune T lymphocytes protected chicks against IBV infection.Previous studies indicated that maximum CTL activity could be observed in lymphocytes prepared from spleens of chicks, 10 days postinfection (p.i.) with the Gray strain of IBV.", [["\u2423\u2424 T lymphocytes", "ANATOMY", 16, 32], ["immune T lymphocytes", "ANATOMY", 117, 137], ["lymphocytes", "ANATOMY", 251, 262], ["spleens", "ANATOMY", 277, 284], ["IBV infection", "DISEASE", 82, 95], ["IBV infection", "DISEASE", 163, 176], ["\u2423\u2424 T lymphocytes", "CELL", 16, 32], ["CD8 antigens", "GENE_OR_GENE_PRODUCT", 41, 53], ["chicks", "ORGANISM", 64, 70], ["IBV", "ORGANISM", 82, 85], ["immune T lymphocytes", "CELL", 117, 137], ["chicks", "ORGANISM", 148, 154], ["IBV", "ORGANISM", 163, 166], ["CTL", "GENE_OR_GENE_PRODUCT", 217, 220], ["lymphocytes", "CELL", 251, 262], ["spleens", "ORGAN", 277, 284], ["chicks", "ORGANISM", 288, 294], ["IBV", "ORGANISM", 349, 352], ["\u2423\u2424 T lymphocytes", "CELL_TYPE", 16, 32], ["CD8 antigens", "PROTEIN", 41, 53], ["immune T lymphocytes", "CELL_TYPE", 117, 137], ["lymphocytes", "CELL_TYPE", 251, 262], ["chicks", "SPECIES", 64, 70], ["chicks", "SPECIES", 148, 154], ["chicks", "SPECIES", 288, 294], ["IBV", "SPECIES", 82, 85], ["IBV", "SPECIES", 163, 166], ["IBV", "SPECIES", 349, 352], ["\u2423\u2424 T lymphocytes bearing CD8 antigens", "TREATMENT", 16, 53], ["acute IBV infection", "PROBLEM", 76, 95], ["immune T lymphocytes", "TREATMENT", 117, 137], ["IBV infection", "PROBLEM", 163, 176], ["Previous studies", "TEST", 177, 193], ["maximum CTL activity", "PROBLEM", 209, 229], ["lymphocytes", "PROBLEM", 251, 262], ["IBV", "PROBLEM", 349, 352], ["acute", "OBSERVATION_MODIFIER", 76, 81], ["IBV", "OBSERVATION_MODIFIER", 82, 85], ["infection", "OBSERVATION", 86, 95], ["infection", "OBSERVATION", 167, 176], ["maximum", "OBSERVATION_MODIFIER", 209, 216], ["CTL activity", "OBSERVATION", 217, 229], ["spleens", "ANATOMY", 277, 284], ["IBV", "OBSERVATION", 349, 352]]], ["The elimination of virus during acute infection was found to be closely correlated with CTL activity, and to a lesser extent with the presence of IgM antibody, but not with the presence of IgG antibody.", [["acute infection", "DISEASE", 32, 47], ["IgM antibody", "GENE_OR_GENE_PRODUCT", 146, 158], ["IgG antibody", "GENE_OR_GENE_PRODUCT", 189, 201], ["IgM antibody", "PROTEIN", 146, 158], ["IgG antibody", "PROTEIN", 189, 201], ["virus", "PROBLEM", 19, 24], ["acute infection", "PROBLEM", 32, 47], ["IgM antibody", "PROBLEM", 146, 158], ["IgG antibody", "PROBLEM", 189, 201], ["virus", "OBSERVATION", 19, 24], ["acute", "OBSERVATION_MODIFIER", 32, 37], ["infection", "OBSERVATION", 38, 47], ["lesser extent", "OBSERVATION_MODIFIER", 111, 124], ["IgM antibody", "OBSERVATION", 146, 158]]], ["The correlation of CTL with elimination of virus in vivo was further investigated through transfer of 4 \u03eb 10 6 immune (group 1) or nonimmune (group 2) lymphocytes to naive 5-day-old B 8 /B 8 chicks, 1 day prior to infection with IBV.", [["nonimmune (group 2) lymphocytes", "ANATOMY", 131, 162], ["infection", "DISEASE", 214, 223], ["CTL", "GENE_OR_GENE_PRODUCT", 19, 22], ["lymphocytes", "CELL", 151, 162], ["B 8 /B 8 chicks", "ORGANISM", 182, 197], ["IBV", "ORGANISM", 229, 232], ["CTL", "CELL_TYPE", 19, 22], ["nonimmune (group 2) lymphocytes", "CELL_TYPE", 131, 162], ["IBV", "SPECIES", 229, 232], ["CTL", "PROBLEM", 19, 22], ["virus", "PROBLEM", 43, 48], ["nonimmune", "PROBLEM", 131, 140], ["lymphocytes", "TEST", 151, 162], ["infection", "PROBLEM", 214, 223], ["IBV", "PROBLEM", 229, 232], ["infection", "OBSERVATION", 214, 223]]], ["A third group with age-matched birds received PBS in the absence of lymphocytes.", [["lymphocytes", "ANATOMY", 68, 79], ["birds", "ORGANISM", 31, 36], ["lymphocytes", "CELL", 68, 79], ["lymphocytes", "CELL_TYPE", 68, 79], ["PBS", "TREATMENT", 46, 49], ["lymphocytes", "PROBLEM", 68, 79], ["lymphocytes", "ANATOMY", 68, 79]]], ["After challenge with the Gray strain, the effects of lymphocyte transfer on associated respiratory illness were examined for 5 days.", [["lymphocyte", "ANATOMY", 53, 63], ["respiratory", "ANATOMY", 87, 98], ["respiratory illness", "DISEASE", 87, 106], ["lymphocyte", "CELL", 53, 63], ["the Gray strain", "PROBLEM", 21, 36], ["lymphocyte transfer", "TREATMENT", 53, 72], ["associated respiratory illness", "PROBLEM", 76, 106]]], ["The transfer of immune cells delayed the onset of clinical illness, reduced the number of chicks infected, and reduced the clinical illness observed (Table 1) .", [["immune cells", "ANATOMY", 16, 28], ["immune cells", "CELL", 16, 28], ["immune cells", "CELL_TYPE", 16, 28], ["immune cells", "PROBLEM", 16, 28], ["clinical illness", "PROBLEM", 50, 66], ["chicks infected", "PROBLEM", 90, 105]]], ["On day 3, only two of six chicks displayed any signs of respiratory illness and they experienced only mild signs of occasional sneezing.", [["respiratory", "ANATOMY", 56, 67], ["respiratory illness", "DISEASE", 56, 75], ["sneezing", "DISEASE", 127, 135], ["chicks", "ORGANISM", 26, 32], ["respiratory illness", "PROBLEM", 56, 75], ["occasional sneezing", "PROBLEM", 116, 135], ["respiratory illness", "OBSERVATION", 56, 75], ["mild", "OBSERVATION_MODIFIER", 102, 106], ["occasional", "OBSERVATION_MODIFIER", 116, 126], ["sneezing", "OBSERVATION", 127, 135]]], ["In contrast, five of five chicks receiving normal lymphocytes or four of five inoculated with only buffer showed mild clinical signs of respiratory illness by day 2.", [["lymphocytes", "ANATOMY", 50, 61], ["respiratory", "ANATOMY", 136, 147], ["respiratory illness", "DISEASE", 136, 155], ["chicks", "ORGANISM", 26, 32], ["lymphocytes", "CELL", 50, 61], ["normal lymphocytes", "CELL_TYPE", 43, 61], ["chicks", "SPECIES", 26, 32], ["respiratory illness", "PROBLEM", 136, 155], ["normal lymphocytes", "OBSERVATION", 43, 61], ["mild", "OBSERVATION_MODIFIER", 113, 117], ["respiratory illness", "OBSERVATION", 136, 155]]], ["On days 3, 4, and 5, all chicks inoculated with only buffer or with nonimmune lymphocytes were sneezing, in addition to experiencing more severe signs of tracheal and lung congestion as indicated by observed rales.Adoptive transfer of immune T lymphocytes protected chicks against IBV infection.The effects of immune lymphocytes on viral replication were determined in lungs collected at 5 days p.i.", [["lymphocytes", "ANATOMY", 78, 89], ["tracheal", "ANATOMY", 154, 162], ["lung", "ANATOMY", 167, 171], ["immune T lymphocytes", "ANATOMY", 235, 255], ["immune lymphocytes", "ANATOMY", 310, 328], ["lungs", "ANATOMY", 369, 374], ["tracheal and lung congestion", "DISEASE", 154, 182], ["IBV infection", "DISEASE", 281, 294], ["chicks", "ORGANISM", 25, 31], ["lymphocytes", "CELL", 78, 89], ["tracheal", "MULTI-TISSUE_STRUCTURE", 154, 162], ["lung", "ORGAN", 167, 171], ["immune T lymphocytes", "CELL", 235, 255], ["chicks", "ORGANISM", 266, 272], ["IBV", "ORGANISM", 281, 284], ["immune lymphocytes", "CELL", 310, 328], ["lungs", "ORGAN", 369, 374], ["nonimmune lymphocytes", "CELL_TYPE", 68, 89], ["immune T lymphocytes", "CELL_TYPE", 235, 255], ["immune lymphocytes", "CELL_TYPE", 310, 328], ["chicks", "SPECIES", 25, 31], ["chicks", "SPECIES", 266, 272], ["IBV", "SPECIES", 281, 284], ["nonimmune lymphocytes", "PROBLEM", 68, 89], ["sneezing", "PROBLEM", 95, 103], ["tracheal and lung congestion", "PROBLEM", 154, 182], ["observed rales", "PROBLEM", 199, 213], ["immune T lymphocytes", "TREATMENT", 235, 255], ["IBV infection", "PROBLEM", 281, 294], ["immune lymphocytes", "PROBLEM", 310, 328], ["viral replication", "TREATMENT", 332, 349], ["severe", "OBSERVATION_MODIFIER", 138, 144], ["tracheal", "ANATOMY", 154, 162], ["lung", "ANATOMY", 167, 171], ["congestion", "OBSERVATION", 172, 182], ["rales", "OBSERVATION", 208, 213], ["infection", "OBSERVATION", 285, 294], ["immune lymphocytes", "OBSERVATION", 310, 328], ["viral replication", "OBSERVATION", 332, 349], ["lungs", "ANATOMY", 369, 374]]], ["No virus was detected in the lungs of chicks given immune lymphocytes, whereas the viral load in lungs from the chicks receiving nonimmune lymphocytes or buffer alone prior to infection was 10 5.06 and 10 5.24 EID 50 , respectively, per 0.5 g of tissue ( Fig. 1) .", [["lungs", "ANATOMY", 29, 34], ["immune lymphocytes", "ANATOMY", 51, 69], ["lungs", "ANATOMY", 97, 102], ["lymphocytes", "ANATOMY", 139, 150], ["tissue", "ANATOMY", 246, 252], ["infection", "DISEASE", 176, 185], ["lungs", "ORGAN", 29, 34], ["chicks", "ORGANISM", 38, 44], ["immune lymphocytes", "CELL", 51, 69], ["lungs", "ORGAN", 97, 102], ["chicks", "ORGANISM", 112, 118], ["lymphocytes", "CELL", 139, 150], ["tissue", "TISSUE", 246, 252], ["immune lymphocytes", "CELL_TYPE", 51, 69], ["nonimmune lymphocytes", "CELL_TYPE", 129, 150], ["chicks", "SPECIES", 38, 44], ["chicks", "SPECIES", 112, 118], ["virus", "PROBLEM", 3, 8], ["immune lymphocytes", "PROBLEM", 51, 69], ["the viral load in lungs", "PROBLEM", 79, 102], ["nonimmune lymphocytes", "PROBLEM", 129, 150], ["infection", "PROBLEM", 176, 185], ["virus", "OBSERVATION", 3, 8], ["lungs", "ANATOMY", 29, 34], ["immune lymphocytes", "OBSERVATION", 51, 69], ["viral load", "OBSERVATION", 83, 93], ["lungs", "ANATOMY", 97, 102], ["nonimmune lymphocytes", "OBSERVATION", 129, 150]]], ["Transfer of immune lymphocytes protected chicks against clinical illness and viral replication in the lungs.", [["immune lymphocytes", "ANATOMY", 12, 30], ["lungs", "ANATOMY", 102, 107], ["immune lymphocytes", "CELL", 12, 30], ["chicks", "ORGANISM", 41, 47], ["lungs", "ORGAN", 102, 107], ["immune lymphocytes", "CELL_TYPE", 12, 30], ["chicks", "SPECIES", 41, 47], ["immune lymphocytes", "TREATMENT", 12, 30], ["clinical illness", "PROBLEM", 56, 72], ["viral replication in the lungs", "PROBLEM", 77, 107], ["viral replication", "OBSERVATION", 77, 94], ["lungs", "ANATOMY", 102, 107]]], ["Because lymphocytes from uninfected chicks had no impact, protection was not the result of providing a more mature population of T lymphocytes.Adoptive transfer of immune T lymphocytes protected chicks against IBV infection.Varying doses of immune lymphocytes were given to B 19 /B 19 chicks 1 day prior to infection with IBV.", [["lymphocytes", "ANATOMY", 8, 19], ["T lymphocytes", "ANATOMY", 129, 142], ["immune T lymphocytes", "ANATOMY", 164, 184], ["immune lymphocytes", "ANATOMY", 241, 259], ["IBV infection", "DISEASE", 210, 223], ["infection", "DISEASE", 307, 316], ["lymphocytes", "CELL", 8, 19], ["chicks", "ORGANISM", 36, 42], ["T lymphocytes", "CELL", 129, 142], ["immune T lymphocytes", "CELL", 164, 184], ["chicks", "ORGANISM", 195, 201], ["IBV", "ORGANISM", 210, 213], ["immune lymphocytes", "CELL", 241, 259], ["B 19 /B", "CELL", 274, 281], ["IBV", "ORGANISM", 322, 325], ["lymphocytes", "CELL_TYPE", 8, 19], ["T lymphocytes", "CELL_TYPE", 129, 142], ["immune T lymphocytes", "CELL_TYPE", 164, 184], ["immune lymphocytes", "CELL_TYPE", 241, 259], ["chicks", "SPECIES", 36, 42], ["chicks", "SPECIES", 195, 201], ["IBV", "SPECIES", 210, 213], ["IBV", "SPECIES", 322, 325], ["lymphocytes", "PROBLEM", 8, 19], ["uninfected chicks", "PROBLEM", 25, 42], ["protection", "TREATMENT", 58, 68], ["immune T lymphocytes", "TREATMENT", 164, 184], ["IBV infection", "PROBLEM", 210, 223], ["immune lymphocytes", "TREATMENT", 241, 259], ["infection", "PROBLEM", 307, 316], ["IBV", "PROBLEM", 322, 325], ["uninfected chicks", "OBSERVATION", 25, 42], ["T lymphocytes", "OBSERVATION", 129, 142], ["infection", "OBSERVATION", 214, 223], ["immune lymphocytes", "OBSERVATION", 241, 259], ["infection", "OBSERVATION", 307, 316]]], ["Protection from transferred immune lymphocytes at 5 days p.i. is shown in Table 2 .", [["immune lymphocytes", "ANATOMY", 28, 46], ["immune lymphocytes", "CELL", 28, 46], ["immune lymphocytes", "CELL_TYPE", 28, 46], ["Protection", "TREATMENT", 0, 10], ["immune lymphocytes", "OBSERVATION", 28, 46]]], ["Protection was negligible or marginal when chicks were given 5 \u03eb 10 4 (data not shown) or 10 5 lymphocytes, respectively.", [["lymphocytes", "ANATOMY", 95, 106], ["chicks", "ORGANISM", 43, 49], ["lymphocytes", "CELL", 95, 106], ["lymphocytes", "CELL_TYPE", 95, 106], ["chicks", "SPECIES", 43, 49], ["Protection", "TREATMENT", 0, 10], ["negligible", "OBSERVATION_MODIFIER", 15, 25], ["marginal", "OBSERVATION_MODIFIER", 29, 37]]], ["Data are representative of three experiments. a Number of B 8 /B 8 chicks with observed respiratory illness, scored as: \u03ea, no illness; \u03e9, sneezing or nasal discharge; \u03e9\u03e9, plus dyspnea or rales; \u03e9\u03e9\u03e9, plus lack of appetite or pale color ataxia.", [["respiratory", "ANATOMY", 88, 99], ["nasal", "ANATOMY", 150, 155], ["respiratory illness", "DISEASE", 88, 107], ["illness", "DISEASE", 126, 133], ["sneezing", "DISEASE", 138, 146], ["dyspnea", "DISEASE", 176, 183], ["rales", "DISEASE", 187, 192], ["ataxia", "DISEASE", 235, 241], ["nasal", "ORGANISM_SUBDIVISION", 150, 155], ["observed respiratory illness", "PROBLEM", 79, 107], ["illness", "PROBLEM", 126, 133], ["\u03e9", "PROBLEM", 135, 136], ["sneezing", "PROBLEM", 138, 146], ["nasal discharge", "PROBLEM", 150, 165], ["\u03e9\u03e9", "PROBLEM", 167, 169], ["dyspnea", "PROBLEM", 176, 183], ["rales", "PROBLEM", 187, 192], ["lack of appetite", "PROBLEM", 204, 220], ["pale color ataxia", "PROBLEM", 224, 241], ["respiratory illness", "OBSERVATION", 88, 107], ["no", "UNCERTAINTY", 123, 125], ["nasal", "ANATOMY", 150, 155], ["rales", "OBSERVATION", 187, 192]]], ["Five or six chicks per group.Adoptive transfer of immune T lymphocytes protected chicks against IBV infection.*Statistically significant (P \u03fd 0.05) by analysis of variance.Adoptive transfer of immune T lymphocytes protected chicks against IBV infection.FIG. 1.", [["immune T lymphocytes", "ANATOMY", 50, 70], ["immune T lymphocytes", "ANATOMY", 193, 213], ["IBV infection", "DISEASE", 96, 109], ["IBV infection", "DISEASE", 239, 252], ["chicks", "ORGANISM", 12, 18], ["immune T lymphocytes", "CELL", 50, 70], ["chicks", "ORGANISM", 81, 87], ["IBV", "ORGANISM", 96, 99], ["immune T lymphocytes", "CELL", 193, 213], ["chicks", "ORGANISM", 224, 230], ["IBV", "ORGANISM", 239, 242], ["immune T lymphocytes", "CELL_TYPE", 50, 70], ["immune T lymphocytes", "CELL_TYPE", 193, 213], ["FIG", "PROTEIN", 253, 256], ["chicks", "SPECIES", 12, 18], ["chicks", "SPECIES", 81, 87], ["chicks", "SPECIES", 224, 230], ["IBV", "SPECIES", 96, 99], ["IBV", "SPECIES", 239, 242], ["immune T lymphocytes", "TREATMENT", 50, 70], ["IBV infection", "PROBLEM", 96, 109], ["immune T lymphocytes", "TREATMENT", 193, 213], ["IBV infection", "PROBLEM", 239, 252], ["infection", "OBSERVATION", 100, 109], ["significant", "OBSERVATION_MODIFIER", 125, 136], ["infection", "OBSERVATION", 243, 252]]], ["Effects of transferred immune cells on viral titers in the lungs of chicks 5 days after infection with IBV.", [["immune cells", "ANATOMY", 23, 35], ["lungs", "ANATOMY", 59, 64], ["infection", "DISEASE", 88, 97], ["immune cells", "CELL", 23, 35], ["lungs", "ORGAN", 59, 64], ["IBV", "ORGANISM", 103, 106], ["transferred immune cells", "CELL_TYPE", 11, 35], ["chicks", "SPECIES", 68, 74], ["IBV", "SPECIES", 103, 106], ["immune cells", "PROBLEM", 23, 35], ["viral titers", "TEST", 39, 51], ["infection", "PROBLEM", 88, 97], ["IBV", "PROBLEM", 103, 106], ["immune cells", "OBSERVATION", 23, 35], ["viral titers", "OBSERVATION", 39, 51], ["lungs", "ANATOMY", 59, 64]]], ["Transferred lymphocytes were collected from the spleens of 38-day-old chicks 10 days p.i. or from uninfected age-matched chicks.", [["lymphocytes", "ANATOMY", 12, 23], ["spleens", "ANATOMY", 48, 55], ["lymphocytes", "CELL", 12, 23], ["spleens", "ORGAN", 48, 55], ["chicks", "ORGANISM", 70, 76], ["chicks", "ORGANISM", 121, 127], ["lymphocytes", "CELL_TYPE", 12, 23], ["chicks", "SPECIES", 70, 76], ["chicks", "SPECIES", 121, 127], ["lymphocytes", "OBSERVATION", 12, 23], ["spleens", "ANATOMY", 48, 55]]], ["T lymphocytes were transferred to naive chicks 1 day before challenge with IBV.", [["T lymphocytes", "ANATOMY", 0, 13], ["T lymphocytes", "CELL", 0, 13], ["chicks", "ORGANISM", 40, 46], ["IBV", "ORGANISM", 75, 78], ["T lymphocytes", "CELL_TYPE", 0, 13], ["chicks", "SPECIES", 40, 46], ["IBV", "SPECIES", 75, 78], ["T lymphocytes", "PROBLEM", 0, 13], ["IBV", "TREATMENT", 75, 78], ["lymphocytes", "ANATOMY", 2, 13]]], ["The mean titer of five animals/group is shown.", [["The mean titer", "TEST", 0, 14]]], ["The standard deviation of the mean for chicks receiving no lymphocytes and that for chicks receiving nonimmune lymphocytes were both 0.17.", [["lymphocytes", "ANATOMY", 59, 70], ["nonimmune lymphocytes", "ANATOMY", 101, 122], ["chicks", "ORGANISM", 39, 45], ["lymphocytes", "CELL", 59, 70], ["chicks", "ORGANISM", 84, 90], ["lymphocytes", "CELL", 111, 122], ["lymphocytes", "CELL_TYPE", 59, 70], ["nonimmune lymphocytes", "CELL_TYPE", 101, 122], ["chicks", "SPECIES", 84, 90], ["lymphocytes", "PROBLEM", 59, 70], ["nonimmune lymphocytes", "PROBLEM", 101, 122], ["deviation", "OBSERVATION", 13, 22]]], ["No virus was detected in the lungs of chicks receiving immune lymphocytes.", [["lungs", "ANATOMY", 29, 34], ["immune lymphocytes", "ANATOMY", 55, 73], ["lungs", "ORGAN", 29, 34], ["chicks", "ORGANISM", 38, 44], ["immune lymphocytes", "CELL", 55, 73], ["immune lymphocytes", "CELL_TYPE", 55, 73], ["chicks", "SPECIES", 38, 44], ["virus", "PROBLEM", 3, 8], ["immune lymphocytes", "PROBLEM", 55, 73], ["virus", "OBSERVATION", 3, 8], ["lungs", "ANATOMY", 29, 34], ["immune lymphocytes", "OBSERVATION", 55, 73]]], ["Significant differences (P \u03fd 0.05) were determined between chicks given 0 or 10 5 and chicks given 10 6 or 10 7 .", [["chicks", "SPECIES", 59, 65], ["Significant differences", "PROBLEM", 0, 23]]], ["The results are representative of two experiments. a B 19 /B 19 chicks; five chicks/group. b Syngeneic lymphocytes.Adoptive transfer of immune T lymphocytes protected chicks against IBV infection.Cytolytic responses following APC stimulation depended on CD8 \u03e9 and \u2423\u2424 T lymphocytes.", [["b Syngeneic lymphocytes", "ANATOMY", 91, 114], ["immune T lymphocytes", "ANATOMY", 136, 156], ["CD8 \u03e9", "ANATOMY", 254, 259], ["\u2423\u2424 T lymphocytes", "ANATOMY", 264, 280], ["IBV infection", "DISEASE", 182, 195], ["APC", "CHEMICAL", 226, 229], ["B 19 /B 19 chicks", "ORGANISM", 53, 70], ["chicks", "ORGANISM", 77, 83], ["b Syngeneic lymphocytes", "CELL", 91, 114], ["immune T lymphocytes", "CELL", 136, 156], ["chicks", "ORGANISM", 167, 173], ["IBV", "ORGANISM", 182, 185], ["APC", "GENE_OR_GENE_PRODUCT", 226, 229], ["CD8", "GENE_OR_GENE_PRODUCT", 254, 257], ["Syngeneic lymphocytes", "CELL_TYPE", 93, 114], ["immune T lymphocytes", "CELL_TYPE", 136, 156], ["APC", "CELL_TYPE", 226, 229], ["CD8 \u03e9 and \u2423\u2424 T lymphocytes", "CELL_TYPE", 254, 280], ["chicks", "SPECIES", 64, 70], ["chicks", "SPECIES", 77, 83], ["chicks", "SPECIES", 167, 173], ["IBV", "SPECIES", 182, 185], ["a B 19 /B", "TEST", 51, 60], ["immune T lymphocytes", "TREATMENT", 136, 156], ["IBV infection", "PROBLEM", 182, 195], ["Cytolytic responses", "TEST", 196, 215], ["APC stimulation", "TEST", 226, 241], ["CD8 \u03e9", "TEST", 254, 259], ["Syngeneic lymphocytes", "OBSERVATION", 93, 114], ["infection", "OBSERVATION", 186, 195], ["lymphocytes", "ANATOMY", 269, 280]]], ["Before the phenotypes of T lymphocytes responsible for in vivo decreases in viral replication were determined, it was necessary to increase the numbers by stimulating immune lymphocytes in the presence of IBV-infected and irradiated APC.", [["T lymphocytes", "ANATOMY", 25, 38], ["immune lymphocytes", "ANATOMY", 167, 185], ["T lymphocytes", "CELL", 25, 38], ["immune lymphocytes", "CELL", 167, 185], ["IBV", "ORGANISM", 205, 208], ["APC", "GENE_OR_GENE_PRODUCT", 233, 236], ["T lymphocytes", "CELL_TYPE", 25, 38], ["immune lymphocytes", "CELL_TYPE", 167, 185], ["APC", "CELL_TYPE", 233, 236], ["IBV", "SPECIES", 205, 208], ["T lymphocytes", "PROBLEM", 25, 38], ["viral replication", "TREATMENT", 76, 93], ["IBV", "PROBLEM", 205, 208], ["irradiated APC", "PROBLEM", 222, 236], ["decreases", "OBSERVATION_MODIFIER", 63, 72], ["viral replication", "OBSERVATION", 76, 93], ["infected", "OBSERVATION", 209, 217], ["irradiated APC", "OBSERVATION", 222, 236]]], ["Because the available cultured chicken kidney (CK) cells used as stimulators originated from B 12 /B 12 Hy-VAC chicks, effector immune T lymphocytes were prepared from B 12 /B 12 chicks.", [["kidney (CK) cells", "ANATOMY", 39, 56], ["immune T lymphocytes", "ANATOMY", 128, 148], ["chicken", "ORGANISM", 31, 38], ["kidney (CK) cells", "CELL", 39, 56], ["B 12 /B 12 Hy-VAC chicks", "ORGANISM", 93, 117], ["effector immune T lymphocytes", "CELL", 119, 148], ["B 12 /B", "CELL", 168, 175], ["cultured chicken kidney (CK) cells", "CELL_LINE", 22, 56], ["effector immune T lymphocytes", "CELL_TYPE", 119, 148], ["chicken", "SPECIES", 31, 38], ["chicks", "SPECIES", 179, 185], ["chicken", "SPECIES", 31, 38], ["the available cultured chicken kidney (CK) cells", "TEST", 8, 56], ["stimulators", "TEST", 65, 76], ["VAC chicks", "TREATMENT", 107, 117], ["effector immune T lymphocytes", "TEST", 119, 148], ["kidney", "ANATOMY", 39, 45], ["VAC", "ANATOMY", 107, 110]]], ["Following stimulation, cells were separated by depletion of CD8-, CD4-, TCR1 (\u2425\u2426)-, or TCR2 (\u2423\u2424)-bearing cells using mouse monoclonal antibody.", [["cells", "ANATOMY", 23, 28], ["TCR2 (\u2423\u2424)-bearing cells", "ANATOMY", 87, 110], ["cells", "CELL", 23, 28], ["CD8", "GENE_OR_GENE_PRODUCT", 60, 63], ["CD4", "GENE_OR_GENE_PRODUCT", 66, 69], ["TCR1", "GENE_OR_GENE_PRODUCT", 72, 76], ["\u2425\u2426", "GENE_OR_GENE_PRODUCT", 78, 80], ["TCR2", "GENE_OR_GENE_PRODUCT", 87, 91], ["\u2423\u2424", "GENE_OR_GENE_PRODUCT", 93, 95], ["cells", "CELL", 105, 110], ["mouse", "ORGANISM", 117, 122], ["CD8", "PROTEIN", 60, 63], ["CD4", "PROTEIN", 66, 69], ["TCR1 (\u2425\u2426)-, or TCR2 (\u2423\u2424)-bearing cells", "CELL_LINE", 72, 110], ["mouse monoclonal antibody", "PROTEIN", 117, 142], ["mouse", "SPECIES", 117, 122], ["mouse", "SPECIES", 117, 122], ["CD8", "TEST", 60, 63], ["CD4", "TEST", 66, 69], ["TCR1", "TEST", 72, 76], ["TCR2", "TEST", 87, 91], ["mouse monoclonal antibody", "TEST", 117, 142], ["bearing cells", "OBSERVATION", 97, 110], ["monoclonal antibody", "OBSERVATION", 123, 142]]], ["The purity of the depleted cells was determined by flow cytometry.", [["cells", "ANATOMY", 27, 32], ["cells", "CELL", 27, 32], ["depleted cells", "CELL_LINE", 18, 32], ["the depleted cells", "PROBLEM", 14, 32], ["flow cytometry", "TEST", 51, 65], ["depleted cells", "OBSERVATION", 18, 32], ["flow cytometry", "OBSERVATION", 51, 65]]], ["The purities of the CD8 \u03e9 enriched and CD4 \u03e9 enriched T lymphocytes were 96 and 95%, respectively.Adoptive transfer of immune T lymphocytes protected chicks against IBV infection.IBV-specific CTL activity of the in vitro stimulated and depleted cell preparations was verified.", [["CD8 \u03e9", "ANATOMY", 20, 25], ["CD4 \u03e9", "ANATOMY", 39, 44], ["T lymphocytes", "ANATOMY", 54, 67], ["immune T lymphocytes", "ANATOMY", 119, 139], ["cell", "ANATOMY", 245, 249], ["IBV infection", "DISEASE", 165, 178], ["CD8", "GENE_OR_GENE_PRODUCT", 20, 23], ["CD4", "GENE_OR_GENE_PRODUCT", 39, 42], ["T lymphocytes", "CELL", 54, 67], ["immune T lymphocytes", "CELL", 119, 139], ["chicks", "ORGANISM", 150, 156], ["IBV", "ORGANISM", 165, 168], ["IBV", "ORGANISM", 179, 182], ["CTL", "CELL", 192, 195], ["cell", "CELL", 245, 249], ["CD8", "PROTEIN", 20, 23], ["CD4 \u03e9 enriched T lymphocytes", "CELL_TYPE", 39, 67], ["immune T lymphocytes", "CELL_TYPE", 119, 139], ["chicks", "SPECIES", 150, 156], ["IBV", "SPECIES", 165, 168], ["IBV", "SPECIES", 179, 182], ["the CD8", "TEST", 16, 23], ["enriched T lymphocytes", "TEST", 45, 67], ["immune T lymphocytes", "TREATMENT", 119, 139], ["IBV infection", "PROBLEM", 165, 178], ["IBV", "TREATMENT", 179, 182], ["depleted cell preparations", "TREATMENT", 236, 262], ["infection", "OBSERVATION", 169, 178], ["depleted cell", "OBSERVATION", 236, 249]]], ["The nondepleted immune lymphocytes or preparations depleted of CD4 \u03e9 cells lysed target IBV-infected CK cells in a dose-dependent manner, whereas the cytolytic activity of effector cells depleted of CD8 \u03e9 T lymphocytes was negligible (Fig. 2a) .", [["immune lymphocytes", "ANATOMY", 16, 34], ["CD4 \u03e9 cells", "ANATOMY", 63, 74], ["CK cells", "ANATOMY", 101, 109], ["effector cells", "ANATOMY", 172, 186], ["CD8 \u03e9 T lymphocytes", "ANATOMY", 199, 218], ["immune lymphocytes", "CELL", 16, 34], ["CD4", "GENE_OR_GENE_PRODUCT", 63, 66], ["IBV", "ORGANISM", 88, 91], ["CK cells", "CELL", 101, 109], ["effector cells", "CELL", 172, 186], ["CD8", "GENE_OR_GENE_PRODUCT", 199, 202], ["nondepleted immune lymphocytes", "CELL_TYPE", 4, 34], ["CD4 \u03e9 cells", "CELL_TYPE", 63, 74], ["CK cells", "CELL_TYPE", 101, 109], ["effector cells", "CELL_TYPE", 172, 186], ["CD8 \u03e9 T lymphocytes", "CELL_TYPE", 199, 218], ["IBV", "SPECIES", 88, 91], ["The nondepleted immune lymphocytes", "TEST", 0, 34], ["CD4 \u03e9 cells", "PROBLEM", 63, 74], ["IBV", "TEST", 88, 91], ["infected CK cells", "PROBLEM", 92, 109], ["effector cells", "PROBLEM", 172, 186], ["CD8 \u03e9 T lymphocytes", "TEST", 199, 218], ["immune lymphocytes", "OBSERVATION", 16, 34], ["infected", "OBSERVATION_MODIFIER", 92, 100], ["CK cells", "OBSERVATION", 101, 109], ["effector cells", "OBSERVATION", 172, 186]]], ["At an effector:target cell ratio of 40:1, about 48% killing was observed with effectors enriched in CD8 \u03e9 lymphocytes.", [["cell", "ANATOMY", 22, 26], ["CD8 \u03e9 lymphocytes", "ANATOMY", 100, 117], ["cell", "CELL", 22, 26], ["CD8", "GENE_OR_GENE_PRODUCT", 100, 103], ["lymphocytes", "CELL", 106, 117], ["CD8 \u03e9 lymphocytes", "CELL_TYPE", 100, 117], ["target cell ratio", "TEST", 15, 32]]], ["Lysis from unfractionated effectors was about 10% less at the same effector:target cell ratio.", [["cell", "ANATOMY", 83, 87], ["cell", "CELL", 83, 87], ["Lysis from unfractionated effectors", "TREATMENT", 0, 35], ["target cell ratio", "TEST", 76, 93]]], ["Uninfected target CK cells were not killed with immune unfractionated lymphocytes.Adoptive transfer of immune T lymphocytes protected chicks against IBV infection.CTL responses were observed with immune lymphocytes depleted of \u2425\u2426 T cells and with undepleted immune effector cells.", [["CK cells", "ANATOMY", 18, 26], ["lymphocytes", "ANATOMY", 70, 81], ["immune T lymphocytes", "ANATOMY", 103, 123], ["immune lymphocytes", "ANATOMY", 196, 214], ["\u2425\u2426 T cells", "ANATOMY", 227, 237], ["immune effector cells", "ANATOMY", 258, 279], ["IBV infection", "DISEASE", 149, 162], ["CK cells", "CELL", 18, 26], ["lymphocytes", "CELL", 70, 81], ["immune T lymphocytes", "CELL", 103, 123], ["chicks", "ORGANISM", 134, 140], ["IBV", "ORGANISM", 149, 152], ["immune lymphocytes", "CELL", 196, 214], ["\u2425\u2426 T cells", "CELL", 227, 237], ["undepleted immune effector cells", "CELL", 247, 279], ["CK cells", "CELL_TYPE", 18, 26], ["immune unfractionated lymphocytes", "CELL_TYPE", 48, 81], ["immune T lymphocytes", "CELL_TYPE", 103, 123], ["immune lymphocytes", "CELL_TYPE", 196, 214], ["\u2425\u2426 T cells", "CELL_TYPE", 227, 237], ["undepleted immune effector cells", "CELL_TYPE", 247, 279], ["chicks", "SPECIES", 134, 140], ["IBV", "SPECIES", 149, 152], ["Uninfected target CK cells", "TEST", 0, 26], ["immune unfractionated lymphocytes", "PROBLEM", 48, 81], ["immune T lymphocytes", "TREATMENT", 103, 123], ["IBV infection", "PROBLEM", 149, 162], ["CTL responses", "TEST", 163, 176], ["immune lymphocytes", "PROBLEM", 196, 214], ["\u2425\u2426 T cells", "PROBLEM", 227, 237], ["undepleted immune effector cells", "PROBLEM", 247, 279], ["CK cells", "OBSERVATION", 18, 26], ["unfractionated lymphocytes", "OBSERVATION", 55, 81], ["infection", "OBSERVATION", 153, 162], ["immune effector cells", "OBSERVATION", 258, 279]]], ["Responses were dose-responsive with approximately 50% lysis at an effector:target ratio of 50:1.", [["target ratio", "TEST", 75, 87]]], ["In contrast, lysis of IBV-infected target cells by effector cells depleted of \u2423\u2424 T cells or lysis of uninfected target cells by effector cells from unfractionated lymphocyte preparations was undetectable (Fig. 2b) .Adoptive transfer of immune T lymphocytes protected chicks against IBV infection.Adoptive transfer of immune CD8 T cells protected chicks from acute IBV infection.", [["cells", "ANATOMY", 42, 47], ["effector cells", "ANATOMY", 51, 65], ["\u2423\u2424 T cells", "ANATOMY", 78, 88], ["cells", "ANATOMY", 119, 124], ["effector cells", "ANATOMY", 128, 142], ["lymphocyte", "ANATOMY", 163, 173], ["immune T lymphocytes", "ANATOMY", 236, 256], ["immune CD8 T cells", "ANATOMY", 317, 335], ["IBV infection", "DISEASE", 282, 295], ["IBV infection", "DISEASE", 364, 377], ["IBV", "ORGANISM", 22, 25], ["cells", "CELL", 42, 47], ["effector cells", "CELL", 51, 65], ["\u2423\u2424 T cells", "CELL", 78, 88], ["cells", "CELL", 119, 124], ["effector cells", "CELL", 128, 142], ["lymphocyte", "CELL", 163, 173], ["immune T lymphocytes", "CELL", 236, 256], ["chicks", "ORGANISM", 267, 273], ["IBV", "ORGANISM", 282, 285], ["immune CD8 T cells", "CELL", 317, 335], ["chicks", "ORGANISM", 346, 352], ["IBV", "ORGANISM", 364, 367], ["IBV-infected target cells", "CELL_TYPE", 22, 47], ["effector cells", "CELL_TYPE", 51, 65], ["\u2423\u2424 T cells", "CELL_TYPE", 78, 88], ["uninfected target cells", "CELL_TYPE", 101, 124], ["effector cells", "CELL_TYPE", 128, 142], ["immune T lymphocytes", "CELL_TYPE", 236, 256], ["immune CD8 T cells", "CELL_TYPE", 317, 335], ["chicks", "SPECIES", 267, 273], ["chicks", "SPECIES", 346, 352], ["IBV", "SPECIES", 22, 25], ["IBV", "SPECIES", 282, 285], ["IBV", "SPECIES", 364, 367], ["lysis", "TREATMENT", 13, 18], ["IBV", "PROBLEM", 22, 25], ["infected target cells", "PROBLEM", 26, 47], ["effector cells", "PROBLEM", 51, 65], ["\u2423\u2424 T cells", "PROBLEM", 78, 88], ["lysis of uninfected target cells", "PROBLEM", 92, 124], ["effector cells", "PROBLEM", 128, 142], ["unfractionated lymphocyte preparations", "TEST", 148, 186], ["immune T lymphocytes", "TREATMENT", 236, 256], ["IBV infection", "PROBLEM", 282, 295], ["immune CD8 T cells", "TREATMENT", 317, 335], ["acute IBV infection", "PROBLEM", 358, 377], ["infected", "OBSERVATION_MODIFIER", 26, 34], ["target cells", "OBSERVATION", 35, 47], ["uninfected target cells", "OBSERVATION", 101, 124], ["effector cells", "OBSERVATION", 128, 142], ["unfractionated lymphocyte", "OBSERVATION", 148, 173], ["infection", "OBSERVATION", 286, 295], ["acute", "OBSERVATION_MODIFIER", 358, 363], ["IBV", "OBSERVATION_MODIFIER", 364, 367], ["infection", "OBSERVATION", 368, 377]]], ["Stimulated T cells depleted of CD8 \u03e9 or CD4 \u03e9 cells (1 \u03eb 10 7 ) were transferred to naive chicks before challenge with IBV.", [["T cells", "ANATOMY", 11, 18], ["CD8 \u03e9", "ANATOMY", 31, 36], ["CD4 \u03e9 cells", "ANATOMY", 40, 51], ["T cells", "CELL", 11, 18], ["CD8", "GENE_OR_GENE_PRODUCT", 31, 34], ["CD4", "GENE_OR_GENE_PRODUCT", 40, 43], ["chicks", "ORGANISM", 90, 96], ["IBV", "ORGANISM", 119, 122], ["T cells", "CELL_TYPE", 11, 18], ["CD8 \u03e9 or CD4 \u03e9 cells", "CELL_TYPE", 31, 51], ["IBV", "SPECIES", 119, 122], ["CD8 \u03e9", "TEST", 31, 36], ["CD4 \u03e9 cells", "PROBLEM", 40, 51], ["IBV", "TREATMENT", 119, 122]]], ["Clinical signs of respiratory illness were minimal in chicks receiving the immune cells depleted of CD4 \u03e9 T lymphocytes.", [["respiratory", "ANATOMY", 18, 29], ["immune cells", "ANATOMY", 75, 87], ["CD4 \u03e9 T lymphocytes", "ANATOMY", 100, 119], ["respiratory illness", "DISEASE", 18, 37], ["immune cells", "CELL", 75, 87], ["CD4", "GENE_OR_GENE_PRODUCT", 100, 103], ["immune cells", "CELL_TYPE", 75, 87], ["CD4 \u03e9 T lymphocytes", "CELL_TYPE", 100, 119], ["respiratory illness", "PROBLEM", 18, 37], ["the immune cells", "TEST", 71, 87], ["respiratory illness", "OBSERVATION", 18, 37], ["minimal", "OBSERVATION_MODIFIER", 43, 50]]], ["In contrast, chicks receiving immune lymphocytes depleted of CD8 \u03e9 cells presented clinical signs that were similar to those of control infected chicks that did not receive immune lymphocytes (Table 3) .", [["immune lymphocytes", "ANATOMY", 30, 48], ["CD8 \u03e9 cells", "ANATOMY", 61, 72], ["immune lymphocytes", "ANATOMY", 173, 191], ["chicks", "ORGANISM", 13, 19], ["immune lymphocytes", "CELL", 30, 48], ["CD8", "GENE_OR_GENE_PRODUCT", 61, 64], ["cells", "CELL", 67, 72], ["chicks", "ORGANISM", 145, 151], ["immune lymphocytes", "CELL", 173, 191], ["immune lymphocytes", "CELL_TYPE", 30, 48], ["CD8 \u03e9 cells", "CELL_TYPE", 61, 72], ["immune lymphocytes", "CELL_TYPE", 173, 191], ["chicks", "SPECIES", 13, 19], ["immune lymphocytes", "PROBLEM", 30, 48], ["CD8 \u03e9 cells", "PROBLEM", 61, 72], ["clinical signs", "TEST", 83, 97], ["control infected chicks", "PROBLEM", 128, 151]]], ["Virus was not detected in either lungs or kidneys of chicks receiving immune T lymphocytes depleted of CD4 \u03e9 cells.", [["lungs", "ANATOMY", 33, 38], ["kidneys", "ANATOMY", 42, 49], ["immune T lymphocytes", "ANATOMY", 70, 90], ["CD4 \u03e9 cells", "ANATOMY", 103, 114], ["Virus", "ORGANISM", 0, 5], ["lungs", "ORGAN", 33, 38], ["kidneys", "ORGAN", 42, 49], ["chicks", "ORGANISM", 53, 59], ["immune T lymphocytes", "CELL", 70, 90], ["CD4", "GENE_OR_GENE_PRODUCT", 103, 106], ["cells", "CELL", 109, 114], ["immune T lymphocytes", "CELL_TYPE", 70, 90], ["CD4 \u03e9 cells", "CELL_TYPE", 103, 114], ["Virus", "PROBLEM", 0, 5], ["chicks", "PROBLEM", 53, 59], ["immune T lymphocytes", "TEST", 70, 90], ["CD4 \u03e9 cells", "PROBLEM", 103, 114], ["not detected", "UNCERTAINTY", 10, 22], ["lungs", "ANATOMY", 33, 38], ["kidneys", "ANATOMY", 42, 49], ["lymphocytes", "OBSERVATION", 79, 90], ["CD4 \u03e9 cells", "OBSERVATION", 103, 114]]], ["In contrast, viral titers in both lungs and kidneys of chicks receiving immune T cells depleted of CD8 \u03e9 T cells were not significantly reduced (P \u03fe 0.05) compared to infected control chicks (Fig. 3) .", [["lungs", "ANATOMY", 34, 39], ["kidneys", "ANATOMY", 44, 51], ["immune T cells", "ANATOMY", 72, 86], ["CD8 \u03e9 T cells", "ANATOMY", 99, 112], ["lungs", "ORGAN", 34, 39], ["kidneys", "ORGAN", 44, 51], ["immune T cells", "CELL", 72, 86], ["CD8", "GENE_OR_GENE_PRODUCT", 99, 102], ["immune T cells", "CELL_TYPE", 72, 86], ["CD8 \u03e9 T cells", "CELL_TYPE", 99, 112], ["chicks", "SPECIES", 55, 61], ["viral titers", "TEST", 13, 25], ["immune T cells", "TEST", 72, 86], ["CD8 \u03e9 T cells", "TEST", 99, 112], ["viral titers", "OBSERVATION", 13, 25], ["both", "ANATOMY_MODIFIER", 29, 33], ["lungs", "ANATOMY", 34, 39], ["kidneys", "ANATOMY", 44, 51], ["infected", "OBSERVATION", 167, 175]]], ["CD8 \u03e9 T lymphocytes are critical in protecting chicks from IBV infection.Adoptive transfer of immune T lymphocytes protected chicks against IBV infection.Adoptive transfer of immune \u2423\u2424 T cells, not \u2425\u2426 T cells, protected chicks from acute IBV infection.", [["CD8 \u03e9 T lymphocytes", "ANATOMY", 0, 19], ["immune T lymphocytes", "ANATOMY", 94, 114], ["immune \u2423\u2424 T cells", "ANATOMY", 175, 192], ["\u2425\u2426 T cells", "ANATOMY", 198, 208], ["IBV infection", "DISEASE", 59, 72], ["IBV infection", "DISEASE", 140, 153], ["IBV infection", "DISEASE", 238, 251], ["CD8", "GENE_OR_GENE_PRODUCT", 0, 3], ["chicks", "ORGANISM", 47, 53], ["IBV", "ORGANISM", 59, 62], ["immune T lymphocytes", "CELL", 94, 114], ["chicks", "ORGANISM", 125, 131], ["IBV", "ORGANISM", 140, 143], ["immune \u2423\u2424 T cells", "CELL", 175, 192], ["\u2425\u2426 T cells", "CELL", 198, 208], ["chicks", "ORGANISM", 220, 226], ["IBV", "ORGANISM", 238, 241], ["CD8", "PROTEIN", 0, 3], ["T lymphocytes", "CELL_TYPE", 6, 19], ["immune T lymphocytes", "CELL_TYPE", 94, 114], ["immune \u2423\u2424 T cells", "CELL_TYPE", 175, 192], ["\u2425\u2426 T cells", "CELL_TYPE", 198, 208], ["chicks", "SPECIES", 47, 53], ["chicks", "SPECIES", 125, 131], ["chicks", "SPECIES", 220, 226], ["IBV", "SPECIES", 59, 62], ["IBV", "SPECIES", 140, 143], ["IBV", "SPECIES", 238, 241], ["CD8", "TEST", 0, 3], ["T lymphocytes", "PROBLEM", 6, 19], ["IBV infection", "PROBLEM", 59, 72], ["immune T lymphocytes", "TREATMENT", 94, 114], ["IBV infection", "PROBLEM", 140, 153], ["immune \u2423\u2424 T cells", "TREATMENT", 175, 192], ["\u2425\u2426 T cells", "PROBLEM", 198, 208], ["protected chicks", "PROBLEM", 210, 226], ["acute IBV infection", "PROBLEM", 232, 251], ["T lymphocytes", "OBSERVATION", 6, 19], ["protecting chicks", "OBSERVATION_MODIFIER", 36, 53], ["IBV", "OBSERVATION_MODIFIER", 59, 62], ["infection", "OBSERVATION", 63, 72], ["infection", "OBSERVATION", 144, 153], ["acute", "OBSERVATION_MODIFIER", 232, 237], ["IBV", "OBSERVATION_MODIFIER", 238, 241], ["infection", "OBSERVATION", 242, 251]]], ["Similarly, 10 7 immune lymphocytes depleted of cells bearing TCR1 (\u2425\u2426) or TCR2 (\u2423\u2424) antigens were inoculated in chicks (five per group) prior to challenge with virus.", [["immune lymphocytes", "ANATOMY", 16, 34], ["cells", "ANATOMY", 47, 52], ["immune lymphocytes", "CELL", 16, 34], ["cells", "CELL", 47, 52], ["TCR1", "GENE_OR_GENE_PRODUCT", 61, 65], ["\u2425\u2426", "GENE_OR_GENE_PRODUCT", 67, 69], ["TCR2 (\u2423\u2424) antigens", "GENE_OR_GENE_PRODUCT", 74, 92], ["chicks", "ORGANISM", 112, 118], ["immune lymphocytes", "CELL_TYPE", 16, 34], ["TCR1", "PROTEIN", 61, 65], ["\u2425\u2426", "PROTEIN", 67, 69], ["TCR2 (\u2423\u2424) antigens", "PROTEIN", 74, 92], ["chicks", "SPECIES", 112, 118], ["immune lymphocytes", "TEST", 16, 34], ["cells bearing TCR1", "TEST", 47, 65], ["TCR2 (\u2423\u2424) antigens", "PROBLEM", 74, 92], ["virus", "PROBLEM", 160, 165]]], ["Following challenge, chicks receiving immune lymphocytes depleted of \u2425\u2426 T cells suffered only minor respiratory illness, whereasAdoptive transfer of immune T lymphocytes protected chicks against IBV infection.Note.", [["immune lymphocytes", "ANATOMY", 38, 56], ["\u2425\u2426 T cells", "ANATOMY", 69, 79], ["respiratory", "ANATOMY", 100, 111], ["immune T lymphocytes", "ANATOMY", 149, 169], ["respiratory illness", "DISEASE", 100, 119], ["IBV infection", "DISEASE", 195, 208], ["chicks", "ORGANISM", 21, 27], ["immune lymphocytes", "CELL", 38, 56], ["\u2425\u2426 T cells", "CELL", 69, 79], ["immune T lymphocytes", "CELL", 149, 169], ["chicks", "ORGANISM", 180, 186], ["IBV", "ORGANISM", 195, 198], ["immune lymphocytes", "CELL_TYPE", 38, 56], ["\u2425\u2426 T cells", "CELL_TYPE", 69, 79], ["immune T lymphocytes", "CELL_TYPE", 149, 169], ["chicks", "SPECIES", 21, 27], ["chicks", "SPECIES", 180, 186], ["IBV", "SPECIES", 195, 198], ["immune lymphocytes", "TREATMENT", 38, 56], ["\u2425\u2426 T cells", "PROBLEM", 69, 79], ["minor respiratory illness", "PROBLEM", 94, 119], ["immune T lymphocytes", "PROBLEM", 149, 169], ["IBV infection", "PROBLEM", 195, 208], ["minor", "OBSERVATION_MODIFIER", 94, 99], ["respiratory illness", "OBSERVATION", 100, 119], ["infection", "OBSERVATION", 199, 208]]], ["The results are representative of three experiments. a Number of B 12 /B 12 chicks with observed respiratory illness, scored as: \u03ea, no illness; \u03e9, sneezing or nasal discharge; \u03e9\u03e9, plus dyspnea or rales; \u03e9\u03e9\u03e9, plus lack of appetite or pale color ataxia.", [["respiratory", "ANATOMY", 97, 108], ["nasal", "ANATOMY", 159, 164], ["respiratory illness", "DISEASE", 97, 116], ["illness", "DISEASE", 135, 142], ["sneezing", "DISEASE", 147, 155], ["dyspnea", "DISEASE", 185, 192], ["rales", "DISEASE", 196, 201], ["ataxia", "DISEASE", 244, 250], ["chicks", "ORGANISM", 76, 82], ["nasal", "ORGANISM_SUBDIVISION", 159, 164], ["observed respiratory illness", "PROBLEM", 88, 116], ["illness", "PROBLEM", 135, 142], ["\u03e9", "PROBLEM", 144, 145], ["sneezing", "PROBLEM", 147, 155], ["nasal discharge", "PROBLEM", 159, 174], ["\u03e9\u03e9", "PROBLEM", 176, 178], ["dyspnea", "PROBLEM", 185, 192], ["rales", "PROBLEM", 196, 201], ["lack of appetite", "PROBLEM", 213, 229], ["pale color ataxia", "PROBLEM", 233, 250], ["respiratory illness", "OBSERVATION", 97, 116], ["no", "UNCERTAINTY", 132, 134], ["nasal", "ANATOMY", 159, 164], ["rales", "OBSERVATION", 196, 201]]], ["Five or six chicks per group. b Statistically significant difference (P \u03fd 0.05) from chicks not receiving transferred lymphocytes and from those receiving CD8-depleted lymphocytes.Adoptive transfer of immune T lymphocytes protected chicks against IBV infection.c Statistically significant difference (P \u03fd 0.05) from chicks not receiving transferred lymphocytes and from those receiving \u2423\u2424-depleted lymphocytes. chicks receiving immune cells depleted of \u2423\u2424 T cells displayed clinical signs that were similar to those in IBV-infected chicks not given immune lymphocytes (Table 3).", [["lymphocytes", "ANATOMY", 118, 129], ["lymphocytes", "ANATOMY", 168, 179], ["immune T lymphocytes", "ANATOMY", 201, 221], ["lymphocytes", "ANATOMY", 349, 360], ["lymphocytes", "ANATOMY", 398, 409], ["immune cells", "ANATOMY", 428, 440], ["\u2423\u2424 T cells", "ANATOMY", 453, 463], ["immune lymphocytes", "ANATOMY", 549, 567], ["IBV-infected", "DISEASE", 519, 531], ["chicks", "ORGANISM", 12, 18], ["chicks", "ORGANISM", 85, 91], ["lymphocytes", "CELL", 118, 129], ["CD8", "GENE_OR_GENE_PRODUCT", 155, 158], ["lymphocytes", "CELL", 168, 179], ["immune T lymphocytes", "CELL", 201, 221], ["chicks", "ORGANISM", 232, 238], ["IBV", "ORGANISM", 247, 250], ["lymphocytes", "CELL", 349, 360], ["lymphocytes", "CELL", 398, 409], ["chicks", "ORGANISM", 411, 417], ["immune cells", "CELL", 428, 440], ["\u2423\u2424 T cells", "CELL", 453, 463], ["IBV", "ORGANISM", 519, 522], ["chicks", "ORGANISM", 532, 538], ["immune lymphocytes", "CELL", 549, 567], ["lymphocytes", "CELL_TYPE", 118, 129], ["CD8-depleted lymphocytes", "CELL_TYPE", 155, 179], ["immune T lymphocytes", "CELL_TYPE", 201, 221], ["lymphocytes", "CELL_TYPE", 349, 360], ["\u2423\u2424-depleted lymphocytes", "CELL_LINE", 386, 409], ["immune cells", "CELL_TYPE", 428, 440], ["\u2423\u2424 T cells", "CELL_TYPE", 453, 463], ["immune lymphocytes", "CELL_TYPE", 549, 567], ["chicks", "SPECIES", 12, 18], ["chicks", "SPECIES", 232, 238], ["chicks", "SPECIES", 411, 417], ["IBV", "SPECIES", 247, 250], ["IBV", "SPECIES", 519, 522], ["lymphocytes", "TEST", 118, 129], ["CD8", "TEST", 155, 158], ["depleted lymphocytes", "PROBLEM", 159, 179], ["immune T lymphocytes", "TREATMENT", 201, 221], ["IBV infection.c", "PROBLEM", 247, 262], ["lymphocytes", "TEST", 349, 360], ["depleted lymphocytes", "PROBLEM", 389, 409], ["immune cells", "TREATMENT", 428, 440], ["\u2423\u2424 T cells", "PROBLEM", 453, 463], ["clinical signs", "PROBLEM", 474, 488], ["IBV", "PROBLEM", 519, 522], ["infected chicks", "PROBLEM", 523, 538], ["immune lymphocytes", "PROBLEM", 549, 567], ["Statistically", "OBSERVATION_MODIFIER", 32, 45], ["significant", "OBSERVATION_MODIFIER", 46, 57], ["difference", "OBSERVATION_MODIFIER", 58, 68], ["depleted lymphocytes", "OBSERVATION", 159, 179], ["significant", "OBSERVATION_MODIFIER", 277, 288], ["difference", "OBSERVATION_MODIFIER", 289, 299], ["depleted lymphocytes", "OBSERVATION", 389, 409], ["infected", "OBSERVATION", 523, 531]]], ["The viral titers in lungs and kidneys of chicks receiving immune cells depleted of either \u2423\u2424 or \u2425\u2426 T lymphocytes were also examined.", [["lungs", "ANATOMY", 20, 25], ["kidneys", "ANATOMY", 30, 37], ["immune cells", "ANATOMY", 58, 70], ["\u2425\u2426 T lymphocytes", "ANATOMY", 96, 112], ["lungs", "ORGAN", 20, 25], ["kidneys", "ORGAN", 30, 37], ["chicks", "ORGANISM", 41, 47], ["immune cells", "CELL", 58, 70], ["\u2423\u2424", "CELL", 90, 92], ["\u2425\u2426 T lymphocytes", "CELL", 96, 112], ["immune cells", "CELL_TYPE", 58, 70], ["\u2423\u2424 or \u2425\u2426 T lymphocytes", "CELL_TYPE", 90, 112], ["chicks", "SPECIES", 41, 47], ["The viral titers", "TEST", 0, 16], ["immune cells", "PROBLEM", 58, 70], ["\u2425\u2426 T lymphocytes", "PROBLEM", 96, 112], ["viral titers", "OBSERVATION", 4, 16], ["lungs", "ANATOMY", 20, 25], ["kidneys", "ANATOMY", 30, 37], ["immune cells depleted", "OBSERVATION", 58, 79]]], ["Viral replication in both lungs and kidneys from infected chicks having received immune cells depleted of \u2423\u2424 T cells was not significantly different (P \u03fe 0.05) from that in control infected chicks receiving only buffer, while no virus was detected in chicks given lymphocytes depleted of \u2425\u2426 cells (Fig. 4) .", [["lungs", "ANATOMY", 26, 31], ["kidneys", "ANATOMY", 36, 43], ["immune cells", "ANATOMY", 81, 93], ["\u2423\u2424 T cells", "ANATOMY", 106, 116], ["lymphocytes", "ANATOMY", 264, 275], ["\u2425\u2426 cells", "ANATOMY", 288, 296], ["Viral", "ORGANISM", 0, 5], ["lungs", "ORGAN", 26, 31], ["kidneys", "ORGAN", 36, 43], ["chicks", "ORGANISM", 58, 64], ["immune cells", "CELL", 81, 93], ["\u2423\u2424 T cells", "CELL", 106, 116], ["chicks", "ORGANISM", 190, 196], ["chicks", "ORGANISM", 251, 257], ["lymphocytes", "CELL", 264, 275], ["\u2425\u2426 cells", "CELL", 288, 296], ["immune cells", "CELL_TYPE", 81, 93], ["\u2423\u2424 T cells", "CELL_TYPE", 106, 116], ["lymphocytes", "CELL_TYPE", 264, 275], ["\u2425\u2426 cells", "CELL_TYPE", 288, 296], ["chicks", "SPECIES", 251, 257], ["Viral replication in both lungs and kidneys", "PROBLEM", 0, 43], ["infected chicks", "PROBLEM", 49, 64], ["immune cells", "TREATMENT", 81, 93], ["\u2423\u2424 T cells", "PROBLEM", 106, 116], ["buffer", "TREATMENT", 212, 218], ["virus", "PROBLEM", 229, 234], ["lymphocytes", "PROBLEM", 264, 275], ["\u2425\u2426 cells", "PROBLEM", 288, 296], ["replication", "OBSERVATION", 6, 17], ["both", "ANATOMY_MODIFIER", 21, 25], ["lungs", "ANATOMY", 26, 31], ["kidneys", "ANATOMY", 36, 43], ["infected", "OBSERVATION_MODIFIER", 49, 57], ["infected", "OBSERVATION", 181, 189]]], ["Therefore, \u2423\u2424 T lymphocytes are capable of controlling IBV infection and associated disease.DISCUSSIONThe capacity for transferred syngeneic immune T lymphocytes to protect birds from challenge infection further indicated that T lymphocytes play a critical role in resolving acute IBV infection.", [["T lymphocytes", "ANATOMY", 14, 27], ["immune T lymphocytes", "ANATOMY", 141, 161], ["T lymphocytes", "ANATOMY", 227, 240], ["IBV infection", "DISEASE", 55, 68], ["infection", "DISEASE", 194, 203], ["IBV infection", "DISEASE", 281, 294], ["\u2423\u2424 T lymphocytes", "CELL", 11, 27], ["IBV", "ORGANISM", 55, 58], ["syngeneic immune T lymphocytes", "CELL", 131, 161], ["birds", "ORGANISM", 173, 178], ["T lymphocytes", "CELL", 227, 240], ["IBV", "ORGANISM", 281, 284], ["\u2423\u2424 T lymphocytes", "CELL_TYPE", 11, 27], ["syngeneic immune T lymphocytes", "CELL_TYPE", 131, 161], ["T lymphocytes", "CELL_TYPE", 227, 240], ["IBV", "SPECIES", 55, 58], ["IBV", "SPECIES", 281, 284], ["controlling IBV infection", "PROBLEM", 43, 68], ["associated disease", "PROBLEM", 73, 91], ["The capacity", "PROBLEM", 102, 114], ["transferred syngeneic immune T lymphocytes", "TREATMENT", 119, 161], ["challenge infection", "PROBLEM", 184, 203], ["T lymphocytes", "PROBLEM", 227, 240], ["acute IBV infection", "PROBLEM", 275, 294], ["IBV", "OBSERVATION_MODIFIER", 55, 58], ["infection", "OBSERVATION", 59, 68], ["disease", "OBSERVATION", 84, 91], ["resolving", "OBSERVATION_MODIFIER", 265, 274], ["acute", "OBSERVATION_MODIFIER", 275, 280], ["IBV", "OBSERVATION_MODIFIER", 281, 284], ["infection", "OBSERVATION", 285, 294]]], ["Consistent with observations that the kinetics of MHC restricted CTL response can be associated with decreases in viral load, CD8 \u03e9 lymphocytes were mostly responsible for the observed protection.", [["CD8 \u03e9 lymphocytes", "ANATOMY", 126, 143], ["CD8", "GENE_OR_GENE_PRODUCT", 126, 129], ["MHC", "PROTEIN", 50, 53], ["CD8 \u03e9 lymphocytes", "CELL_TYPE", 126, 143], ["decreases in viral load", "PROBLEM", 101, 124], ["CD8 \u03e9 lymphocytes", "PROBLEM", 126, 143], ["viral load", "OBSERVATION", 114, 124]]], ["In addition, cells that play a critical role in resolving early IBV infection in chicks were TCR2-bearing (\u2423\u2424) lymphocytes.", [["cells", "ANATOMY", 13, 18], ["TCR2-bearing (\u2423\u2424) lymphocytes", "ANATOMY", 93, 122], ["IBV infection", "DISEASE", 64, 77], ["cells", "CELL", 13, 18], ["IBV", "ORGANISM", 64, 67], ["chicks", "ORGANISM", 81, 87], ["TCR2", "GENE_OR_GENE_PRODUCT", 93, 97], ["\u2423\u2424) lymphocytes", "CELL", 107, 122], ["TCR2-bearing (\u2423\u2424) lymphocytes", "CELL_LINE", 93, 122], ["chicks", "SPECIES", 81, 87], ["IBV", "SPECIES", 64, 67], ["early IBV infection", "PROBLEM", 58, 77], ["resolving", "OBSERVATION_MODIFIER", 48, 57], ["early", "OBSERVATION_MODIFIER", 58, 63], ["IBV", "OBSERVATION_MODIFIER", 64, 67], ["infection", "OBSERVATION", 68, 77]]], ["Thus, the transfer of immune cells depleted of CD4 \u03e9 T cells or \u2425\u2426 T cells protected chicks from acute IBV infection.DISCUSSIONAntibody responses do not appear to participate in the initial elimination of viral replication following infection, although their control of chronic infection is probably critical (Ignjatovic and Galli, 1994; .", [["immune cells", "ANATOMY", 22, 34], ["CD4 \u03e9 T cells", "ANATOMY", 47, 60], ["\u2425\u2426 T cells", "ANATOMY", 64, 74], ["IBV infection", "DISEASE", 103, 116], ["infection", "DISEASE", 233, 242], ["chronic infection", "DISEASE", 270, 287], ["immune cells", "CELL", 22, 34], ["CD4", "GENE_OR_GENE_PRODUCT", 47, 50], ["\u2425\u2426 T cells", "CELL", 64, 74], ["chicks", "ORGANISM", 85, 91], ["IBV", "ORGANISM", 103, 106], ["immune cells", "CELL_TYPE", 22, 34], ["CD4 \u03e9 T cells", "CELL_TYPE", 47, 60], ["\u2425\u2426 T cells", "CELL_TYPE", 64, 74], ["chicks", "SPECIES", 85, 91], ["IBV", "SPECIES", 103, 106], ["immune cells", "PROBLEM", 22, 34], ["CD4 \u03e9 T cells", "PROBLEM", 47, 60], ["\u2425\u2426 T cells", "PROBLEM", 64, 74], ["acute IBV infection", "PROBLEM", 97, 116], ["viral replication", "PROBLEM", 205, 222], ["infection", "PROBLEM", 233, 242], ["chronic infection", "PROBLEM", 270, 287], ["acute", "OBSERVATION_MODIFIER", 97, 102], ["IBV infection", "OBSERVATION", 103, 116], ["infection", "OBSERVATION", 233, 242], ["chronic", "OBSERVATION_MODIFIER", 270, 277], ["infection", "OBSERVATION", 278, 287], ["probably", "UNCERTAINTY", 291, 299], ["Galli", "ANATOMY", 325, 330]]], ["Cook et al. (1991) also showed that in ovo bursectomy did not appear to increase the level of mortality or early control of IBV replication in leghorn chickens al-though bursectomized chicks experienced longer lasting infection and illness than intact chicks.", [["infection", "DISEASE", 218, 227], ["illness", "DISEASE", 232, 239], ["IBV", "ORGANISM", 124, 127], ["leghorn chickens", "ORGANISM", 143, 159], ["chicks", "ORGANISM", 184, 190], ["chickens", "SPECIES", 151, 159], ["chicks", "SPECIES", 184, 190], ["chicks", "SPECIES", 252, 258], ["IBV", "SPECIES", 124, 127], ["chickens", "SPECIES", 151, 159], ["ovo bursectomy", "TREATMENT", 39, 53], ["IBV replication", "TREATMENT", 124, 139], ["bursectomized chicks", "PROBLEM", 170, 190], ["illness", "PROBLEM", 232, 239], ["bursectomy", "OBSERVATION", 43, 53], ["infection", "OBSERVATION", 218, 227]]], ["The cellular immune responses were not evaluated.", [["cellular", "ANATOMY", 4, 12], ["cellular", "CELL", 4, 12], ["cellular immune", "OBSERVATION", 4, 19]]], ["However, we have found that bursectomy does not decrease, but may actually increase, the IBV-specific CTL response (Seo and Collisson, unpublished data) .DISCUSSIONIn evaluating the role of T lymphocytes in murine hepatitis virus (MHV) infection in the central nervous system, the adoptive transfer of both a CD8 \u03e9 T cell clone and a CD4 \u03e9 T cell clone was shown to suppress viral growth and viral antigen-positive cells in the brain (Yamaguchi et al., 1988) .", [["T lymphocytes", "ANATOMY", 190, 203], ["central nervous system", "ANATOMY", 253, 275], ["CD8 \u03e9 T cell clone", "ANATOMY", 309, 327], ["CD4 \u03e9 T cell clone", "ANATOMY", 334, 352], ["cells", "ANATOMY", 415, 420], ["brain", "ANATOMY", 428, 433], ["murine hepatitis virus (MHV) infection", "DISEASE", 207, 245], ["T lymphocytes", "CELL", 190, 203], ["murine hepatitis virus (MHV)", "ORGANISM", 207, 235], ["central nervous system", "ANATOMICAL_SYSTEM", 253, 275], ["CD8", "GENE_OR_GENE_PRODUCT", 309, 312], ["CD4", "GENE_OR_GENE_PRODUCT", 334, 337], ["brain", "ORGAN", 428, 433], ["T lymphocytes", "CELL_TYPE", 190, 203], ["CD8 \u03e9 T cell clone", "CELL_LINE", 309, 327], ["CD4 \u03e9 T cell clone", "CELL_LINE", 334, 352], ["viral antigen-positive cells", "CELL_TYPE", 392, 420], ["murine hepatitis virus", "SPECIES", 207, 229], ["IBV", "SPECIES", 89, 92], ["murine hepatitis virus", "SPECIES", 207, 229], ["MHV", "SPECIES", 231, 234], ["bursectomy", "TREATMENT", 28, 38], ["the IBV", "TEST", 85, 92], ["T lymphocytes", "PROBLEM", 190, 203], ["murine hepatitis virus", "PROBLEM", 207, 229], ["MHV) infection in the central nervous system", "PROBLEM", 231, 275], ["a CD8 \u03e9 T cell clone", "TEST", 307, 327], ["a CD4 \u03e9 T cell clone", "TEST", 332, 352], ["viral growth", "TEST", 375, 387], ["viral antigen", "TEST", 392, 405], ["positive cells in the brain", "PROBLEM", 406, 433], ["bursectomy", "OBSERVATION", 28, 38], ["decrease", "OBSERVATION_MODIFIER", 48, 56], ["hepatitis virus", "OBSERVATION", 214, 229], ["infection", "OBSERVATION", 236, 245], ["central", "ANATOMY_MODIFIER", 253, 260], ["nervous system", "ANATOMY", 261, 275], ["cell clone", "OBSERVATION", 317, 327], ["positive cells", "OBSERVATION", 406, 420], ["brain", "ANATOMY", 428, 433]]], ["In addition, the transfer of MHV nucleoprotein-specific CTL protected mice from a subsequent lethal MHV challenge by reducing virus replication within the central nervous system (Stohlman et al., 1995) .", [["central nervous system", "ANATOMY", 155, 177], ["MHV nucleoprotein", "ORGANISM", 29, 46], ["CTL", "GENE_OR_GENE_PRODUCT", 56, 59], ["mice", "ORGANISM", 70, 74], ["MHV", "ORGANISM", 100, 103], ["central nervous system", "ANATOMICAL_SYSTEM", 155, 177], ["MHV nucleoprotein", "PROTEIN", 29, 46], ["CTL", "CELL_TYPE", 56, 59], ["mice", "SPECIES", 70, 74], ["MHV", "SPECIES", 29, 32], ["mice", "SPECIES", 70, 74], ["MHV", "SPECIES", 100, 103], ["MHV nucleoprotein", "TREATMENT", 29, 46], ["a subsequent lethal MHV challenge", "TREATMENT", 80, 113], ["reducing virus replication", "TREATMENT", 117, 143], ["central", "ANATOMY_MODIFIER", 155, 162], ["nervous system", "ANATOMY", 163, 177]]], ["Transfer of these CTL directly into the central nervous system was at least 10-fold more effective than peripheral transfer.", [["central nervous system", "ANATOMY", 40, 62], ["CTL", "GENE_OR_GENE_PRODUCT", 18, 21], ["central nervous system", "ANATOMICAL_SYSTEM", 40, 62], ["CTL", "CELL_TYPE", 18, 21], ["central", "ANATOMY_MODIFIER", 40, 47], ["nervous system", "ANATOMY", 48, 62]]], ["Histological analysis demonstrated that CTL reduced virus replication in ependymal cells, astrocytes, and microglia.", [["ependymal cells", "ANATOMY", 73, 88], ["astrocytes", "ANATOMY", 90, 100], ["microglia", "ANATOMY", 106, 115], ["CTL", "GENE_OR_GENE_PRODUCT", 40, 43], ["ependymal cells", "CELL", 73, 88], ["astrocytes", "CELL", 90, 100], ["microglia", "CELL", 106, 115], ["CTL", "CELL_TYPE", 40, 43], ["ependymal cells", "CELL_TYPE", 73, 88], ["astrocytes", "CELL_TYPE", 90, 100], ["microglia", "CELL_TYPE", 106, 115], ["Histological analysis", "TEST", 0, 21], ["CTL reduced virus replication in ependymal cells", "PROBLEM", 40, 88], ["astrocytes", "PROBLEM", 90, 100], ["microglia", "PROBLEM", 106, 115], ["virus replication", "OBSERVATION", 52, 69], ["ependymal cells", "OBSERVATION", 73, 88], ["astrocytes", "ANATOMY", 90, 100], ["microglia", "ANATOMY", 106, 115]]], ["However, CD4 \u03e9 T lymphocytes do not appear to play a critical role in resolving the viral load after infection with IBV in chicks.", [["CD4 \u03e9 T lymphocytes", "ANATOMY", 9, 28], ["infection", "DISEASE", 101, 110], ["CD4", "GENE_OR_GENE_PRODUCT", 9, 12], ["IBV", "ORGANISM", 116, 119], ["CD4", "PROTEIN", 9, 12], ["T lymphocytes", "CELL_TYPE", 15, 28], ["chicks", "SPECIES", 123, 129], ["IBV", "SPECIES", 116, 119], ["CD4 \u03e9 T lymphocytes", "TEST", 9, 28], ["the viral load", "PROBLEM", 80, 94], ["infection", "PROBLEM", 101, 110], ["IBV", "PROBLEM", 116, 119], ["viral load", "OBSERVATION", 84, 94], ["infection", "OBSERVATION", 101, 110]]], ["Therefore, the impact of various cellular immune responses to distinct coronaviruses differs, depending on the host and virus.DISCUSSIONThe distribution of chicken \u2423\u2424 and \u2425\u2426 T lymphocytes can be differentiated in developing chicks and chick embryos .", [["cellular", "ANATOMY", 33, 41], ["\u2425\u2426 T lymphocytes", "ANATOMY", 171, 187], ["embryos", "ANATOMY", 241, 248], ["cellular", "CELL", 33, 41], ["coronaviruses", "ORGANISM", 71, 84], ["chicken", "ORGANISM", 156, 163], ["\u2423\u2424", "CELL", 164, 166], ["\u2425\u2426 T lymphocytes", "CELL", 171, 187], ["chicks", "ORGANISM", 224, 230], ["chick", "ORGANISM", 235, 240], ["embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 241, 248], ["chicken \u2423\u2424 and \u2425\u2426 T lymphocytes", "CELL_TYPE", 156, 187], ["chicken", "SPECIES", 156, 163], ["chicks", "SPECIES", 224, 230], ["chick", "SPECIES", 235, 240], ["chicken", "SPECIES", 156, 163], ["various cellular immune responses", "TREATMENT", 25, 58], ["distinct coronaviruses", "PROBLEM", 62, 84], ["the host and virus", "PROBLEM", 107, 125], ["chicken \u2423\u2424 and \u2425\u2426 T lymphocytes", "PROBLEM", 156, 187], ["chick embryos", "PROBLEM", 235, 248], ["cellular immune", "OBSERVATION", 33, 48], ["distribution", "OBSERVATION_MODIFIER", 140, 152], ["chick embryos", "OBSERVATION", 235, 248]]], ["The \u2425\u2426 T lymphocytes appear earlier and migrate more quickly from thymic cortex to medulla and to peripheral lymphoid tissues and differ in their composition of CD4-and CD8-bearing cells compared to mammalian \u2425\u2426 T cells (Bucy et al., 1988 George and Cooper, 1990) .", [["\u2425\u2426 T lymphocytes", "ANATOMY", 4, 20], ["thymic cortex", "ANATOMY", 66, 79], ["medulla", "ANATOMY", 83, 90], ["peripheral lymphoid tissues", "ANATOMY", 98, 125], ["CD8-bearing cells", "ANATOMY", 169, 186], ["mammalian \u2425\u2426 T cells", "ANATOMY", 199, 219], ["\u2425\u2426 T lymphocytes", "CELL", 4, 20], ["thymic cortex", "MULTI-TISSUE_STRUCTURE", 66, 79], ["medulla", "ORGAN", 83, 90], ["peripheral lymphoid tissues", "TISSUE", 98, 125], ["CD4", "GENE_OR_GENE_PRODUCT", 161, 164], ["CD8", "GENE_OR_GENE_PRODUCT", 169, 172], ["cells", "CELL", 181, 186], ["mammalian \u2425\u2426 T cells", "CELL", 199, 219], ["\u2425\u2426 T lymphocytes", "CELL_LINE", 4, 20], ["CD4", "PROTEIN", 161, 164], ["CD8-bearing cells", "CELL_TYPE", 169, 186], ["mammalian \u2425\u2426 T cells", "CELL_TYPE", 199, 219], ["The \u2425\u2426 T lymphocytes", "TEST", 0, 20], ["CD4", "TEST", 161, 164], ["lymphocytes", "ANATOMY", 9, 20], ["thymic", "ANATOMY", 66, 72], ["cortex", "ANATOMY_MODIFIER", 73, 79], ["medulla", "ANATOMY", 83, 90], ["peripheral", "ANATOMY_MODIFIER", 98, 108], ["lymphoid tissues", "OBSERVATION", 109, 125]]], ["Greater numbers of T lymphocytes in chickens are \u2425\u2426 cells than in mammals.", [["T lymphocytes", "ANATOMY", 19, 32], ["\u2425\u2426 cells", "ANATOMY", 49, 57], ["T lymphocytes", "CELL", 19, 32], ["chickens", "ORGANISM", 36, 44], ["\u2425\u2426 cells", "CELL", 49, 57], ["T lymphocytes", "CELL_TYPE", 19, 32], ["\u2425\u2426 cells", "CELL_TYPE", 49, 57], ["chickens", "SPECIES", 36, 44], ["chickens", "SPECIES", 36, 44], ["T lymphocytes", "OBSERVATION_MODIFIER", 19, 32], ["\u2425\u2426 cells", "OBSERVATION", 49, 57]]], ["Thirty percent of the splenic T lymphocytes in the FIG.", [["splenic T lymphocytes", "ANATOMY", 22, 43], ["splenic T lymphocytes", "CELL", 22, 43], ["FIG", "GENE_OR_GENE_PRODUCT", 51, 54], ["splenic T lymphocytes", "CELL_TYPE", 22, 43], ["splenic", "ANATOMY", 22, 29], ["T lymphocytes", "OBSERVATION", 30, 43], ["FIG", "OBSERVATION_MODIFIER", 51, 54]]], ["Viral titers of IBV target organs from chicks receiving immune cells depleted of \u2425\u2426 or \u2423\u2424 T cells before challenge with IBV.", [["organs", "ANATOMY", 27, 33], ["immune cells", "ANATOMY", 56, 68], ["\u2423\u2424 T cells", "ANATOMY", 87, 97], ["Viral", "ORGANISM", 0, 5], ["IBV", "ORGANISM", 16, 19], ["organs", "ORGAN", 27, 33], ["chicks", "ORGANISM", 39, 45], ["immune cells", "CELL", 56, 68], ["\u2425\u2426", "CELL", 81, 83], ["\u2423\u2424 T cells", "CELL", 87, 97], ["IBV", "ORGANISM", 120, 123], ["immune cells", "CELL_TYPE", 56, 68], ["\u2425\u2426 or \u2423\u2424 T cells", "CELL_TYPE", 81, 97], ["chicks", "SPECIES", 39, 45], ["IBV", "SPECIES", 16, 19], ["IBV", "SPECIES", 120, 123], ["Viral titers", "TEST", 0, 12], ["IBV target organs", "PROBLEM", 16, 33], ["immune cells", "PROBLEM", 56, 68], ["IBV", "TREATMENT", 120, 123], ["IBV", "OBSERVATION", 16, 19]]], ["Viral replication was determined in kidneys and lungs collected and pooled from each group of five chicks.", [["kidneys", "ANATOMY", 36, 43], ["lungs", "ANATOMY", 48, 53], ["Viral", "ORGANISM", 0, 5], ["kidneys", "ORGAN", 36, 43], ["lungs", "ORGAN", 48, 53], ["chicks", "ORGANISM", 99, 105], ["Viral replication", "TREATMENT", 0, 17], ["replication", "OBSERVATION", 6, 17], ["kidneys", "ANATOMY", 36, 43], ["lungs", "ANATOMY", 48, 53]]], ["The viral load of chicks that did not receive lymphocytes is shown by the black bar, that of chicks that received lymphocytes depleted of \u2423\u2424 \u03e9 lymphocytes is shown by the hatched bar, and that of chicks receiving lymphocytes depleted of \u2425\u2426 \u03e9 cells is shown by the white bar.", [["lymphocytes", "ANATOMY", 46, 57], ["lymphocytes", "ANATOMY", 114, 125], ["\u2423\u2424 \u03e9 lymphocytes", "ANATOMY", 138, 154], ["lymphocytes", "ANATOMY", 213, 224], ["\u2425\u2426 \u03e9 cells", "ANATOMY", 237, 247], ["chicks", "ORGANISM", 18, 24], ["lymphocytes", "CELL", 46, 57], ["chicks", "ORGANISM", 93, 99], ["lymphocytes", "CELL", 114, 125], ["\u2423\u2424 \u03e9 lymphocytes", "CELL", 138, 154], ["chicks", "ORGANISM", 196, 202], ["lymphocytes", "CELL", 213, 224], ["\u2425\u2426 \u03e9 cells", "CELL", 237, 247], ["lymphocytes", "CELL_TYPE", 46, 57], ["lymphocytes", "CELL_TYPE", 114, 125], ["\u2423\u2424 \u03e9 lymphocytes", "CELL_TYPE", 138, 154], ["lymphocytes", "CELL_TYPE", 213, 224], ["\u2425\u2426 \u03e9 cells", "CELL_LINE", 237, 247], ["chicks", "SPECIES", 18, 24], ["chicks", "SPECIES", 93, 99], ["The viral load", "TEST", 0, 14], ["lymphocytes", "PROBLEM", 46, 57], ["lymphocytes depleted", "PROBLEM", 114, 134], ["\u2423\u2424 \u03e9 lymphocytes", "PROBLEM", 138, 154], ["lymphocytes", "TEST", 213, 224], ["\u2425\u2426 \u03e9 cells", "PROBLEM", 237, 247], ["viral load", "OBSERVATION", 4, 14]]], ["Standard deviations of viral titers were less than 0.5.", [["viral titers", "TEST", 23, 35], ["deviations", "OBSERVATION", 9, 19], ["viral titers", "OBSERVATION", 23, 35]]], ["The results are representative of three experiments.FIG.3.", [["FIG", "PROTEIN", 52, 55]]], ["Viral titers in lungs and kidneys of chicks receiving the immune T cells depleted of CD4 \u03e9 or CD8 \u03e9 T cells before challenge with IBV.", [["lungs", "ANATOMY", 16, 21], ["kidneys", "ANATOMY", 26, 33], ["immune T cells", "ANATOMY", 58, 72], ["CD4 \u03e9", "ANATOMY", 85, 90], ["CD8 \u03e9 T cells", "ANATOMY", 94, 107], ["Viral", "ORGANISM", 0, 5], ["lungs", "ORGAN", 16, 21], ["kidneys", "ORGAN", 26, 33], ["chicks", "ORGANISM", 37, 43], ["immune T cells", "CELL", 58, 72], ["CD4", "GENE_OR_GENE_PRODUCT", 85, 88], ["CD8", "GENE_OR_GENE_PRODUCT", 94, 97], ["IBV", "ORGANISM", 130, 133], ["immune T cells", "CELL_TYPE", 58, 72], ["CD4 \u03e9 or CD8 \u03e9 T cells", "CELL_TYPE", 85, 107], ["chicks", "SPECIES", 37, 43], ["IBV", "SPECIES", 130, 133], ["Viral titers in lungs and kidneys of chicks", "PROBLEM", 0, 43], ["the immune T cells", "TREATMENT", 54, 72], ["CD4", "TEST", 85, 88], ["IBV", "TREATMENT", 130, 133], ["titers", "OBSERVATION", 6, 12], ["lungs", "ANATOMY", 16, 21], ["kidneys", "ANATOMY", 26, 33]]], ["Viral replication was determined in kidneys and lungs collected and pooled from each group of five chicks.", [["kidneys", "ANATOMY", 36, 43], ["lungs", "ANATOMY", 48, 53], ["Viral", "ORGANISM", 0, 5], ["kidneys", "ORGAN", 36, 43], ["lungs", "ORGAN", 48, 53], ["chicks", "ORGANISM", 99, 105], ["Viral replication", "TREATMENT", 0, 17], ["replication", "OBSERVATION", 6, 17], ["kidneys", "ANATOMY", 36, 43], ["lungs", "ANATOMY", 48, 53]]], ["The viral load of chicks that did not receive lymphocytes is shown by the black bar, that of chicks that received lymphocytes depleted of CD8 \u03e9 lymphocytes is shown by the hatched bar, and that of chicks receiving lymphocytes depleted of CD4 \u03e9 cells is shown by the white bar.", [["lymphocytes", "ANATOMY", 46, 57], ["lymphocytes", "ANATOMY", 114, 125], ["CD8 \u03e9 lymphocytes", "ANATOMY", 138, 155], ["lymphocytes", "ANATOMY", 214, 225], ["CD4 \u03e9 cells", "ANATOMY", 238, 249], ["chicks", "ORGANISM", 18, 24], ["lymphocytes", "CELL", 46, 57], ["chicks", "ORGANISM", 93, 99], ["lymphocytes", "CELL", 114, 125], ["CD8", "GENE_OR_GENE_PRODUCT", 138, 141], ["lymphocytes", "CELL", 144, 155], ["chicks", "ORGANISM", 197, 203], ["lymphocytes", "CELL", 214, 225], ["CD4", "GENE_OR_GENE_PRODUCT", 238, 241], ["cells", "CELL", 244, 249], ["lymphocytes", "CELL_TYPE", 46, 57], ["lymphocytes", "CELL_TYPE", 114, 125], ["CD8 \u03e9 lymphocytes", "CELL_TYPE", 138, 155], ["lymphocytes", "CELL_TYPE", 214, 225], ["CD4 \u03e9 cells", "CELL_TYPE", 238, 249], ["chicks", "SPECIES", 18, 24], ["chicks", "SPECIES", 93, 99], ["The viral load", "TEST", 0, 14], ["lymphocytes", "PROBLEM", 46, 57], ["lymphocytes", "TEST", 114, 125], ["CD8 \u03e9 lymphocytes", "PROBLEM", 138, 155], ["lymphocytes", "PROBLEM", 214, 225], ["CD4 \u03e9 cells", "PROBLEM", 238, 249], ["viral load", "OBSERVATION", 4, 14], ["CD4 \u03e9 cells", "OBSERVATION", 238, 249]]], ["The results are representative of three experiments. chicken have the \u2425\u2426, CD3 phenotypes (Bucy et al., 1988; Sowder et al., 1988) .", [["chicken", "ORGANISM", 53, 60], ["CD3", "GENE_OR_GENE_PRODUCT", 74, 77], ["CD3", "PROTEIN", 74, 77], ["chicken", "SPECIES", 53, 60], ["chicken", "SPECIES", 53, 60]]], ["Avian \u2425\u2426 T cells are found predominantly in sinusoid areas of the spleen and intestinal epithelium, whereas \u2423\u2424 T cells reside primarily in the splenic periarterial sheath (Vainio et al., 1990) .", [["\u2425\u2426 T cells", "ANATOMY", 6, 16], ["sinusoid areas", "ANATOMY", 44, 58], ["spleen", "ANATOMY", 66, 72], ["intestinal epithelium", "ANATOMY", 77, 98], ["\u2423\u2424 T cells", "ANATOMY", 108, 118], ["splenic periarterial sheath", "ANATOMY", 143, 170], ["Avian", "ORGANISM", 0, 5], ["\u2425\u2426 T cells", "CELL", 6, 16], ["sinusoid areas", "MULTI-TISSUE_STRUCTURE", 44, 58], ["spleen", "ORGAN", 66, 72], ["intestinal epithelium", "TISSUE", 77, 98], ["\u2423\u2424 T cells", "CELL", 108, 118], ["splenic periarterial sheath", "MULTI-TISSUE_STRUCTURE", 143, 170], ["Avian \u2425\u2426 T cells", "CELL_TYPE", 0, 16], ["\u2423\u2424 T cells", "CELL_TYPE", 108, 118], ["Avian", "SPECIES", 0, 5], ["Avian \u2425\u2426 T cells", "TEST", 0, 16], ["predominantly", "OBSERVATION_MODIFIER", 27, 40], ["sinusoid", "ANATOMY_MODIFIER", 44, 52], ["areas", "ANATOMY_MODIFIER", 53, 58], ["spleen", "ANATOMY", 66, 72], ["intestinal epithelium", "ANATOMY", 77, 98], ["splenic", "ANATOMY", 143, 150], ["periarterial", "ANATOMY_MODIFIER", 151, 163], ["sheath", "ANATOMY_MODIFIER", 164, 170]]], ["The mammalian \u2425\u2426 lymphocytes, displaying less diversity than \u2423\u2424 T cells, are present in smaller numbers in the peripheral lymphoid tissues, but are relatively abundant in the epithelia of the intestines, skin, and reproductive organs, such as the uterus and vagina (Durum et al., 1998; Guehler et al., 1999; Livak et al., 1999; Salerno and Dieli, 1998; Zorbas and Scollay, 1995) .FIG.The mammalian \u2425\u2426 T cells appear to play a protective role in early infection with intracellular bacteria, such as Listeria monocytogenes (Hasegawa et al., 1992) , Mycobacterium bovis (Inoue et al., 1991) , and Salmonella cholerasuis (Emoto et al., 1992) .", [["\u2425\u2426 lymphocytes", "ANATOMY", 14, 28], ["\u2423\u2424 T cells", "ANATOMY", 61, 71], ["peripheral lymphoid tissues", "ANATOMY", 111, 138], ["epithelia", "ANATOMY", 175, 184], ["intestines", "ANATOMY", 192, 202], ["skin", "ANATOMY", 204, 208], ["reproductive organs", "ANATOMY", 214, 233], ["uterus", "ANATOMY", 247, 253], ["vagina", "ANATOMY", 258, 264], ["\u2425\u2426 T cells", "ANATOMY", 398, 408], ["intracellular", "ANATOMY", 466, 479], ["infection", "DISEASE", 451, 460], ["mammalian \u2425\u2426 lymphocytes", "CELL", 4, 28], ["\u2423\u2424 T cells", "CELL", 61, 71], ["peripheral lymphoid tissues", "TISSUE", 111, 138], ["epithelia", "TISSUE", 175, 184], ["intestines", "ORGAN", 192, 202], ["skin", "ORGAN", 204, 208], ["reproductive", "ORGAN", 214, 226], ["organs", "ORGAN", 227, 233], ["uterus", "ORGAN", 247, 253], ["vagina", "ORGAN", 258, 264], ["mammalian \u2425\u2426 T cells", "CELL", 388, 408], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 466, 479], ["Listeria monocytogenes", "ORGANISM", 498, 520], ["Mycobacterium bovis", "ORGANISM", 547, 566], ["Salmonella cholerasuis", "ORGANISM", 594, 616], ["mammalian \u2425\u2426 lymphocytes", "CELL_TYPE", 4, 28], ["\u2423\u2424 T cells", "CELL_TYPE", 61, 71], ["FIG", "PROTEIN", 380, 383], ["mammalian \u2425\u2426 T cells", "CELL_TYPE", 388, 408], ["Listeria monocytogenes", "SPECIES", 498, 520], ["Mycobacterium bovis", "SPECIES", 547, 566], ["Salmonella cholerasuis", "SPECIES", 594, 616], ["Listeria monocytogenes", "SPECIES", 498, 520], ["Mycobacterium bovis", "SPECIES", 547, 566], ["Salmonella cholerasuis", "SPECIES", 594, 616], ["The mammalian \u2425\u2426 lymphocytes", "TEST", 0, 28], ["The mammalian \u2425\u2426 T cells", "TREATMENT", 384, 408], ["early infection", "PROBLEM", 445, 460], ["intracellular bacteria", "PROBLEM", 466, 488], ["Listeria monocytogenes", "PROBLEM", 498, 520], ["Mycobacterium bovis", "PROBLEM", 547, 566], ["mammalian", "OBSERVATION_MODIFIER", 4, 13], ["\u2425\u2426 lymphocytes", "OBSERVATION", 14, 28], ["less", "OBSERVATION_MODIFIER", 41, 45], ["diversity", "OBSERVATION_MODIFIER", 46, 55], ["smaller", "OBSERVATION_MODIFIER", 88, 95], ["numbers", "OBSERVATION_MODIFIER", 96, 103], ["peripheral", "ANATOMY_MODIFIER", 111, 121], ["lymphoid tissues", "ANATOMY", 122, 138], ["relatively", "OBSERVATION_MODIFIER", 148, 158], ["abundant", "OBSERVATION_MODIFIER", 159, 167], ["epithelia", "ANATOMY_MODIFIER", 175, 184], ["intestines", "ANATOMY", 192, 202], ["skin", "ANATOMY", 204, 208], ["uterus", "ANATOMY", 247, 253], ["vagina", "ANATOMY", 258, 264], ["early", "OBSERVATION_MODIFIER", 445, 450], ["infection", "OBSERVATION", 451, 460], ["intracellular bacteria", "OBSERVATION", 466, 488], ["Mycobacterium bovis", "OBSERVATION", 547, 566]]], ["Murine \u2425\u2426 T lymphocytes were prevalent within inflammatory lesions late, rather than early, in the course of pneumonia caused by influenza virus A (Carding et al., 1990) or Sendai virus (Hou et al., 1992) and might, therefore, be important for the resolution of the inflammatory process.", [["\u2425\u2426 T lymphocytes", "ANATOMY", 7, 23], ["inflammatory lesions", "ANATOMY", 46, 66], ["pneumonia", "DISEASE", 109, 118], ["influenza virus A", "DISEASE", 129, 146], ["Sendai virus", "DISEASE", 173, 185], ["Murine", "ORGANISM", 0, 6], ["\u2425\u2426 T lymphocytes", "CELL", 7, 23], ["inflammatory lesions", "PATHOLOGICAL_FORMATION", 46, 66], ["influenza virus A", "ORGANISM", 129, 146], ["Sendai virus", "ORGANISM", 173, 185], ["Murine \u2425\u2426 T lymphocytes", "CELL_LINE", 0, 23], ["Murine", "SPECIES", 0, 6], ["influenza virus", "SPECIES", 129, 144], ["Sendai virus", "SPECIES", 173, 185], ["influenza virus A", "SPECIES", 129, 146], ["Sendai virus", "SPECIES", 173, 185], ["Murine \u2425\u2426 T lymphocytes", "TEST", 0, 23], ["inflammatory lesions", "PROBLEM", 46, 66], ["pneumonia", "PROBLEM", 109, 118], ["influenza virus A", "PROBLEM", 129, 146], ["Sendai virus", "PROBLEM", 173, 185], ["the inflammatory process", "PROBLEM", 262, 286], ["lymphocytes", "ANATOMY", 12, 23], ["inflammatory", "OBSERVATION_MODIFIER", 46, 58], ["lesions", "OBSERVATION", 59, 66], ["pneumonia", "OBSERVATION", 109, 118], ["influenza virus", "OBSERVATION", 129, 144], ["inflammatory", "OBSERVATION", 266, 278]]], ["In mice infected with Sendai virus (Ogasawara et al., 1994) , the time course of virus propagation was immediately and coincidentally followed by the developmental course of \u2425\u2426 T cells.", [["\u2425\u2426 T cells", "ANATOMY", 174, 184], ["mice", "ORGANISM", 3, 7], ["Sendai virus", "ORGANISM", 22, 34], ["\u2425\u2426 T cells", "CELL", 174, 184], ["\u2425\u2426 T cells", "CELL_TYPE", 174, 184], ["mice", "SPECIES", 3, 7], ["Sendai virus", "SPECIES", 22, 34], ["mice", "SPECIES", 3, 7], ["Sendai virus", "SPECIES", 22, 34], ["Sendai virus", "PROBLEM", 22, 34], ["virus propagation", "TREATMENT", 81, 98], ["\u2425\u2426 T cells", "PROBLEM", 174, 184], ["infected", "OBSERVATION_MODIFIER", 8, 16], ["Sendai virus", "OBSERVATION", 22, 34]]], ["In our study, \u2425\u2426 T lymphocytes do not appear to be important in resolving IBV infection in chicks, although we cannot rule out the possibility that they produce cytokines that influence \u2423\u2424 T cell function.", [["T lymphocytes", "ANATOMY", 17, 30], ["\u2423\u2424 T cell", "ANATOMY", 186, 195], ["IBV infection", "DISEASE", 74, 87], ["\u2425\u2426 T lymphocytes", "CELL", 14, 30], ["IBV", "ORGANISM", 74, 77], ["chicks", "ORGANISM", 91, 97], ["\u2423\u2424 T cell", "CELL", 186, 195], ["\u2425\u2426 T lymphocytes", "CELL_TYPE", 14, 30], ["cytokines", "PROTEIN", 161, 170], ["IBV", "SPECIES", 74, 77], ["our study", "TEST", 3, 12], ["IBV infection in chicks", "PROBLEM", 74, 97], ["not appear to be", "UNCERTAINTY", 34, 50], ["resolving", "OBSERVATION_MODIFIER", 64, 73], ["IBV", "OBSERVATION_MODIFIER", 74, 77], ["infection", "OBSERVATION", 78, 87]]], ["Human \u2425\u2426 T lymphocytes from peripheral blood lymphocytes of healthy donors secreted IL-2 following exposure to mycobacteria (Munk et al., 1990) .", [["\u2425\u2426 T lymphocytes", "ANATOMY", 6, 22], ["peripheral blood lymphocytes", "ANATOMY", 28, 56], ["Human", "ORGANISM", 0, 5], ["\u2425\u2426 T lymphocytes", "CELL", 6, 22], ["peripheral blood lymphocytes", "CELL", 28, 56], ["donors", "ORGANISM", 68, 74], ["IL-2", "GENE_OR_GENE_PRODUCT", 84, 88], ["Human \u2425\u2426 T lymphocytes", "CELL_TYPE", 0, 22], ["peripheral blood lymphocytes", "CELL_TYPE", 28, 56], ["IL-2", "PROTEIN", 84, 88], ["Human", "SPECIES", 0, 5], ["Human", "SPECIES", 0, 5], ["Human \u2425\u2426 T lymphocytes", "TEST", 0, 22], ["peripheral blood lymphocytes", "TEST", 28, 56], ["healthy donors secreted IL", "TREATMENT", 60, 86], ["mycobacteria", "PROBLEM", 111, 123], ["peripheral", "ANATOMY_MODIFIER", 28, 38], ["blood", "ANATOMY", 39, 44], ["lymphocytes", "OBSERVATION", 45, 56], ["mycobacteria", "OBSERVATION", 111, 123]]], ["Consistent with IBV infection in chickens, the CTL response to reticuloendotheliosis virus infection in chickens was mediated by \u2423\u2424, but not by \u2425\u2426, T cells (Merkle et al., 1992) .", [["T cells", "ANATOMY", 148, 155], ["IBV infection", "DISEASE", 16, 29], ["infection", "DISEASE", 91, 100], ["IBV", "ORGANISM", 16, 19], ["chickens", "ORGANISM", 33, 41], ["CTL", "GENE_OR_GENE_PRODUCT", 47, 50], ["reticuloendotheliosis virus", "ORGANISM", 63, 90], ["chickens", "ORGANISM", 104, 112], ["\u2423\u2424", "GENE_OR_GENE_PRODUCT", 129, 131], ["T cells", "CELL", 148, 155], ["T cells", "CELL_TYPE", 148, 155], ["chickens", "SPECIES", 33, 41], ["chickens", "SPECIES", 104, 112], ["IBV", "SPECIES", 16, 19], ["chickens", "SPECIES", 33, 41], ["chickens", "SPECIES", 104, 112], ["IBV infection in chickens", "PROBLEM", 16, 41], ["reticuloendotheliosis virus infection", "PROBLEM", 63, 100], ["Consistent with", "UNCERTAINTY", 0, 15], ["IBV", "OBSERVATION_MODIFIER", 16, 19], ["infection", "OBSERVATION", 20, 29], ["reticuloendotheliosis virus infection", "OBSERVATION", 63, 100]]], ["Because avian \u2425\u2426 cells represent a large proportion of T lymphocytes in peripheral organs in the chicken, the actual role of \u2425\u2426 T cells in chicks infected with avian viruses should be further examined.FIG.The chicken is proving to be a rewarding model in examining the role of CTL in the pathogenesis and control of viral infection.", [["\u2425\u2426 cells", "ANATOMY", 14, 22], ["T lymphocytes", "ANATOMY", 55, 68], ["peripheral organs", "ANATOMY", 72, 89], ["\u2425\u2426 T cells", "ANATOMY", 125, 135], ["avian viruses", "DISEASE", 160, 173], ["viral infection", "DISEASE", 316, 331], ["avian", "ORGANISM", 8, 13], ["\u2425\u2426 cells", "CELL", 14, 22], ["T lymphocytes", "CELL", 55, 68], ["peripheral organs", "MULTI-TISSUE_STRUCTURE", 72, 89], ["chicken", "ORGANISM", 97, 104], ["\u2425\u2426 T cells", "CELL", 125, 135], ["chicks", "ORGANISM", 139, 145], ["avian viruses", "ORGANISM", 160, 173], ["chicken", "ORGANISM", 209, 216], ["CTL", "CELL", 277, 280], ["avian \u2425\u2426 cells", "CELL_TYPE", 8, 22], ["T lymphocytes", "CELL_TYPE", 55, 68], ["\u2425\u2426 T cells", "CELL_TYPE", 125, 135], ["FIG", "PROTEIN", 201, 204], ["CTL", "CELL_TYPE", 277, 280], ["chicken", "SPECIES", 97, 104], ["chicks", "SPECIES", 139, 145], ["chicken", "SPECIES", 209, 216], ["chicken", "SPECIES", 97, 104], ["chicken", "SPECIES", 209, 216], ["avian \u2425\u2426 cells", "PROBLEM", 8, 22], ["T lymphocytes in peripheral organs", "PROBLEM", 55, 89], ["\u2425\u2426 T cells", "TREATMENT", 125, 135], ["avian viruses", "TREATMENT", 160, 173], ["CTL", "TREATMENT", 277, 280], ["viral infection", "PROBLEM", 316, 331], ["large", "OBSERVATION_MODIFIER", 35, 40], ["proportion", "OBSERVATION_MODIFIER", 41, 51], ["T lymphocytes", "OBSERVATION", 55, 68], ["peripheral", "ANATOMY_MODIFIER", 72, 82], ["organs", "ANATOMY", 83, 89], ["viral", "OBSERVATION_MODIFIER", 316, 321], ["infection", "OBSERVATION", 322, 331]]], ["Ongoing studies making use of \u2423\u2424, CD8 \u03e9 T lymphocytes from chicks exposed to IBV are critical in determining factors that protect chickens against IBV infection.", [["CD8 \u03e9 T lymphocytes", "ANATOMY", 34, 53], ["IBV infection", "DISEASE", 147, 160], ["CD8", "GENE_OR_GENE_PRODUCT", 34, 37], ["IBV", "ORGANISM", 77, 80], ["chickens", "ORGANISM", 130, 138], ["IBV", "ORGANISM", 147, 150], ["CD8 \u03e9 T lymphocytes", "CELL_TYPE", 34, 53], ["chickens", "SPECIES", 130, 138], ["IBV", "SPECIES", 77, 80], ["chickens", "SPECIES", 130, 138], ["IBV", "SPECIES", 147, 150], ["Ongoing studies", "TEST", 0, 15], ["IBV", "PROBLEM", 77, 80], ["IBV infection", "PROBLEM", 147, 160], ["infection", "OBSERVATION", 151, 160]]], ["Future experiments will utilize available MHC recombinants.", [["MHC recombinants", "DNA", 42, 58]]], ["Because cells with the MHC restricted capacity to protect against challenge virus correlated with the CTL response, it may be suggested that the major mechanism for control of acute infection is due to CD8 \u03e9 , MHC restricted \u2423\u2424 T lymphocytes.", [["cells", "ANATOMY", 8, 13], ["\u2423\u2424 T lymphocytes", "ANATOMY", 225, 241], ["infection", "DISEASE", 182, 191], ["cells", "CELL", 8, 13], ["CD8", "GENE_OR_GENE_PRODUCT", 202, 205], ["MHC", "PROTEIN", 23, 26], ["CD8", "PROTEIN", 202, 205], ["MHC restricted \u2423\u2424 T lymphocytes", "CELL_TYPE", 210, 241], ["the MHC restricted capacity", "PROBLEM", 19, 46], ["challenge virus", "PROBLEM", 66, 81], ["acute infection", "PROBLEM", 176, 191], ["CD8", "TEST", 202, 205], ["acute", "OBSERVATION_MODIFIER", 176, 181], ["infection", "OBSERVATION", 182, 191]]], ["Because IBV-specific CTL tend to recognize epitopes conserved among serologically distinct strains , mechanisms that induce CTL should be exploited with the development of effective vaccines.MATERIALS AND METHODSExperimental animals.", [["IBV", "ORGANISM", 8, 11], ["CTL", "CELL", 21, 24], ["CTL", "CELL", 124, 127], ["CTL", "CELL_TYPE", 21, 24], ["epitopes", "PROTEIN", 43, 51], ["CTL", "CELL_TYPE", 124, 127], ["IBV", "SPECIES", 8, 11], ["IBV", "PROBLEM", 8, 11], ["serologically distinct strains", "PROBLEM", 68, 98], ["effective vaccines", "TREATMENT", 172, 190]]], ["Chicks used in these studies were Hy-VAC B 12 /B 12 (Hy-VAC, Adel, IA) as well as B 8 /B 8 B 19 /B 19 from the Department of Biological Sciences, Northern Illinois University (DeKalb, IL) (Briles and Briles, 1982) .", [["Chicks", "ORGANISM", 0, 6], ["Chicks", "SPECIES", 0, 6], ["these studies", "TEST", 15, 28], ["Hy", "TEST", 34, 36], ["VAC B", "TEST", 37, 42], ["VAC", "TREATMENT", 56, 59], ["VAC", "ANATOMY", 56, 59]]], ["Chicks were hatched in our laboratory and housed in a specific, pathogen-free environment at the Laboratory Animal and Resources Facility (Texas A & M University, College Station, TX).MATERIALS AND METHODSViral inoculations.", [["Chicks", "ORGANISM", 0, 6], ["Chicks", "SPECIES", 0, 6], ["METHODSViral inoculations", "TREATMENT", 198, 223], ["METHODSViral inoculations", "OBSERVATION", 198, 223]]], ["The nephrotrophic Gray strain of IBV, used as the source for viral inoculation, was propagated by inoculating the allantoic sac of 11-day-old chicken embryos and harvesting the allantoic fluid 36 h p.i.", [["allantoic sac", "ANATOMY", 114, 127], ["embryos", "ANATOMY", 150, 157], ["allantoic fluid", "ANATOMY", 177, 192], ["IBV", "ORGANISM", 33, 36], ["allantoic sac", "MULTI-TISSUE_STRUCTURE", 114, 127], ["chicken", "ORGANISM", 142, 149], ["embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 150, 157], ["chicken", "SPECIES", 142, 149], ["IBV", "SPECIES", 33, 36], ["chicken", "SPECIES", 142, 149], ["The nephrotrophic Gray strain of IBV", "TREATMENT", 0, 36], ["viral inoculation", "PROBLEM", 61, 78], ["old chicken embryos", "TREATMENT", 138, 157], ["harvesting the allantoic fluid", "TREATMENT", 162, 192], ["IBV", "OBSERVATION", 33, 36], ["viral", "OBSERVATION_MODIFIER", 61, 66], ["inoculation", "OBSERVATION", 67, 78], ["allantoic sac", "ANATOMY", 114, 127]]], ["(Sneed et al., 1989) .MATERIALS AND METHODSPreparation of donor lymphocytes.", [["donor lymphocytes", "ANATOMY", 58, 75], ["donor lymphocytes", "CELL", 58, 75], ["donor lymphocytes", "CELL_TYPE", 58, 75], ["donor lymphocytes", "PROBLEM", 58, 75], ["donor lymphocytes", "OBSERVATION", 58, 75]]], ["Chicks at the age of 28 days were infected with 10 7 EID 50 of the Gray strain of IBV.", [["Chicks", "ORGANISM", 0, 6], ["IBV", "ORGANISM", 82, 85], ["Chicks", "SPECIES", 0, 6], ["IBV", "SPECIES", 82, 85], ["IBV", "PROBLEM", 82, 85], ["IBV", "OBSERVATION", 82, 85]]], ["Splenocytes were collected from IBV-infected chicks at 10 days p.i.", [["Splenocytes", "ANATOMY", 0, 11], ["IBV-infected", "DISEASE", 32, 44], ["Splenocytes", "CELL", 0, 11], ["IBV", "ORGANISM", 32, 35], ["chicks", "ORGANISM", 45, 51], ["Splenocytes", "CELL_TYPE", 0, 11], ["chicks", "SPECIES", 45, 51], ["IBV", "SPECIES", 32, 35], ["Splenocytes", "TEST", 0, 11], ["IBV", "PROBLEM", 32, 35], ["infected", "OBSERVATION_MODIFIER", 36, 44], ["chicks", "OBSERVATION_MODIFIER", 45, 51]]], ["Control donor cells were prepared from age-matched uninfected chicks.", [["donor cells", "ANATOMY", 8, 19], ["Control donor cells", "CELL", 0, 19], ["chicks", "ORGANISM", 62, 68], ["donor cells", "CELL_TYPE", 8, 19], ["Control donor cells", "TREATMENT", 0, 19], ["donor cells", "OBSERVATION", 8, 19], ["uninfected chicks", "OBSERVATION", 51, 68]]], ["Lymphocytes were separated with a Ficoll-Hypaque density gradient (Histopaque 1.077; Sigma, St. Louis, MO), adherent cells were removed by incubation on plastic petri dishes, and B lymphocytes were depleted using nylon wool columns .", [["Lymphocytes", "ANATOMY", 0, 11], ["cells", "ANATOMY", 117, 122], ["B lymphocytes", "ANATOMY", 179, 192], ["Lymphocytes", "CELL", 0, 11], ["cells", "CELL", 117, 122], ["B lymphocytes", "CELL", 179, 192], ["Lymphocytes", "CELL_TYPE", 0, 11], ["adherent cells", "CELL_TYPE", 108, 122], ["B lymphocytes", "CELL_TYPE", 179, 192], ["Lymphocytes", "TEST", 0, 11], ["a Ficoll", "TEST", 32, 40], ["Histopaque", "TEST", 67, 77], ["adherent cells", "PROBLEM", 108, 122], ["plastic petri dishes", "TEST", 153, 173], ["nylon wool columns", "TREATMENT", 213, 231], ["Hypaque density", "OBSERVATION_MODIFIER", 41, 56], ["gradient", "OBSERVATION_MODIFIER", 57, 65], ["adherent cells", "OBSERVATION", 108, 122], ["petri dishes", "OBSERVATION", 161, 173], ["lymphocytes", "ANATOMY", 181, 192], ["nylon wool columns", "OBSERVATION", 213, 231]]], ["T-cell-enriched preparations were transferred directly to naive chicks or were first stimulated in vitro for 10 days with antigen-presenting cells (APC) in RPMI with 10% chicken serum, 50 g/ml gentamycin, 5 \u03eb 10 \u03ea5 M 2-mercaptoethanol, and 2 mM L-glutamine from Gibco BRL (Grand Island, NY).", [["T-cell", "ANATOMY", 0, 6], ["cells", "ANATOMY", 141, 146], ["APC", "ANATOMY", 148, 151], ["serum", "ANATOMY", 178, 183], ["gentamycin", "CHEMICAL", 193, 203], ["2-mercaptoethanol", "CHEMICAL", 217, 234], ["L-glutamine", "CHEMICAL", 245, 256], ["gentamycin", "CHEMICAL", 193, 203], ["2-mercaptoethanol", "CHEMICAL", 217, 234], ["L-glutamine", "CHEMICAL", 245, 256], ["T-cell", "CELL", 0, 6], ["chicks", "ORGANISM", 64, 70], ["cells", "CELL", 141, 146], ["APC", "CELL", 148, 151], ["chicken", "ORGANISM", 170, 177], ["serum", "ORGANISM_SUBSTANCE", 178, 183], ["gentamycin", "SIMPLE_CHEMICAL", 193, 203], ["2-mercaptoethanol", "SIMPLE_CHEMICAL", 217, 234], ["L-glutamine", "ORGANISM_SUBSTANCE", 245, 256], ["antigen-presenting cells", "CELL_TYPE", 122, 146], ["APC", "CELL_TYPE", 148, 151], ["chicken", "SPECIES", 170, 177], ["chicken", "SPECIES", 170, 177], ["RPMI", "TEST", 156, 160], ["10% chicken serum", "TREATMENT", 166, 183], ["gentamycin", "TREATMENT", 193, 203], ["mercaptoethanol", "TREATMENT", 219, 234], ["2 mM L-glutamine", "TREATMENT", 240, 256]]], ["IBVinfected CK cells , irradiated with 10,000 rad, were used as APC.MATERIALS AND METHODSInoculation of donor lymphocytes and challenge virus.", [["CK cells", "ANATOMY", 12, 20], ["donor lymphocytes", "ANATOMY", 104, 121], ["APC", "CHEMICAL", 64, 67], ["CK cells", "CELL", 12, 20], ["APC", "GENE_OR_GENE_PRODUCT", 64, 67], ["donor lymphocytes", "CELL", 104, 121], ["IBVinfected CK cells", "CELL_LINE", 0, 20], ["APC", "CELL_TYPE", 64, 67], ["donor lymphocytes", "CELL_TYPE", 104, 121], ["IBVinfected CK cells", "PROBLEM", 0, 20], ["donor lymphocytes", "PROBLEM", 104, 121], ["challenge virus", "TREATMENT", 126, 141], ["CK cells", "OBSERVATION", 12, 20], ["donor lymphocytes", "OBSERVATION", 104, 121]]], ["Each group consisted of at least five chicks.", [["chicks", "ORGANISM", 38, 44]]], ["Immune or nonimmune donor lymphocytes were given at 5 days of age through a wing vein.", [["lymphocytes", "ANATOMY", 26, 37], ["wing vein", "ANATOMY", 76, 85], ["nonimmune donor lymphocytes", "CELL", 10, 37], ["wing vein", "MULTI-TISSUE_STRUCTURE", 76, 85], ["Immune or nonimmune donor lymphocytes", "CELL_TYPE", 0, 37], ["nonimmune donor lymphocytes", "TREATMENT", 10, 37], ["a wing vein", "TREATMENT", 74, 85], ["donor lymphocytes", "OBSERVATION", 20, 37], ["wing vein", "ANATOMY", 76, 85]]], ["One day after receiving donor lymphocytes, chicks were challenged with 2 to 4 \u03eb 10 6 EID 50 of the Gray strain of IBV by the nasal-ocular route.", [["lymphocytes", "ANATOMY", 30, 41], ["nasal", "ANATOMY", 125, 130], ["ocular", "ANATOMY", 131, 137], ["lymphocytes", "CELL", 30, 41], ["chicks", "ORGANISM", 43, 49], ["IBV", "ORGANISM", 114, 117], ["nasal", "ORGANISM_SUBDIVISION", 125, 130], ["donor lymphocytes", "CELL_TYPE", 24, 41], ["chicks", "SPECIES", 43, 49], ["IBV", "SPECIES", 114, 117], ["donor lymphocytes", "TREATMENT", 24, 41], ["IBV", "TREATMENT", 114, 117], ["lymphocytes", "OBSERVATION", 30, 41], ["nasal", "ANATOMY", 125, 130], ["ocular", "ANATOMY", 131, 137]]], ["Birds were observed twice each day for clinical signs of illness, such as coughing, sneezing, rales, or dyspnea.", [["illness", "DISEASE", 57, 64], ["coughing", "DISEASE", 74, 82], ["sneezing", "DISEASE", 84, 92], ["rales", "DISEASE", 94, 99], ["dyspnea", "DISEASE", 104, 111], ["illness", "PROBLEM", 57, 64], ["coughing", "PROBLEM", 74, 82], ["sneezing", "PROBLEM", 84, 92], ["rales", "PROBLEM", 94, 99], ["dyspnea", "PROBLEM", 104, 111], ["rales", "OBSERVATION", 94, 99]]], ["Statistical differences in illness were determined by analysis of variance (Ott, 1984) .", [["illness", "DISEASE", 27, 34], ["Statistical differences in illness", "PROBLEM", 0, 34]]], ["Viral load was evaluated in lungs and kidneys collected 5 days p.i. .MATERIALS AND METHODSDepletion of T lymphocyte subtypes.", [["lungs", "ANATOMY", 28, 33], ["kidneys", "ANATOMY", 38, 45], ["T lymphocyte", "ANATOMY", 103, 115], ["Viral", "ORGANISM", 0, 5], ["lungs", "ORGAN", 28, 33], ["kidneys", "ORGAN", 38, 45], ["T lymphocyte", "CELL", 103, 115], ["T lymphocyte subtypes", "CELL_TYPE", 103, 124], ["Viral load", "TEST", 0, 10], ["T lymphocyte subtypes", "PROBLEM", 103, 124], ["load", "OBSERVATION", 6, 10], ["lungs", "ANATOMY", 28, 33], ["kidneys", "ANATOMY", 38, 45], ["T lymphocyte subtypes", "OBSERVATION", 103, 124]]], ["Stimulated T cell subtypes were enriched, after B cells and adherent cells were removed, with antisera specific for CD4, CD8, TCR1, or TCR2 .", [["T cell", "ANATOMY", 11, 17], ["B cells", "ANATOMY", 48, 55], ["adherent cells", "ANATOMY", 60, 74], ["T cell", "CELL", 11, 17], ["B cells", "CELL", 48, 55], ["adherent cells", "CELL", 60, 74], ["CD4", "GENE_OR_GENE_PRODUCT", 116, 119], ["CD8", "GENE_OR_GENE_PRODUCT", 121, 124], ["TCR1", "GENE_OR_GENE_PRODUCT", 126, 130], ["TCR2", "GENE_OR_GENE_PRODUCT", 135, 139], ["B cells", "CELL_TYPE", 48, 55], ["adherent cells", "CELL_TYPE", 60, 74], ["CD4", "PROTEIN", 116, 119], ["CD8", "PROTEIN", 121, 124], ["TCR1", "PROTEIN", 126, 130], ["TCR2", "PROTEIN", 135, 139], ["Stimulated T cell subtypes", "PROBLEM", 0, 26], ["B cells", "PROBLEM", 48, 55], ["adherent cells", "PROBLEM", 60, 74], ["antisera", "TEST", 94, 102], ["CD4", "TEST", 116, 119], ["CD8", "TEST", 121, 124], ["TCR1", "TEST", 126, 130], ["TCR2", "PROBLEM", 135, 139], ["adherent cells", "OBSERVATION", 60, 74]]], ["Briefly, tissue culture flasks were coated with goat anti-mouse IgG.", [["tissue", "ANATOMY", 9, 15], ["tissue", "TISSUE", 9, 15], ["goat", "ORGANISM", 48, 52], ["goat anti-mouse IgG", "PROTEIN", 48, 67], ["goat", "SPECIES", 48, 52], ["anti-mouse", "SPECIES", 53, 63], ["goat", "SPECIES", 48, 52], ["tissue culture flasks", "TEST", 9, 30], ["goat anti-mouse IgG", "TREATMENT", 48, 67]]], ["The immune T cells were labeled with mouse anti-chicken CD4, CD8, TCR1, or TCR2 monoclonal antibody (Southern Biotechnology Associates, Birmingham, AL) before being added to IgG-coated plates and being incubated at room temperature for 30 min.", [["immune T cells", "ANATOMY", 4, 18], ["immune T cells", "CELL", 4, 18], ["mouse", "ORGANISM", 37, 42], ["CD4", "GENE_OR_GENE_PRODUCT", 56, 59], ["CD8", "GENE_OR_GENE_PRODUCT", 61, 64], ["TCR1", "GENE_OR_GENE_PRODUCT", 66, 70], ["TCR2", "GENE_OR_GENE_PRODUCT", 75, 79], ["immune T cells", "CELL_TYPE", 4, 18], ["mouse anti-chicken CD4", "PROTEIN", 37, 59], ["CD8", "PROTEIN", 61, 64], ["TCR1", "PROTEIN", 66, 70], ["TCR2 monoclonal antibody", "PROTEIN", 75, 99], ["IgG", "PROTEIN", 174, 177], ["mouse", "SPECIES", 37, 42], ["mouse", "SPECIES", 37, 42], ["The immune T cells", "TEST", 0, 18], ["mouse anti-chicken CD4", "TEST", 37, 59], ["CD8", "TEST", 61, 64], ["TCR1", "TEST", 66, 70], ["IgG-coated plates", "TREATMENT", 174, 191]]], ["The suspensions were swirled gently before being incubated for an additional 30 min at room temperature.", [["suspensions", "ANATOMY", 4, 15], ["The suspensions", "TREATMENT", 0, 15]]], ["Nonadherent cells were decanted from the plates following gentle agitation, centrifuged for 10 min at 600 g, and resuspended in PBS before being transferred to chicks.MATERIALS AND METHODSCTL assay.", [["cells", "ANATOMY", 12, 17], ["agitation", "DISEASE", 65, 74], ["cells", "CELL", 12, 17], ["Nonadherent cells", "CELL_TYPE", 0, 17], ["Nonadherent cells", "TEST", 0, 17], ["gentle agitation", "TREATMENT", 58, 74], ["PBS", "TREATMENT", 128, 131], ["METHODSCTL assay", "TEST", 181, 197]]], ["In vitro stimulated T lymphocytes depleted of T cell subtypes were tested for CTL activity using target CK cells infected with the Gray strain of IBV as described previously .", [["T lymphocytes", "ANATOMY", 20, 33], ["T cell", "ANATOMY", 46, 52], ["CK cells", "ANATOMY", 104, 112], ["T lymphocytes", "CELL", 20, 33], ["T cell", "CELL", 46, 52], ["CTL", "GENE_OR_GENE_PRODUCT", 78, 81], ["CK cells", "CELL", 104, 112], ["IBV", "ORGANISM", 146, 149], ["vitro stimulated T lymphocytes", "CELL_LINE", 3, 33], ["CK cells", "CELL_TYPE", 104, 112], ["IBV", "SPECIES", 146, 149], ["T cell subtypes", "PROBLEM", 46, 61], ["CTL activity", "PROBLEM", 78, 90], ["target CK cells", "PROBLEM", 97, 112], ["the Gray strain of IBV", "PROBLEM", 127, 149], ["IBV", "OBSERVATION", 146, 149]]], ["Target cells were labeled with 51 Cr for 90 min before being washed and mixed with effector lymphocytes .", [["cells", "ANATOMY", 7, 12], ["effector lymphocytes", "ANATOMY", 83, 103], ["Cr", "CHEMICAL", 34, 36], ["Cr", "CHEMICAL", 34, 36], ["cells", "CELL", 7, 12], ["lymphocytes", "CELL", 92, 103], ["effector lymphocytes", "CELL_TYPE", 83, 103], ["Target cells", "TEST", 0, 12], ["Cr", "TEST", 34, 36], ["effector lymphocytes", "OBSERVATION", 83, 103]]], ["Varying amounts of effector cells in 100 l of RPMI with 10% chicken sera were added to each well in 96-well round-bottom microtiter plates, and 100 l of 2 \u03eb 10 4 of 51 Cr-labeled target cells that were infected with IBV or uninfected was added to each well.", [["effector cells", "ANATOMY", 19, 33], ["sera", "ANATOMY", 68, 72], ["cells", "ANATOMY", 186, 191], ["Cr", "CHEMICAL", 168, 170], ["Cr", "CHEMICAL", 168, 170], ["cells", "CELL", 28, 33], ["chicken", "ORGANISM", 60, 67], ["sera", "ORGANISM_SUBSTANCE", 68, 72], ["Cr", "SIMPLE_CHEMICAL", 168, 170], ["cells", "CELL", 186, 191], ["IBV", "ORGANISM", 216, 219], ["effector cells", "CELL_TYPE", 19, 33], ["Cr-labeled target cells", "CELL_LINE", 168, 191], ["chicken", "SPECIES", 60, 67], ["chicken", "SPECIES", 60, 67], ["IBV", "SPECIES", 216, 219], ["effector cells", "TREATMENT", 19, 33], ["RPMI", "TREATMENT", 46, 50], ["10% chicken sera", "TREATMENT", 56, 72], ["bottom microtiter plates", "TEST", 114, 138], ["Cr", "TEST", 168, 170], ["target cells", "PROBLEM", 179, 191], ["IBV", "PROBLEM", 216, 219], ["amounts", "OBSERVATION_MODIFIER", 8, 15], ["effector cells", "OBSERVATION", 19, 33]]], ["Microtiter plates were centrifuged at 100 g for 5 min before being incubated for 4 h at 40\u00b0C. After being centrifuged at 600 g for 10 min, 100 l of the supernatants in triplicate samples was collected for determining 51 Cr release using a gamma radiation counter (Cobra Autogamma, Canberra Packard).", [["supernatants", "ANATOMY", 152, 164], ["samples", "ANATOMY", 179, 186], ["Cr", "CHEMICAL", 220, 222], ["Cr", "CHEMICAL", 220, 222], ["Cr", "SIMPLE_CHEMICAL", 220, 222], ["Microtiter plates", "TREATMENT", 0, 17], ["triplicate samples", "TEST", 168, 186], ["a gamma radiation counter (Cobra Autogamma", "TREATMENT", 237, 279]]], ["The percentage of specific lysis was calculated as (E-S/M-S) \u03eb 100, where E is the mean of three test wells, S is the mean of spontaneous release from the three target cells without effector cells, and M is the mean maximal release from the three target cells with 3% Triton X-100.", [["cells", "ANATOMY", 168, 173], ["cells", "ANATOMY", 191, 196], ["cells", "ANATOMY", 254, 259], ["Triton X-100", "CHEMICAL", 268, 280], ["Triton X-100", "CHEMICAL", 268, 280], ["cells", "CELL", 168, 173], ["cells", "CELL", 191, 196], ["cells", "CELL", 254, 259], ["Triton X-100", "SIMPLE_CHEMICAL", 268, 280], ["target cells", "CELL_TYPE", 161, 173], ["effector cells", "CELL_TYPE", 182, 196], ["target cells", "CELL_TYPE", 247, 259], ["specific lysis", "TEST", 18, 32], ["three test wells", "TEST", 91, 107], ["spontaneous release", "PROBLEM", 126, 145], ["effector cells", "PROBLEM", 182, 196], ["percentage", "OBSERVATION_MODIFIER", 4, 14], ["lysis", "OBSERVATION", 27, 32], ["without", "UNCERTAINTY", 174, 181], ["effector cells", "OBSERVATION", 182, 196]]], ["The spontaneous 51 Cr release of target cells was less than 15% of the maximum release.MATERIALS AND METHODSDetermination of viral load in chicken lungs or kidneys.", [["cells", "ANATOMY", 40, 45], ["lungs", "ANATOMY", 147, 152], ["kidneys", "ANATOMY", 156, 163], ["Cr", "CHEMICAL", 19, 21], ["Cr", "CHEMICAL", 19, 21], ["cells", "CELL", 40, 45], ["chicken", "ORGANISM", 139, 146], ["lungs", "ORGAN", 147, 152], ["kidneys", "ORGAN", 156, 163], ["target cells", "CELL_TYPE", 33, 45], ["chicken", "SPECIES", 139, 146], ["chicken", "SPECIES", 139, 146], ["target cells", "TEST", 33, 45], ["viral load in chicken lungs or kidneys", "PROBLEM", 125, 163], ["target cells", "OBSERVATION", 33, 45], ["viral load", "OBSERVATION", 125, 135], ["lungs", "ANATOMY", 147, 152], ["kidneys", "ANATOMY", 156, 163]]], ["Lungs and kidneys were collected and pooled from syngeneic chicks in each group .", [["Lungs", "ANATOMY", 0, 5], ["kidneys", "ANATOMY", 10, 17], ["Lungs", "ORGAN", 0, 5], ["kidneys", "ORGAN", 10, 17], ["chicks", "ORGANISM", 59, 65], ["chicks", "SPECIES", 59, 65], ["kidneys", "ANATOMY", 10, 17], ["syngeneic chicks", "OBSERVATION", 49, 65]]], ["Tissues from the chicks in each group were pooled before being weighed and homogenized.", [["Tissues", "ANATOMY", 0, 7], ["Tissues", "CANCER", 0, 7], ["chicks", "ORGANISM", 17, 23], ["chicks", "SPECIES", 17, 23], ["chicks", "OBSERVATION_MODIFIER", 17, 23]]], ["A 10% w/v tissue suspension was prepared in Eagle's MEM containing 200 U/ml of penicillin and 200 g/ml streptomycin.", [["tissue", "ANATOMY", 10, 16], ["penicillin", "CHEMICAL", 79, 89], ["streptomycin", "CHEMICAL", 103, 115], ["penicillin", "CHEMICAL", 79, 89], ["streptomycin", "CHEMICAL", 103, 115], ["tissue", "TISSUE", 10, 16], ["penicillin", "SIMPLE_CHEMICAL", 79, 89], ["streptomycin", "SIMPLE_CHEMICAL", 103, 115], ["A 10% w/v tissue suspension", "TREATMENT", 0, 27], ["penicillin", "TREATMENT", 79, 89], ["streptomycin", "TREATMENT", 103, 115]]], ["After standing for 90 min at 4\u00b0C, cells were pelleted by centrifuging for 20 min at 2000 g and serial 10-fold dilutions of supernatants were prepared in Eagle's MEM.", [["cells", "ANATOMY", 34, 39], ["supernatants", "ANATOMY", 123, 135], ["cells", "CELL", 34, 39], ["serial 10-fold dilutions of supernatants", "TREATMENT", 95, 135]]], ["One-tenth of a milliliter of each virus dilution was injected into the allantoic sac of six 11-day-old embryonated chicken eggs (Cook, 1983) .", [["allantoic sac", "ANATOMY", 71, 84], ["eggs", "ANATOMY", 123, 127], ["allantoic sac", "MULTI-TISSUE_STRUCTURE", 71, 84], ["chicken", "ORGANISM", 115, 122], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 123, 127], ["chicken", "SPECIES", 115, 122], ["chicken", "SPECIES", 115, 122], ["a milliliter of each virus dilution", "TREATMENT", 13, 48], ["allantoic sac", "ANATOMY", 71, 84]]], ["The eggs were sealed with collodion before being incubated at 38\u00b0C for 5 days and then the embryos were examined for dwarfing by weighing.", [["eggs", "ANATOMY", 4, 8], ["embryos", "ANATOMY", 91, 98], ["eggs", "ORGANISM_SUBSTANCE", 4, 8], ["embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 91, 98], ["The eggs", "TREATMENT", 0, 8], ["collodion", "TREATMENT", 26, 35], ["dwarfing", "PROBLEM", 117, 125]]]], "d4718ccc1c08a82371c1d7525aae8cc567ff2424": [["IntroductionSocial media have become increasingly useful in digital disease detection and surveillance [1, 2, 3, 4] , such as Twitter data analysis in experimental digital surveillance of influenza [5, 6] and cholera [7] .", [["influenza", "DISEASE", 188, 197], ["cholera", "DISEASE", 209, 216], ["IntroductionSocial media", "TREATMENT", 0, 24], ["digital disease detection", "TEST", 60, 85], ["surveillance", "TEST", 90, 102], ["Twitter data analysis", "TEST", 126, 147], ["influenza", "PROBLEM", 188, 197]]], ["Social media are also used as communication tools in public health [8, 9, 10, 11, 12] , such as health communications via Twitter on breast cancer and diabetes [13, 14] .IntroductionEquivalent to Twitter, which is blocked by the Chinese authorities, Weibo is a popular microblogging service in China [15] .", [["breast cancer", "ANATOMY", 133, 146], ["breast cancer", "DISEASE", 133, 146], ["diabetes", "DISEASE", 151, 159], ["breast cancer", "CANCER", 133, 146], ["breast cancer", "PROBLEM", 133, 146], ["diabetes", "PROBLEM", 151, 159], ["breast", "ANATOMY", 133, 139], ["cancer", "OBSERVATION", 140, 146]]], ["Weibo users discuss a variety of social issues, including post-disaster management and politics [17, 18, 19] .", [["post-disaster management", "TREATMENT", 58, 82]]], ["For example, Weibo users' reactions to a self-presented suicide attempt [21] and to the outbreaks of Middle East Respiratory Syndrome coronavirus (MERS-CoV) and avian influenza A(H7N9) merited our attention [22] .", [["Middle East Respiratory Syndrome coronavirus", "DISEASE", 101, 145], ["avian influenza A", "DISEASE", 161, 178], ["Middle East Respiratory Syndrome coronavirus", "ORGANISM", 101, 145], ["MERS-CoV", "ORGANISM", 147, 155], ["avian influenza A", "ORGANISM", 161, 178], ["avian influenza A", "SPECIES", 161, 178], ["Middle East Respiratory Syndrome coronavirus", "SPECIES", 101, 145], ["MERS-CoV", "SPECIES", 147, 155], ["H7N9", "SPECIES", 179, 183], ["Middle East Respiratory Syndrome coronavirus", "PROBLEM", 101, 145], ["avian influenza A", "PROBLEM", 161, 178], ["Middle", "ANATOMY_MODIFIER", 101, 107], ["Respiratory Syndrome", "OBSERVATION", 113, 133]]], ["A recent study also revealed the great variety of health-related keywords used in Weibo posts [23] .IntroductionWhile outbreak detection and incidence prediction are one of the goals of digital epidemiology [4, 24] , a good theoretical understanding of why people tweet about diseases or health conditions is largely lacking.", [["people", "ORGANISM", 257, 263], ["people", "SPECIES", 257, 263], ["A recent study", "TEST", 0, 14]]], ["Our understanding of online reaction to media exposure of disease information should go beyond seeing it as social media \"chatter\" [5] or as spikes of search queries that reduce the predictive power of digital epidemiological tools [25] .", [["online reaction", "PROBLEM", 21, 36]]], ["A better understanding will allow public health agencies to improve their health communication strategies and digital epidemiologists to better understand and model the relationship between time series of social media trends and disease incidence trends.IntroductionIn this article, we extend our previous study [22] to cover keywords associated with all the infectious diseases that were notifiable in mainland China in 2012.", [["infectious diseases", "DISEASE", 359, 378], ["social media trends", "TREATMENT", 205, 224], ["our previous study", "TEST", 293, 311], ["all the infectious diseases", "PROBLEM", 351, 378], ["infectious", "OBSERVATION", 359, 369]]], ["Qualitative content analysis was performed to identify the news and information that triggered an elevated volume of microblog traffic (peaks in daily Weibo count on certain keywords).", [["Qualitative content analysis", "TEST", 0, 28], ["an elevated volume of microblog traffic", "PROBLEM", 95, 134], ["elevated", "OBSERVATION", 98, 106]]], ["Our results will allow public health practitioners to better formulate their health communication messages and shed light upon the underlying assumption of digital epidemiology that an increase in disease incidence may trigger an increase in social media messages related to the disease.Data acquisition and samplingOur Weibo data were collected via the Weiboscope project, maintained by KWF and his team in the University of Hong Kong, as described elsewhere [18, 22] .", [["disease incidence", "PROBLEM", 197, 214], ["social media messages", "TREATMENT", 242, 263], ["the disease", "PROBLEM", 275, 286], ["Data acquisition", "TEST", 287, 303], ["increase", "OBSERVATION_MODIFIER", 185, 193], ["increase", "OBSERVATION_MODIFIER", 230, 238], ["disease", "OBSERVATION", 279, 286]]], ["Initially, a list of about 350,000 indexed microbloggers was generated by systematically searching the Sina Weibo user population using the Sina Weibo Application Programming Interface (API) (Fig 1) .", [["the Sina Weibo Application Programming Interface (API)", "TREATMENT", 136, 190]]], ["The rationale for our high-follower-count samples was two-fold.", [["samples", "ANATOMY", 42, 49], ["count samples", "TEST", 36, 49]]], ["Second, this criterion can exclude the spam accounts that are very common among Chinese social media [26] .Data acquisition and samplingAs previously described [18] , the raw Chinese microblog data were acquired in Comma-Separated Values (CSV) format and sorted by week.", [["Data acquisition", "TEST", 107, 123], ["sampling", "TEST", 128, 136], ["the raw Chinese microblog data", "TEST", 167, 197]]], ["In the CSV files, metadata, such as the post content, the created date and user ID, are available for secondary analysis.", [["secondary analysis", "TEST", 102, 120]]], ["The user identity codes were obfuscated using an algorithm similar to base64 algorithm to generate the unique but anonymized identifier.", [["an algorithm", "TEST", 46, 58]]], ["The screen names referenced in the posts were replaced with the corresponding obfuscated user identity codes.", [["obfuscated user identity codes", "DNA", 78, 108], ["The screen", "TEST", 0, 10]]], ["For the purpose of this study, we limited our time frame from January 1, 2012 to December 31, 2012.Keyword detection and data analysisSimilar to our previous study [22] , we prescribed a list of keywords for keyword search in the dataset.", [["this study", "TEST", 19, 29], ["Keyword detection", "TEST", 99, 116], ["our previous study", "TEST", 145, 163]]], ["They were based on the list of notifiable infectious diseases in mainland China, as specified by the Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases, as of 2012 [27] (Table 1 ; viral hepatitis is counted as one disease in the law, but we counted Hepatitis A, B, C and E separately following the disease reporting scheme of the Chinese Center for Disease Control and Prevention).", [["infectious diseases", "DISEASE", 42, 61], ["Infectious Diseases", "DISEASE", 174, 193], ["viral hepatitis", "DISEASE", 222, 237], ["Hepatitis A", "DISEASE", 291, 302], ["People", "SPECIES", 112, 118], ["Infectious Diseases", "PROBLEM", 174, 193], ["viral hepatitis", "PROBLEM", 222, 237], ["Disease Control", "TREATMENT", 391, 406], ["infectious", "OBSERVATION", 42, 52], ["Infectious", "OBSERVATION", 174, 184], ["hepatitis", "OBSERVATION", 228, 237]]], ["We then obtained a time series of aggregated daily counts of Weibo posts containing a specified keyword for each disease.", [["each disease", "PROBLEM", 108, 120]]], ["We selected the day of the year with the largest number of posts pertinent to each disease and, using an online platform that we developed, obtained the content of the Chinese posts that were generated on that day.", [["an online platform", "TEST", 102, 120], ["largest", "OBSERVATION_MODIFIER", 41, 48]]], ["We obtained the microblog content of the whole year of 2012 for typhus (n = 14) and leishmaniasis (n = 24), given their small numbers.", [["typhus", "DISEASE", 64, 70], ["leishmaniasis", "DISEASE", 84, 97], ["the microblog content", "TEST", 12, 33], ["typhus", "PROBLEM", 64, 70], ["leishmaniasis", "PROBLEM", 84, 97], ["small", "OBSERVATION_MODIFIER", 120, 125]]], ["They manually searched online and identified the relevant news, events or information that triggered the elevated microblog traffic.", [["the elevated microblog traffic", "PROBLEM", 101, 131]]], ["Afterwards, the first author manually performed quality check by selecting the microblog posts of about one-third of the list of diseases and performed the grouping himself.", [["quality check", "TEST", 48, 61], ["diseases", "PROBLEM", 129, 137], ["diseases", "OBSERVATION", 129, 137]]], ["News of (a) outbreaks or (b) cases;Keyword detection and data analysis2.", [["Keyword detection", "TEST", 35, 52], ["data analysis2", "TEST", 57, 71]]], ["Health education or information, as released by health authorities, news agencies, education institutions, etc., that conform to modern scientific medicine;Keyword detection and data analysis3.", [["Keyword detection", "TEST", 156, 173], ["data analysis3", "TEST", 178, 192]]], ["Alternative health information that fell out of the realm of modern scientific medicine (such as information of Traditional Chinese Medicine); 4.", [["Traditional Chinese Medicine", "TREATMENT", 112, 140]]], ["Social issues, including the conflicts between the medical profession and the patients ( Table 2 ).Keyword detection and data analysisThe representative post for each group was then translated into English to be presented in S1 File.", [["patients", "ORGANISM", 78, 86], ["patients", "SPECIES", 78, 86], ["Keyword detection", "TEST", 99, 116], ["data analysis", "TEST", 121, 134]]], ["Please refer to S1 File for detailed content analysis for the peak of daily microblog post count for each disease in 2012.Ethics StatementThe protocol of data processing and anonymization was approved by the Human Research Ethics Committee for Non-Clinical Faculties, The University of Hong Kong, and by the Institutional Review Board, Georgia Southern University (H14167).", [["Human", "ORGANISM", 208, 213], ["S1", "PROTEIN", 16, 18], ["Human", "SPECIES", 208, 213], ["detailed content analysis", "TEST", 28, 53], ["daily microblog post count", "TEST", 70, 96], ["each disease", "PROBLEM", 101, 113]]], ["This paper is the report of a international concern, of which cholera and plague (listed in the law) are (or were) endemic in parts of China.", [["cholera", "DISEASE", 62, 69]]], ["The law specified that outbreaks of class A diseases require prompt infection control measures including immediate isolation of patients and quarantine (medical observation) of their contacts.Ethics StatementCollection, transportation and testing specimens of Class A pathogens require approval from the provincial authorities or the central government [27] . \u2020 Influenza A(H1N1) was classified as a Class B infectious disease and was added to the list as a separate entity during the 2009 pandemic [29] .", [["infection", "DISEASE", 68, 77], ["Influenza A", "DISEASE", 362, 373], ["Class B infectious disease", "DISEASE", 400, 426], ["patients", "ORGANISM", 128, 136], ["\u2020", "ORGANISM", 360, 361], ["Influenza A", "ORGANISM", 362, 373], ["H1N1", "ORGANISM", 374, 378], ["patients", "SPECIES", 128, 136], ["class A", "SPECIES", 36, 43], ["Influenza A(H1N1)", "SPECIES", 362, 379], ["A diseases", "PROBLEM", 42, 52], ["prompt infection control measures", "TREATMENT", 61, 94], ["immediate isolation of patients", "TREATMENT", 105, 136], ["testing specimens", "TEST", 239, 256], ["A pathogens", "PROBLEM", 266, 277], ["Influenza", "PROBLEM", 362, 371], ["infection", "OBSERVATION", 68, 77], ["infectious", "OBSERVATION", 408, 418]]], ["On October 28, 2013, it was announced by the Chinese government that starting from January 1, 2014, influenza A(H1N1) would cease to be listed separately and would be grouped with other influenza strains as an aggregated number listed in Class C [30] .Ethics Statementdoi:10.1371/journal.pone.0126092.t001 secondary data analysis of the WeiboScope dataset of 2012.", [["influenza", "DISEASE", 186, 195], ["other influenza strains", "PROBLEM", 180, 203], ["secondary data analysis", "TEST", 306, 329], ["the WeiboScope dataset", "TEST", 333, 355]]], ["No attempt was made to inform Weibo users of the current study.", [["the current study", "TEST", 45, 62]]], ["The data had been de-identified before the current analysis began.1(a) News (outbreaks)Chinese microbloggers reacted to news about outbreaks of cholera, hepatitis C, influenza A (H1N1) and anthrax in different parts of China (Table 2 ).", [["cholera, hepatitis C", "DISEASE", 144, 164], ["influenza A (H1N1) and anthrax", "DISEASE", 166, 196], ["hepatitis C", "ORGANISM", 153, 164], ["influenza A (H1N1)", "ORGANISM", 166, 184], ["influenza A (H1N1", "SPECIES", 166, 183], ["the current analysis", "TEST", 39, 59], ["cholera", "PROBLEM", 144, 151], ["hepatitis C", "PROBLEM", 153, 164], ["influenza A (H1N1)", "PROBLEM", 166, 184], ["anthrax", "PROBLEM", 189, 196], ["hepatitis", "ANATOMY", 153, 162]]], ["An example was the news of an outbreak of hepatitis C infection in Zijin County, Guangdong Province (Fig 2; Table 3 ).", [["hepatitis C infection", "DISEASE", 42, 63], ["hepatitis C", "ORGANISM", 42, 53], ["hepatitis C infection", "PROBLEM", 42, 63], ["outbreak", "OBSERVATION_MODIFIER", 30, 38], ["hepatitis", "OBSERVATION", 42, 51], ["infection", "OBSERVATION", 54, 63]]], ["Other posts include personal comments, including the personal experience of a journalist who investigated the case and who overcame many hurdles before the report was published (see S1 File for details).1(b) News (cases)News of cases of human infection of avian influenza, epidemic hemorrhagic fever (in the United Kingdom), epidemic encephalitis B, scarlet fever, malaria, echinococciosis and diarrhea also attracted microblog users' attention ( Table 2) .", [["infection", "DISEASE", 243, 252], ["avian influenza", "DISEASE", 256, 271], ["hemorrhagic fever", "DISEASE", 282, 299], ["encephalitis B", "DISEASE", 334, 348], ["scarlet fever", "DISEASE", 350, 363], ["malaria", "DISEASE", 365, 372], ["echinococciosis", "DISEASE", 374, 389], ["diarrhea", "DISEASE", 394, 402], ["human", "ORGANISM", 237, 242], ["avian influenza", "ORGANISM", 256, 271], ["human", "SPECIES", 237, 242], ["avian influenza", "SPECIES", 256, 271], ["epidemic hemorrhagic fever", "SPECIES", 273, 299], ["human", "SPECIES", 237, 242], ["human infection", "PROBLEM", 237, 252], ["avian influenza", "PROBLEM", 256, 271], ["epidemic hemorrhagic fever", "PROBLEM", 273, 299], ["epidemic encephalitis B", "PROBLEM", 325, 348], ["scarlet fever", "PROBLEM", 350, 363], ["malaria", "PROBLEM", 365, 372], ["echinococciosis", "PROBLEM", 374, 389], ["diarrhea", "PROBLEM", 394, 402], ["infection", "OBSERVATION", 243, 252], ["epidemic", "OBSERVATION_MODIFIER", 325, 333], ["encephalitis", "OBSERVATION", 334, 346], ["scarlet fever", "OBSERVATION", 350, 363], ["malaria", "OBSERVATION", 365, 372]]], ["One example was a severe malaria infection in a Chinese worker who had returned from Africa; this case attracted a lot of attention (Fig 2; Table 3 ), including newspaper coverage [31] (see S1 File for details).Health education / informationHealth promotion campaigns organized by the Chinese health authorities, such as World AIDS Day (Fig 2) and National Immunization Day for poliomyelitis could attract Weibo users' attention.", [["malaria infection", "DISEASE", 25, 42], ["AIDS", "DISEASE", 327, 331], ["poliomyelitis", "DISEASE", 378, 391], ["a severe malaria infection", "PROBLEM", 16, 42], ["poliomyelitis", "PROBLEM", 378, 391], ["severe", "OBSERVATION_MODIFIER", 18, 24], ["malaria", "OBSERVATION_MODIFIER", 25, 32], ["infection", "OBSERVATION", 33, 42]]], ["Weibo users could also share health information from other sources too, as in the case of hepatitis A, hepatitis E, measles, typhoid, pertussis, diphtheria, tetanus, scarlet fever, brucellosis, leptospirosis, mumps, rubella, conjunctivitis and filariasis (Table 2 ).", [["Weibo", "CHEMICAL", 0, 5], ["hepatitis A", "DISEASE", 90, 101], ["hepatitis E", "DISEASE", 103, 114], ["measles, typhoid, pertussis", "DISEASE", 116, 143], ["diphtheria", "DISEASE", 145, 155], ["tetanus", "DISEASE", 157, 164], ["scarlet fever", "DISEASE", 166, 179], ["brucellosis", "DISEASE", 181, 192], ["leptospirosis", "DISEASE", 194, 207], ["mumps", "DISEASE", 209, 214], ["rubella", "DISEASE", 216, 223], ["conjunctivitis", "DISEASE", 225, 239], ["filariasis", "DISEASE", 244, 254], ["hepatitis A", "ORGANISM", 90, 101], ["hepatitis E", "ORGANISM", 103, 114], ["measles", "ORGANISM", 116, 123], ["hepatitis A", "SPECIES", 90, 101], ["hepatitis E", "SPECIES", 103, 114], ["hepatitis A", "PROBLEM", 90, 101], ["hepatitis E", "PROBLEM", 103, 114], ["measles", "PROBLEM", 116, 123], ["typhoid", "PROBLEM", 125, 132], ["pertussis", "PROBLEM", 134, 143], ["diphtheria", "PROBLEM", 145, 155], ["tetanus", "PROBLEM", 157, 164], ["scarlet fever", "PROBLEM", 166, 179], ["brucellosis", "PROBLEM", 181, 192], ["leptospirosis", "PROBLEM", 194, 207], ["mumps", "PROBLEM", 209, 214], ["rubella", "PROBLEM", 216, 223], ["conjunctivitis", "PROBLEM", 225, 239], ["filariasis", "PROBLEM", 244, 254], ["hepatitis", "OBSERVATION", 90, 99], ["brucellosis", "OBSERVATION", 181, 192], ["conjunctivitis", "OBSERVATION", 225, 239], ["filariasis", "OBSERVATION", 244, 254]]], ["One example is that the recommendation made by the Advisory Committee of Immunization Practice of the U.S. Centers for Disease Control and Prevention that all pregnant women should receive the Tdap 3-in-1 vaccine was circulated online by certain microbloggers in China (Fig 2; Table 3 ).Health education / informationBoth peaks of posts about diphtheria and pertussis were online conversations about this recommendation.", [["diphtheria", "DISEASE", 343, 353], ["women", "ORGANISM", 168, 173], ["women", "SPECIES", 168, 173], ["Immunization", "TREATMENT", 73, 85], ["Disease Control", "TREATMENT", 119, 134], ["the Tdap", "TREATMENT", 189, 197], ["diphtheria", "PROBLEM", 343, 353], ["pertussis", "PROBLEM", 358, 367]]], ["For example, the peaks for measles and mumps were about \"Four diseases that have symptoms similar to the common cold\" (see S1 File for details).Alternative health information / Traditional Chinese MedicineAlternative health information or knowledge of Traditional Chinese Medicine may attract Weibo users' attention, as in the case of dysentery.", [["measles", "DISEASE", 27, 34], ["mumps", "DISEASE", 39, 44], ["dysentery", "DISEASE", 335, 344], ["measles", "PROBLEM", 27, 34], ["mumps", "PROBLEM", 39, 44], ["Four diseases", "PROBLEM", 57, 70], ["symptoms", "PROBLEM", 81, 89], ["Traditional Chinese Medicine", "TREATMENT", 252, 280], ["dysentery", "PROBLEM", 335, 344], ["dysentery", "OBSERVATION", 335, 344]]], ["The peak for \"dysentery\" was generated by a post (and its reposts) about \"food that cannot be consumed together with chicken meat\", including penis et testis canis, a type of traditional Chinese medicine (Fig 2; Table 3 ).", [["meat", "ANATOMY", 125, 129], ["dysentery", "DISEASE", 14, 23], ["chicken", "ORGANISM", 117, 124], ["meat", "ORGANISM_SUBDIVISION", 125, 129], ["penis et testis canis", "ORGANISM", 142, 163], ["chicken", "SPECIES", 117, 124], ["testis canis", "SPECIES", 151, 163], ["chicken", "SPECIES", 117, 124], ["\"dysentery", "PROBLEM", 13, 23], ["penis et testis canis", "PROBLEM", 142, 163], ["traditional Chinese medicine", "TREATMENT", 175, 203], ["peak", "OBSERVATION_MODIFIER", 4, 8], ["penis", "ANATOMY", 142, 147], ["testis", "ANATOMY", 151, 157]]], ["According to that post, consuming it together with chicken meat will lead to dysentery (see S1 File for details).Commercial advertisement / entertainmentCommercial advertisements and the entertainment industry might also lead to an increase in Weibo posts that mentioned certain diseases, as in the case of plague, dengue, influenza and leprosy (Table 2 ).", [["meat", "ANATOMY", 59, 63], ["dysentery", "DISEASE", 77, 86], ["plague", "DISEASE", 307, 313], ["dengue", "DISEASE", 315, 321], ["influenza", "DISEASE", 323, 332], ["leprosy", "DISEASE", 337, 344], ["chicken", "ORGANISM", 51, 58], ["meat", "ORGANISM_SUBDIVISION", 59, 63], ["chicken", "SPECIES", 51, 58], ["chicken", "SPECIES", 51, 58], ["dysentery", "PROBLEM", 77, 86], ["an increase in Weibo posts", "PROBLEM", 229, 255], ["certain diseases", "PROBLEM", 271, 287], ["plague", "PROBLEM", 307, 313], ["dengue", "PROBLEM", 315, 321], ["influenza", "PROBLEM", 323, 332], ["increase", "OBSERVATION_MODIFIER", 232, 240], ["plague", "OBSERVATION", 307, 313]]], ["The travel agency gave customers mosquito repellent cream as a gift to prevent dengue (Fig 2; Table 3 ; see S1 File for details).Social issuesWeibo users discussed various social issues, such as gender equality (gonorrhea and syphilis), discrimination against carriers of certain viruses (hepatitis B), the loss of trust between the government and the citizens (SARS), and the loss of trust between the medical profession and the patients (meningitis, schistosomiasis and hand-foot-and-mouth disease) (Fig 2; Table 2 ).", [["hand", "ANATOMY", 472, 476], ["dengue", "DISEASE", 79, 85], ["gonorrhea", "DISEASE", 212, 221], ["syphilis", "DISEASE", 226, 234], ["hepatitis B", "DISEASE", 289, 300], ["loss of trust", "DISEASE", 307, 320], ["SARS", "DISEASE", 362, 366], ["meningitis", "DISEASE", 440, 450], ["schistosomiasis", "DISEASE", 452, 467], ["hand-foot-and-mouth disease", "DISEASE", 472, 499], ["hepatitis B", "ORGANISM", 289, 300], ["patients", "ORGANISM", 430, 438], ["hand", "ORGANISM_SUBDIVISION", 472, 476], ["foot", "ORGANISM_SUBDIVISION", 477, 481], ["patients", "SPECIES", 430, 438], ["foot-and-mouth", "SPECIES", 477, 491], ["dengue", "SPECIES", 79, 85], ["dengue", "PROBLEM", 79, 85], ["gonorrhea", "PROBLEM", 212, 221], ["syphilis", "PROBLEM", 226, 234], ["certain viruses (hepatitis B", "PROBLEM", 272, 300], ["meningitis", "PROBLEM", 440, 450], ["schistosomiasis and hand-foot", "PROBLEM", 452, 481], ["mouth disease", "PROBLEM", 486, 499], ["meningitis", "OBSERVATION", 440, 450], ["hand", "ANATOMY", 472, 476], ["foot", "ANATOMY", 477, 481], ["mouth", "ANATOMY", 486, 491]]], ["One example was a petition to end discrimination against hepatitis B virus (HBV) carriers, addressed to the Chinese People's Congress and the Chinese People's Political Consultative Conference (Fig 2; Table 3 ).", [["hepatitis B", "DISEASE", 57, 68], ["hepatitis B virus", "ORGANISM", 57, 74], ["HBV", "ORGANISM", 76, 79], ["hepatitis B virus", "SPECIES", 57, 74], ["People", "SPECIES", 116, 122], ["People", "SPECIES", 150, 156], ["hepatitis B virus", "SPECIES", 57, 74], ["HBV", "SPECIES", 76, 79], ["hepatitis B virus", "PROBLEM", 57, 74]]], ["A civil rights advocate who was also an HBV carrier used Weibo to contact delegates and asked if they would submit the proposal on behalf of the China's 100 million HBV carriers (see S1 File for details).OthersNews and online discussion that were not pertaining to infectious diseases might mention the infectious diseases (rabies and tuberculosis) for other reasons.", [["infectious diseases", "DISEASE", 265, 284], ["infectious diseases", "DISEASE", 303, 322], ["rabies", "DISEASE", 324, 330], ["tuberculosis", "DISEASE", 335, 347], ["HBV", "ORGANISM", 40, 43], ["HBV", "ORGANISM", 165, 168], ["HBV", "SPECIES", 40, 43], ["HBV", "SPECIES", 165, 168], ["infectious diseases", "PROBLEM", 265, 284], ["the infectious diseases", "PROBLEM", 299, 322], ["tuberculosis", "PROBLEM", 335, 347]]], ["An example was the so-called \"Miami cannibal attack\" in the United States leading to a peak on the keyword for rabies (Fig 2 ; Table 3 ; see S1 File for details).DiscussionWe performed qualitative content analysis to investigate what news, events or information would trigger a reaction among Chinese social media users, leading to a peak in the daily count of Weibo posts containing keywords for a list of infectious diseases, notifiable in mainland China as of 2012.", [["rabies", "DISEASE", 111, 117], ["infectious diseases", "DISEASE", 407, 426], ["qualitative content analysis", "TEST", 185, 213], ["infectious diseases", "PROBLEM", 407, 426], ["infectious", "OBSERVATION", 407, 417]]], ["First, digital epidemiologists use time series of search query data or social media data to predict trends of infectious diseases, such as influenza [5, 32] .", [["infectious diseases", "DISEASE", 110, 129], ["influenza", "DISEASE", 139, 148], ["query data", "TEST", 57, 67], ["infectious diseases", "PROBLEM", 110, 129], ["influenza", "PROBLEM", 139, 148]]], ["These prediction analyses rely on keywords or their combinations to identify the relevant search query data or Twitter tweets.", [["These prediction analyses", "TEST", 0, 25]]], ["The underlying assumption is that an increase in disease incidence would motivate people to search online for health information or to share their experiences online via social media.", [["people", "ORGANISM", 82, 88], ["people", "SPECIES", 82, 88], ["an increase in disease incidence", "PROBLEM", 34, 66], ["increase", "OBSERVATION_MODIFIER", 37, 45], ["disease", "OBSERVATION", 49, 56]]], ["Our analysis highlights the fact that social media trends of disease-specific keywords could reflect people's online reaction to a variety of events and information, of which many are not related to any actual outbreak.", [["people", "ORGANISM", 101, 107], ["people", "SPECIES", 101, 107], ["Our analysis", "TEST", 0, 12], ["disease", "PROBLEM", 61, 68]]], ["Our study paves the way for future studies that can investigate the predictive value of similar news, events or information.DiscussionSecond, public health agencies use social media to communicate messages of health promotion or disease prevention to the public [10, 11, 12, 14] .", [["Our study", "TEST", 0, 9], ["future studies", "TEST", 28, 42]]], ["Our analysis identified examples of health promotion events or messages that triggered people's reactions (e.g. World AIDS Day, Fig 2) , as well as examples of alternative health information.", [["AIDS", "DISEASE", 118, 122], ["people", "ORGANISM", 87, 93], ["people", "SPECIES", 87, 93], ["Our analysis", "TEST", 0, 12]]], ["For example, concurring with previous reports [33] , our content analysis revealed that tension between the medical and public health professions and the general public is often a topic of heated discussion on social media in China.", [["our content analysis", "TEST", 53, 73], ["tension", "OBSERVATION_MODIFIER", 88, 95]]], ["Examples such as the news of an alleged cover-up of a hepatitis C outbreak or the conflict associated with testing for sexually transmitted diseases, leading to the peaks of microblog posts that we observed, revealed a mistrust of government institutions and the medical profession at large.", [["hepatitis C", "DISEASE", 54, 65], ["sexually transmitted diseases", "DISEASE", 119, 148], ["a hepatitis C outbreak", "PROBLEM", 52, 74], ["testing", "TEST", 107, 114], ["sexually transmitted diseases", "PROBLEM", 119, 148], ["hepatitis", "OBSERVATION", 54, 63], ["large", "OBSERVATION_MODIFIER", 285, 290]]], ["Transparency in disease control efforts and outbreak data management should be part and parcel of an effective public health communications strategy.Strength and limitationsOur study is the first to categorize Chinese microblog contents on 42 infectious diseases and also identify the related news and/or information.", [["infectious diseases", "DISEASE", 243, 262], ["Transparency in disease control efforts", "PROBLEM", 0, 39], ["outbreak data management", "TREATMENT", 44, 68], ["Our study", "TEST", 173, 182], ["disease", "OBSERVATION", 16, 23]]], ["While another study compared Chinese and US social media use in health communication at the onset of the H1N1 pandemic, no Weibo data were analyzed therein [34] .Strength and limitationsIn our study, we manually coded Chinese microblog posts to obtain a better understanding of the actual contents.", [["H1N1", "DISEASE", 105, 109], ["another study", "TEST", 6, 19], ["our study", "TEST", 189, 198]]], ["While there are other studies that used computerized machine learning methods [35, 36] , or keyword search to analyze health-related Twitter contents [37] , there are others that manually coded Twitter data on: childhood obesity [38] , influenza A(H1N1) [39] , and antibiotics [40] .Strength and limitationsThe Chinese microblogger community is a fraction of the 1.3 billion people living in mainland China.", [["obesity", "DISEASE", 221, 228], ["influenza A", "DISEASE", 236, 247], ["influenza A", "ORGANISM", 236, 247], ["people", "ORGANISM", 375, 381], ["people", "SPECIES", 375, 381], ["other studies", "TEST", 16, 29], ["childhood obesity", "PROBLEM", 211, 228], ["influenza A(H1N1)", "PROBLEM", 236, 253], ["antibiotics", "TREATMENT", 265, 276]]], ["According to a random sampling study, Weibo users are more likely to be male and living in provinces/regions that are more economically developed (with some exceptions) [15] .", [["a random sampling study", "TEST", 13, 36]]], ["Of these 350,000 users, 5000 were Chinese dissident writers, journalists and scholars, and another 38,000 were users with an authenticated (also known as VIP) status with more than 10,000 followers, as discussed in the original study [18] .", [["the original study", "TEST", 215, 233]]], ["While our sample constituted less than 1% of all registered users of Sina Weibo, this sampling strategy allowed us to avoid many spam accounts [15] .", [["this sampling strategy", "TREATMENT", 81, 103]]], ["The Weibo universe is highly heterogeneous.", [["highly", "OBSERVATION_MODIFIER", 22, 28], ["heterogeneous", "OBSERVATION_MODIFIER", 29, 42]]], ["A random sampling study found that over 50% of Sina Weibo users have never posted anything, whereas 80% of the original posts were created by 5% of the users [15] .", [["A random sampling study", "TEST", 0, 23]]], ["Nonetheless, our findings may not be generalizable to samples obtained through other sampling strategies.", [["samples", "ANATOMY", 54, 61], ["other sampling strategies", "TREATMENT", 79, 104], ["may not be", "UNCERTAINTY", 26, 36]]], ["Our operational sampling parameters were not determined to optimize data collection specific to any diseases.", [["Our operational sampling parameters", "TEST", 0, 35], ["data collection", "TEST", 68, 83], ["any diseases", "PROBLEM", 96, 108]]], ["Future research design that is customized for specific epidemiologic research may help reconfirm our research findings.Strength and limitationsIn the absence of content analysis of Weibo posts for each disease keyword at the baseline, and given the diversity of information that triggered the elevated Weibo activities, we did not attempt to compare across the categories of information that triggered the elevated Weibo activities.", [["content analysis", "TEST", 161, 177], ["each disease keyword", "PROBLEM", 197, 217], ["the elevated Weibo activities", "PROBLEM", 289, 318], ["the elevated Weibo activities", "PROBLEM", 402, 431], ["elevated", "OBSERVATION", 406, 414]]], ["Future research along that direction is warranted.Strength and limitationsOur analysis is only a small step towards a better understanding of the Chinese online community's understanding and communications about health issues.", [["Our analysis", "TEST", 74, 86]]], ["Our study provides the ground work for future research that will shed light upon these issues.ConclusionsInfectious disease-related information triggered Chinese social media users' reactions to create and repost microblog posts.", [["Our study", "TEST", 0, 9], ["Infectious", "OBSERVATION", 105, 115]]], ["Our study opens the door towards a better understanding of online health information diffusion and health information seeking behavior that will better equip digital epidemiologists to fine-tune their prediction and detection tools, and will enable health communicators to finetune their social media messages.ConclusionsThe identification of news and information pertaining to infectious diseases that trigger an elevated microblog activity and the contents thereof has utility and significance in health communications and disease surveillance.", [["infectious diseases", "DISEASE", 378, 397], ["Our study", "TEST", 0, 9], ["infectious diseases", "PROBLEM", 378, 397], ["an elevated microblog activity", "PROBLEM", 411, 441], ["disease surveillance", "TEST", 525, 545], ["elevated", "OBSERVATION_MODIFIER", 414, 422], ["microblog activity", "OBSERVATION", 423, 441]]], ["Our study covers 42 infectious diseases.", [["infectious diseases", "DISEASE", 20, 39], ["Our study", "TEST", 0, 9]]], ["We demonstrated how information and issues about these diseases drew social media users' attention and led to increased social media traffic.", [["these diseases", "PROBLEM", 49, 63]]], ["Such finding, in turn, will pave the way for future studies about online health communications.", [["future studies", "TEST", 45, 59]]], ["This study contributes to the literature by analyzing data from Sina Weibo, the leading microblogging platforms in China, where Twitter is blocked.", [["This study", "TEST", 0, 10]]], ["This helps facilitate better social media health communication and may shed light on the \"false positives\" in digital disease detection.", [["digital disease detection", "PROBLEM", 110, 135]]], ["The lessons learned in our study can be transferrable to other middle income countries.", [["our study", "TEST", 23, 32]]]], "PMC7438749": [["IntroductionThe last two decades witnessed the emergence of three zoonotic coronaviruses that crossed the species barrier and caused outbreaks in humans: severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002, Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, and most recently, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in 2019 (1).", [["zoonotic coronaviruses", "DISEASE", 66, 88], ["acute respiratory syndrome coronavirus", "DISEASE", 161, 199], ["SARS-CoV)", "DISEASE", 201, 210], ["Middle East respiratory syndrome coronavirus", "DISEASE", 220, 264], ["acute respiratory syndrome coronavirus", "DISEASE", 311, 349], ["coronaviruses", "ORGANISM", 75, 88], ["humans", "ORGANISM", 146, 152], ["severe acute respiratory syndrome coronavirus", "ORGANISM", 154, 199], ["SARS-CoV", "ORGANISM", 201, 209], ["Middle East respiratory syndrome coronavirus", "ORGANISM", 220, 264], ["MERS-CoV", "ORGANISM", 266, 274], ["humans", "SPECIES", 146, 152], ["humans", "SPECIES", 146, 152], ["severe acute respiratory syndrome coronavirus", "SPECIES", 154, 199], ["SARS-CoV", "SPECIES", 201, 209], ["Middle East respiratory syndrome coronavirus", "SPECIES", 220, 264], ["MERS-CoV", "SPECIES", 266, 274], ["severe acute respiratory syndrome coronavirus", "SPECIES", 304, 349], ["SARS-CoV-2", "SPECIES", 353, 363], ["three zoonotic coronaviruses", "PROBLEM", 60, 88], ["severe acute respiratory syndrome coronavirus", "PROBLEM", 154, 199], ["Middle East respiratory syndrome coronavirus", "PROBLEM", 220, 264], ["severe acute respiratory syndrome coronavirus", "PROBLEM", 304, 349], ["CoV", "TEST", 358, 361], ["severe", "OBSERVATION_MODIFIER", 154, 160], ["acute", "OBSERVATION_MODIFIER", 161, 166], ["respiratory syndrome coronavirus", "OBSERVATION", 167, 199], ["Middle", "ANATOMY_MODIFIER", 220, 226], ["respiratory syndrome", "OBSERVATION", 232, 252], ["severe", "OBSERVATION_MODIFIER", 304, 310], ["acute", "OBSERVATION_MODIFIER", 311, 316], ["respiratory syndrome coronavirus", "OBSERVATION", 317, 349]]], ["All three viruses are \u03b2-coronaviruses belonging to the Orthocoronavirinae subfamily in the Coronaviriade viral family (1).", [["\u03b2-coronaviruses", "GENE_OR_GENE_PRODUCT", 22, 37], ["Orthocoronavirinae", "GENE_OR_GENE_PRODUCT", 55, 73], ["Coronaviriade viral", "ORGANISM", 91, 110], ["Orthocoronavirinae subfamily", "PROTEIN", 55, 83], ["Coronaviriade viral family", "PROTEIN", 91, 117], ["viruses", "OBSERVATION", 10, 17]]], ["Similar to SARS-CoV, the newly emerged SARS-CoV-2 utilizes the angiotensin-converting enzyme 2 (ACE2) cellular receptor for cell entry (2).", [["cellular", "ANATOMY", 102, 110], ["cell", "ANATOMY", 124, 128], ["SARS", "DISEASE", 11, 15], ["SARS", "DISEASE", 39, 43], ["angiotensin", "CHEMICAL", 63, 74], ["SARS-CoV", "GENE_OR_GENE_PRODUCT", 11, 19], ["SARS-CoV-2", "ORGANISM", 39, 49], ["angiotensin-converting enzyme 2", "GENE_OR_GENE_PRODUCT", 63, 94], ["ACE2", "GENE_OR_GENE_PRODUCT", 96, 100], ["cellular", "CELL", 102, 110], ["cell", "CELL", 124, 128], ["angiotensin-converting enzyme 2 (ACE2) cellular receptor", "PROTEIN", 63, 119], ["SARS-CoV", "SPECIES", 11, 19], ["SARS-CoV", "SPECIES", 39, 47], ["CoV", "TEST", 44, 47], ["the angiotensin-converting enzyme 2 (ACE2) cellular receptor", "TREATMENT", 59, 119], ["SARS", "OBSERVATION", 11, 15]]], ["Although many drugs have been proposed as potential therapeutic agents for coronavirus disease 2019 (COVID-19), no specific antiviral agent has been proven effective to date (3).", [["coronavirus disease", "DISEASE", 75, 94], ["COVID-19", "CHEMICAL", 101, 109], ["many drugs", "TREATMENT", 9, 19], ["therapeutic agents", "TREATMENT", 52, 70], ["coronavirus disease", "PROBLEM", 75, 94], ["COVID", "TEST", 101, 106], ["specific antiviral agent", "TREATMENT", 115, 139]]], ["Convalescent plasma is effective in treating many viral conditions, including respiratory infections (4).", [["plasma", "ANATOMY", 13, 19], ["respiratory", "ANATOMY", 78, 89], ["respiratory infections", "DISEASE", 78, 100], ["plasma", "ORGANISM_SUBSTANCE", 13, 19], ["Convalescent plasma", "TEST", 0, 19], ["many viral conditions", "PROBLEM", 45, 66], ["respiratory infections", "PROBLEM", 78, 100], ["effective", "OBSERVATION_MODIFIER", 23, 32], ["viral conditions", "OBSERVATION", 50, 66], ["respiratory", "ANATOMY", 78, 89], ["infections", "OBSERVATION", 90, 100]]], ["Hence, the therapeutic potential of convalescent plasma for COVID-19 is a noteworthy topic.", [["plasma", "ANATOMY", 49, 55], ["COVID-19", "CHEMICAL", 60, 68], ["convalescent", "ORGANISM", 36, 48], ["plasma", "ORGANISM_SUBSTANCE", 49, 55], ["convalescent plasma", "TEST", 36, 55], ["COVID", "TEST", 60, 65]]], ["This viewpoint discusses the plausibility of using convalescent plasma from COVID-19 recovered patients as an effective, feasible therapeutic intervention for COVID-19.HistoryConvalescent plasma has been used since the 1890s to treat several infectious diseases (5).", [["plasma", "ANATOMY", 64, 70], ["plasma", "ANATOMY", 188, 194], ["infectious diseases", "DISEASE", 242, 261], ["convalescent", "ORGANISM", 51, 63], ["plasma", "ORGANISM_SUBSTANCE", 64, 70], ["COVID-19", "CELL", 76, 84], ["patients", "ORGANISM", 95, 103], ["plasma", "ORGANISM_SUBSTANCE", 188, 194], ["patients", "SPECIES", 95, 103], ["convalescent plasma", "TEST", 51, 70], ["COVID", "TEST", 76, 81], ["therapeutic intervention", "TREATMENT", 130, 154], ["COVID", "TEST", 159, 164], ["several infectious diseases", "PROBLEM", 234, 261], ["infectious", "OBSERVATION", 242, 252]]], ["In the early 20th century, convalescent sera obtained from recovered individuals during outbreaks of viral etiology, such as influenza and measles, were used for therapeutic purposes (5).", [["sera", "ANATOMY", 40, 44], ["viral etiology", "DISEASE", 101, 115], ["influenza", "DISEASE", 125, 134], ["measles", "DISEASE", 139, 146], ["convalescent", "ORGANISM", 27, 39], ["sera", "ORGANISM_SUBSTANCE", 40, 44], ["convalescent sera", "TEST", 27, 44], ["viral etiology", "PROBLEM", 101, 115], ["influenza", "PROBLEM", 125, 134], ["measles", "PROBLEM", 139, 146]]], ["In the early 21st century, convalescent plasma was utilized to increase the survival rate among critically ill patients during the H1N1 pandemic in 2009, as well as during the SARS-CoV and MERS-CoV outbreaks in 2002 and 2012, respectively (5).", [["plasma", "ANATOMY", 40, 46], ["critically ill", "DISEASE", 96, 110], ["SARS", "DISEASE", 176, 180], ["convalescent", "ORGANISM", 27, 39], ["plasma", "ORGANISM_SUBSTANCE", 40, 46], ["patients", "ORGANISM", 111, 119], ["SARS-CoV", "ORGANISM", 176, 184], ["MERS-CoV", "ORGANISM", 189, 197], ["patients", "SPECIES", 111, 119], ["SARS-CoV", "SPECIES", 176, 184], ["MERS-CoV", "SPECIES", 189, 197], ["convalescent plasma", "TEST", 27, 46], ["the survival rate", "TREATMENT", 72, 89]]], ["Thirty-two studies demonstrated a consistent reduction in mortality among convalescent plasma-treated patients with severe SARS and influenza infections without convalescent plasma-related adverse effects (6).", [["plasma", "ANATOMY", 87, 93], ["SARS", "DISEASE", 123, 127], ["influenza infections", "DISEASE", 132, 152], ["convalescent", "ORGANISM", 74, 86], ["plasma", "ORGANISM_SUBSTANCE", 87, 93], ["patients", "ORGANISM", 102, 110], ["patients", "SPECIES", 102, 110], ["two studies", "TEST", 7, 18], ["convalescent plasma", "TEST", 74, 93], ["severe SARS", "PROBLEM", 116, 127], ["influenza infections", "PROBLEM", 132, 152], ["reduction", "OBSERVATION_MODIFIER", 45, 54], ["severe", "OBSERVATION_MODIFIER", 116, 122], ["SARS", "OBSERVATION", 123, 127], ["influenza", "OBSERVATION", 132, 141]]], ["The pooled data from 27 out of these 32 studies revealed a statistically significant reduction in the pooled odds of death among the convalescent plasma-treated group compared with the control group (6).", [["plasma", "ANATOMY", 146, 152], ["death", "DISEASE", 117, 122], ["plasma", "ORGANISM_SUBSTANCE", 146, 152], ["The pooled data", "TEST", 0, 15], ["these 32 studies", "TEST", 31, 47], ["death", "PROBLEM", 117, 122], ["the convalescent plasma", "TEST", 129, 152], ["significant", "OBSERVATION_MODIFIER", 73, 84], ["reduction", "OBSERVATION_MODIFIER", 85, 94]]], ["Further, during the Ebola virus epidemic in West Africa in 2014, convalescent plasma therapy (CPT) was used empirically, as recommended by the World Health Organization (7).Mode of ActionConvalescent plasma exemplifies passive immune therapy, which combats invading pathogens by administering antibodies (2).", [["plasma", "ANATOMY", 78, 84], ["plasma", "ANATOMY", 200, 206], ["Ebola virus epidemic", "DISEASE", 20, 40], ["Ebola virus", "ORGANISM", 20, 31], ["plasma", "ORGANISM_SUBSTANCE", 78, 84], ["plasma", "ORGANISM_SUBSTANCE", 200, 206], ["antibodies", "PROTEIN", 293, 303], ["Ebola virus", "SPECIES", 20, 31], ["Ebola virus", "SPECIES", 20, 31], ["the Ebola virus", "PROBLEM", 16, 31], ["convalescent plasma therapy (CPT)", "TREATMENT", 65, 98], ["ActionConvalescent plasma", "TREATMENT", 181, 206], ["passive immune therapy", "TREATMENT", 219, 241], ["invading pathogens", "PROBLEM", 257, 275]]], ["It is hypothesized that polyclonal antibodies in convalescent plasma neutralize the circulating initial inoculum of microbes and facilitate antibody-dependent cellular cytotoxicity and phagocytosis (5).", [["plasma", "ANATOMY", 62, 68], ["cellular", "ANATOMY", 159, 167], ["convalescent", "ORGANISM", 49, 61], ["plasma", "ORGANISM_SUBSTANCE", 62, 68], ["cellular", "CELL", 159, 167], ["polyclonal antibodies", "PROTEIN", 24, 45], ["polyclonal antibodies", "TEST", 24, 45], ["convalescent plasma neutralize", "TREATMENT", 49, 79], ["antibody", "TEST", 140, 148], ["dependent cellular cytotoxicity", "PROBLEM", 149, 180], ["phagocytosis", "TEST", 185, 197], ["cellular cytotoxicity", "OBSERVATION", 159, 180]]], ["In the context of CPT for COVID-19, the antibodies are anticipated to employ both immune mechanisms, but the main one would be neutralization, which occurs when neutralizing antibodies block SARS-CoV-2 spike proteins, thereby aborting viral entry (2, 4, 5).", [["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 191, 201], ["antibodies", "PROTEIN", 40, 50], ["neutralizing antibodies", "PROTEIN", 161, 184], ["SARS-CoV-2 spike proteins", "PROTEIN", 191, 216], ["CPT", "TEST", 18, 21], ["COVID", "TEST", 26, 31], ["the antibodies", "TREATMENT", 36, 50], ["neutralization", "PROBLEM", 127, 141], ["neutralizing antibodies block SARS", "PROBLEM", 161, 195], ["CoV", "TEST", 196, 199], ["2 spike proteins", "PROBLEM", 200, 216], ["neutralization", "OBSERVATION", 127, 141]]], ["Hosts naturally develop antibodies 10\u201314 days post-infection; therefore, convalescent plasma administration before seroconversion is believed to be more therapeutically effective (4, 5).CPT for SARS and MERS ::: CPT in Treating Emerging CoronavirusesSeveral studies have shown a favorable outcome of CPT in treating infections caused by emerging coronaviruses (3, 5, 7\u201310).", [["plasma", "ANATOMY", 86, 92], ["SARS", "DISEASE", 194, 198], ["CPT", "CHEMICAL", 212, 215], ["CPT", "CHEMICAL", 300, 303], ["infections", "DISEASE", 316, 326], ["CPT", "CHEMICAL", 300, 303], ["convalescent", "ORGANISM", 73, 85], ["plasma", "ORGANISM_SUBSTANCE", 86, 92], ["CPT", "SIMPLE_CHEMICAL", 300, 303], ["coronaviruses", "ORGANISM", 346, 359], ["antibodies", "PROTEIN", 24, 34], ["antibodies", "PROBLEM", 24, 34], ["convalescent plasma administration", "TREATMENT", 73, 107], ["seroconversion", "TREATMENT", 115, 129], ["SARS", "PROBLEM", 194, 198], ["CPT", "TREATMENT", 212, 215], ["Several studies", "TEST", 250, 265], ["CPT", "PROBLEM", 300, 303], ["treating infections", "PROBLEM", 307, 326], ["infections", "OBSERVATION", 316, 326], ["coronaviruses", "OBSERVATION", 346, 359]]], ["A retrospective non-randomized comparison study addressed the outcome of 40 severely affected SARS-CoV patients, where the treatment group (n = 19) received SARS convalescent plasma while the control group was kept only on methylprednisolone after both groups had finished an empirical combination of ribavirin and methylprednisolone (8).", [["plasma", "ANATOMY", 175, 181], ["SARS-CoV", "DISEASE", 94, 102], ["SARS", "DISEASE", 157, 161], ["methylprednisolone", "CHEMICAL", 223, 241], ["ribavirin", "CHEMICAL", 301, 310], ["methylprednisolone", "CHEMICAL", 315, 333], ["methylprednisolone", "CHEMICAL", 223, 241], ["ribavirin", "CHEMICAL", 301, 310], ["methylprednisolone", "CHEMICAL", 315, 333], ["CoV", "ORGANISM", 99, 102], ["patients", "ORGANISM", 103, 111], ["convalescent", "ORGANISM", 162, 174], ["plasma", "ORGANISM_SUBSTANCE", 175, 181], ["methylprednisolone", "SIMPLE_CHEMICAL", 223, 241], ["ribavirin", "SIMPLE_CHEMICAL", 301, 310], ["methylprednisolone", "SIMPLE_CHEMICAL", 315, 333], ["patients", "SPECIES", 103, 111], ["SARS-CoV", "SPECIES", 94, 102], ["A retrospective non-randomized comparison study", "TEST", 0, 47], ["the treatment group", "TREATMENT", 119, 138], ["SARS convalescent plasma", "TREATMENT", 157, 181], ["methylprednisolone", "TREATMENT", 223, 241], ["ribavirin", "TREATMENT", 301, 310], ["methylprednisolone", "TREATMENT", 315, 333]]], ["Patients in the treatment group were given 200\u2013400 ml of convalescent plasma obtained using an apheresis device from SARS-recovered individuals with a SARS-IgG titer ranging from 160 to 2,560 (8).", [["plasma", "ANATOMY", 70, 76], ["SARS", "DISEASE", 117, 121], ["SARS", "DISEASE", 151, 155], ["Patients", "ORGANISM", 0, 8], ["plasma", "ORGANISM_SUBSTANCE", 70, 76], ["Patients", "SPECIES", 0, 8], ["convalescent plasma", "TREATMENT", 57, 76], ["an apheresis device", "TREATMENT", 92, 111], ["SARS", "PROBLEM", 117, 121], ["a SARS", "TEST", 149, 155], ["IgG titer", "TEST", 156, 165]]], ["In 2003, researchers addressed the outcome in 80 SARS-CoV-infected patients on convalescent plasma (7).", [["plasma", "ANATOMY", 92, 98], ["SARS-CoV-infected", "DISEASE", 49, 66], ["SARS-CoV", "ORGANISM", 49, 57], ["patients", "ORGANISM", 67, 75], ["plasma", "ORGANISM_SUBSTANCE", 92, 98], ["patients", "SPECIES", 67, 75], ["SARS-CoV", "SPECIES", 49, 57], ["convalescent plasma", "TEST", 79, 98]]], ["The SARS-CoV convalescent plasma volume used in this study ranged from 160 to 640 ml with a SARS-IgG titer ranging from 160 to 2,560 (7).", [["plasma", "ANATOMY", 26, 32], ["SARS", "DISEASE", 4, 8], ["SARS-CoV", "ORGANISM", 4, 12], ["convalescent", "ORGANISM", 13, 25], ["plasma", "ORGANISM_SUBSTANCE", 26, 32], ["IgG", "PROTEIN", 97, 100], ["SARS-CoV", "SPECIES", 4, 12], ["The SARS", "TEST", 0, 8], ["CoV convalescent plasma volume", "TEST", 9, 39], ["this study", "TEST", 48, 58], ["a SARS", "TEST", 90, 96], ["IgG titer", "TEST", 97, 106]]], ["The mortality rate among those 80 critical SARS patients was 12.5%, while the overall mortality rate when the SARS epidemic struck Hong Kong in 2003 was 17% (8).", [["SARS", "DISEASE", 43, 47], ["SARS", "DISEASE", 110, 114], ["patients", "ORGANISM", 48, 56], ["patients", "SPECIES", 48, 56], ["The mortality rate", "TEST", 0, 18]]], ["Moreover, this study found that convalescent plasma administration before the 14th day post-onset is associated with a better outcome than its administration after this point (58.3 vs. 15.6%).", [["plasma", "ANATOMY", 45, 51], ["convalescent", "ORGANISM", 32, 44], ["plasma", "ORGANISM_SUBSTANCE", 45, 51], ["this study", "TEST", 10, 20], ["convalescent plasma administration", "TREATMENT", 32, 66]]], ["It was also evident from this study that convalescent plasma administration in SARS-CoV PCR-positive but SARS-seronegative patients was more therapeutically effective than in SARS-CoV PCR-positive and SARS-seropositive patients (66.7 vs. 20%) (7).", [["plasma", "ANATOMY", 54, 60], ["SARS", "DISEASE", 105, 109], ["SARS", "DISEASE", 201, 205], ["convalescent", "ORGANISM", 41, 53], ["plasma", "ORGANISM_SUBSTANCE", 54, 60], ["SARS-CoV", "ORGANISM", 79, 87], ["patients", "ORGANISM", 123, 131], ["SARS-CoV", "ORGANISM", 175, 183], ["patients", "ORGANISM", 219, 227], ["patients", "SPECIES", 123, 131], ["patients", "SPECIES", 219, 227], ["SARS-CoV", "SPECIES", 79, 87], ["SARS-CoV", "SPECIES", 175, 183], ["this study", "TEST", 25, 35], ["convalescent plasma administration", "TEST", 41, 75], ["SARS", "TEST", 79, 83], ["CoV PCR", "TEST", 84, 91], ["SARS", "PROBLEM", 105, 109], ["seronegative patients", "PROBLEM", 110, 131], ["SARS", "TEST", 175, 179], ["CoV PCR", "TEST", 180, 187], ["SARS", "TEST", 201, 205], ["seropositive patients", "TEST", 206, 227]]], ["These findings are in accordance with the notion that the effectiveness of CPT is directly related to its early administration prior to seroconversion (3, 5, 8).", [["CPT", "CHEMICAL", 75, 78], ["CPT", "CHEMICAL", 75, 78], ["CPT", "SIMPLE_CHEMICAL", 75, 78], ["CPT", "TEST", 75, 78], ["seroconversion", "TEST", 136, 150]]], ["A study involving three critical SARS-CoV-infected patients who were treated with 500 ml SARS-CoV convalescent plasma of SARS-CoV IgG titer >640 infusion each showed clinical improvement followed by viral burden decline (9).", [["plasma", "ANATOMY", 111, 117], ["SARS-CoV-infected", "DISEASE", 33, 50], ["SARS", "DISEASE", 121, 125], ["SARS-CoV", "ORGANISM", 33, 41], ["patients", "ORGANISM", 51, 59], ["CoV", "ORGANISM", 94, 97], ["convalescent", "ORGANISM", 98, 110], ["plasma", "ORGANISM_SUBSTANCE", 111, 117], ["CoV", "ORGANISM", 126, 129], ["patients", "SPECIES", 51, 59], ["SARS-CoV", "SPECIES", 33, 41], ["SARS-CoV", "SPECIES", 89, 97], ["SARS-CoV", "SPECIES", 121, 129], ["A study", "TEST", 0, 7], ["SARS", "TEST", 121, 125], ["CoV IgG titer", "TEST", 126, 139], ["viral burden decline", "PROBLEM", 199, 219]]], ["CPT was used to treat three critically ill MERS cases in South Korea (10).", [["CPT", "CHEMICAL", 0, 3], ["critically ill", "DISEASE", 28, 42], ["MERS", "DISEASE", 43, 47], ["CPT", "CHEMICAL", 0, 3], ["CPT", "SIMPLE_CHEMICAL", 0, 3], ["CPT", "TREATMENT", 0, 3]]], ["The study concluded that effective convalescent plasma treatment was associated with a MERS-IgG titer \u226580, while an IgG titer of 40 was ineffective (10).", [["plasma", "ANATOMY", 48, 54], ["convalescent", "ORGANISM", 35, 47], ["plasma", "ORGANISM_SUBSTANCE", 48, 54], ["IgG", "PROTEIN", 92, 95], ["IgG", "PROTEIN", 116, 119], ["The study", "TEST", 0, 9], ["effective convalescent plasma treatment", "TREATMENT", 25, 64], ["a MERS", "TEST", 85, 91], ["IgG titer", "TEST", 92, 101], ["an IgG titer", "TEST", 113, 125]]], ["Further, the neutralization activity could be predicted by ELISA-IgG without conducting sophisticated BSL-3 laboratory-dependent procedures, such as the plaque reduction neutralization test.", [["plaque", "ANATOMY", 153, 159], ["plaque", "PATHOLOGICAL_FORMATION", 153, 159], ["IgG", "PROTEIN", 65, 68], ["the neutralization activity", "TEST", 9, 36], ["ELISA", "TEST", 59, 64], ["dependent procedures", "TREATMENT", 119, 139], ["the plaque reduction neutralization test", "TEST", 149, 189], ["plaque", "OBSERVATION", 153, 159]]], ["At a cutoff optical density of 1.6 and 1.9, the specificity of ELISA-IgG in predicting the neutralization activity was \u226595 and 100%, respectively (10).CPT for COVID-19 ::: CPT in Treating Emerging CoronavirusesIn an uncontrolled case series, five ARDS-complicated COVID-19 patients were on mechanical ventilation, four of whom were \u226550 years of age.", [["CPT", "CHEMICAL", 172, 175], ["ARDS", "DISEASE", 247, 251], ["COVID", "DISEASE", 264, 269], ["COVID-19", "CHEMICAL", 159, 167], ["CPT", "SIMPLE_CHEMICAL", 172, 175], ["patients", "ORGANISM", 273, 281], ["IgG", "PROTEIN", 69, 72], ["patients", "SPECIES", 273, 281], ["a cutoff optical density", "TEST", 3, 27], ["ELISA", "TEST", 63, 68], ["the neutralization activity", "TEST", 87, 114], ["CPT", "TREATMENT", 172, 175], ["Emerging Coronaviruses", "PROBLEM", 188, 210], ["five ARDS", "PROBLEM", 242, 251], ["mechanical ventilation", "TREATMENT", 290, 312], ["optical", "OBSERVATION_MODIFIER", 12, 19], ["density", "OBSERVATION", 20, 27], ["neutralization activity", "OBSERVATION", 91, 114], ["mechanical ventilation", "OBSERVATION", 290, 312]]], ["They received 400 ml of convalescent plasma infusion each immediately after being obtained by apheresis from ABO-compatible donors (3).", [["plasma", "ANATOMY", 37, 43], ["convalescent", "ORGANISM", 24, 36], ["plasma", "ORGANISM_SUBSTANCE", 37, 43], ["donors", "ORGANISM", 124, 130], ["convalescent plasma infusion", "TREATMENT", 24, 52], ["ABO", "TEST", 109, 112]]], ["The convalescent plasma had an IgG titer >1000 and a neutralization titer >40.", [["plasma", "ANATOMY", 17, 23], ["convalescent", "ORGANISM", 4, 16], ["plasma", "ORGANISM_SUBSTANCE", 17, 23], ["IgG", "GENE_OR_GENE_PRODUCT", 31, 34], ["IgG", "PROTEIN", 31, 34], ["The convalescent plasma", "TEST", 0, 23], ["an IgG titer", "TEST", 28, 40], ["a neutralization titer", "TEST", 51, 73]]], ["Following plasma transfusion, all patients manifested a restored normal body temperature within 3 days and the range of their PaO2/FiO2 improved from 172\u2013276 to 284\u2013366 within 12 days (3) (Table 1).", [["plasma", "ANATOMY", 10, 16], ["body", "ANATOMY", 72, 76], ["plasma", "ORGANISM_SUBSTANCE", 10, 16], ["patients", "ORGANISM", 34, 42], ["body", "ORGANISM_SUBDIVISION", 72, 76], ["patients", "SPECIES", 34, 42], ["plasma transfusion", "TREATMENT", 10, 28], ["their PaO2", "TEST", 120, 130], ["FiO2", "TEST", 131, 135], ["body temperature", "OBSERVATION_MODIFIER", 72, 88]]], ["Further, viral load and inflammatory cytokines started to decline while serological responses began to mount after the CPT.", [["CPT", "CHEMICAL", 119, 122], ["inflammatory cytokines", "PROTEIN", 24, 46], ["Further, viral load", "TEST", 0, 19], ["inflammatory cytokines", "PROBLEM", 24, 46], ["serological responses", "TEST", 72, 93], ["the CPT", "TEST", 115, 122], ["viral load", "OBSERVATION", 9, 19], ["inflammatory cytokines", "OBSERVATION", 24, 46]]], ["Moreover, three out of the five patients were extubated and discharged (3).", [["patients", "ORGANISM", 32, 40], ["patients", "SPECIES", 32, 40]]], ["Anecdotal pieces of evidence on the safety and efficacy of convalescent plasma in treating COVID-19 have been reported (11).", [["plasma", "ANATOMY", 72, 78], ["COVID-19", "CHEMICAL", 91, 99], ["COVID-19", "CHEMICAL", 91, 99], ["plasma", "ORGANISM_SUBSTANCE", 72, 78], ["Anecdotal pieces", "TREATMENT", 0, 16], ["convalescent plasma", "TEST", 59, 78], ["COVID", "TEST", 91, 96]]], ["After infusion with 200 ml volume and \u2265640 neutralization titer convalescent plasma, 10 critical COVID-19 patients on supportive and antiviral treatments improved in terms of clinical and laboratory parameters (11).", [["plasma", "ANATOMY", 77, 83], ["plasma", "ORGANISM_SUBSTANCE", 77, 83], ["patients", "ORGANISM", 106, 114], ["patients", "SPECIES", 106, 114], ["neutralization titer convalescent plasma", "TREATMENT", 43, 83], ["supportive and antiviral treatments", "TREATMENT", 118, 153], ["laboratory parameters", "TEST", 188, 209]]], ["Post-plasma infusion, fever, and respiratory symptoms subsided within 3 days while RNAemia took 6 days to become undetected.", [["plasma", "ANATOMY", 5, 11], ["respiratory", "ANATOMY", 33, 44], ["fever", "DISEASE", 22, 27], ["respiratory symptoms", "DISEASE", 33, 53], ["plasma", "ORGANISM_SUBSTANCE", 5, 11], ["Post-plasma infusion", "TREATMENT", 0, 20], ["fever", "PROBLEM", 22, 27], ["respiratory symptoms", "PROBLEM", 33, 53], ["respiratory", "ANATOMY", 33, 44]]], ["No serious adverse reactions were reported (11) (Table 1).", [["serious adverse reactions", "PROBLEM", 3, 28], ["serious", "OBSERVATION_MODIFIER", 3, 10]]], ["Another four severe SARS-CoV-2-infected cases on supportive and antiviral therapy improved following convalescent plasma administration with no adverse effects.", [["plasma", "ANATOMY", 114, 120], ["SARS-CoV-2-infected", "DISEASE", 20, 39], ["SARS-CoV-2", "ORGANISM", 20, 30], ["plasma", "ORGANISM_SUBSTANCE", 114, 120], ["CoV-", "SPECIES", 25, 29], ["Another four severe SARS", "PROBLEM", 0, 24], ["CoV", "TEST", 25, 28], ["infected cases", "PROBLEM", 31, 45], ["antiviral therapy", "TREATMENT", 64, 81], ["convalescent plasma administration", "TREATMENT", 101, 135], ["adverse effects", "PROBLEM", 144, 159], ["severe", "OBSERVATION_MODIFIER", 13, 19], ["SARS", "OBSERVATION", 20, 24]]], ["The volume of CPT ranged from 200 to 2,400 ml (12) (Table 1).", [["CPT", "CHEMICAL", 14, 17], ["CPT", "TEST", 14, 17], ["volume", "OBSERVATION_MODIFIER", 4, 10]]], ["The first reported use of CPT for COVID-19 in South Korea was on two ARDS-complicated SARS-CoV-2-infected patients (13).", [["CPT", "CHEMICAL", 26, 29], ["COVID-19", "CHEMICAL", 34, 42], ["ARDS", "DISEASE", 69, 73], ["SARS-CoV-2-infected", "DISEASE", 86, 105], ["CPT", "CHEMICAL", 26, 29], ["CPT", "SIMPLE_CHEMICAL", 26, 29], ["SARS-CoV-2", "ORGANISM", 86, 96], ["patients", "ORGANISM", 106, 114], ["CoV-", "SPECIES", 91, 95], ["patients", "SPECIES", 106, 114], ["CPT", "TEST", 26, 29], ["COVID", "TEST", 34, 39], ["two ARDS", "PROBLEM", 65, 73], ["complicated SARS", "PROBLEM", 74, 90], ["CoV", "TEST", 91, 94], ["ARDS", "OBSERVATION", 69, 73]]], ["Convalescent plasma was obtained from two fully recovered SARS-CoV-2-causing pneumonia cases with anti-SARS-CoV-2 ELISA optical density of 0.586 and 0.532 (cutoff: 0.22).", [["plasma", "ANATOMY", 13, 19], ["SARS", "DISEASE", 58, 62], ["pneumonia", "DISEASE", 77, 86], ["plasma", "ORGANISM_SUBSTANCE", 13, 19], ["SARS-CoV-2", "ORGANISM", 58, 68], ["SARS-CoV", "SPECIES", 58, 66], ["Convalescent plasma", "TEST", 0, 19], ["SARS", "TEST", 58, 62], ["CoV", "TEST", 63, 66], ["pneumonia cases", "PROBLEM", 77, 92], ["anti-SARS", "TEST", 98, 107], ["CoV", "TEST", 108, 111], ["ELISA optical density", "TEST", 114, 135], ["cutoff", "TEST", 156, 162], ["pneumonia", "OBSERVATION", 77, 86]]], ["Despite being on lopinavir/ritonavir and hydroxychloroquine, both CPT recipients had been suffering from a worsening course of ARDS-complicated SARS-CoV-2 infection (PaO2/FiO2: < 100) prior to the convalescent plasma infusion.", [["plasma", "ANATOMY", 210, 216], ["lopinavir/ritonavir", "CHEMICAL", 17, 36], ["hydroxychloroquine", "CHEMICAL", 41, 59], ["CPT", "CHEMICAL", 66, 69], ["ARDS", "DISEASE", 127, 131], ["SARS", "DISEASE", 144, 148], ["infection", "DISEASE", 155, 164], ["lopinavir", "CHEMICAL", 17, 26], ["ritonavir", "CHEMICAL", 27, 36], ["hydroxychloroquine", "CHEMICAL", 41, 59], ["CPT", "CHEMICAL", 66, 69], ["lopinavir", "SIMPLE_CHEMICAL", 17, 26], ["ritonavir", "SIMPLE_CHEMICAL", 27, 36], ["hydroxychloroquine", "SIMPLE_CHEMICAL", 41, 59], ["CPT recipients", "ORGANISM", 66, 80], ["plasma", "ORGANISM_SUBSTANCE", 210, 216], ["lopinavir", "TREATMENT", 17, 26], ["ritonavir", "TREATMENT", 27, 36], ["hydroxychloroquine", "TREATMENT", 41, 59], ["both CPT recipients", "TREATMENT", 61, 80], ["ARDS", "PROBLEM", 127, 131], ["complicated SARS", "PROBLEM", 132, 148], ["CoV", "PROBLEM", 149, 152], ["2 infection", "PROBLEM", 153, 164], ["PaO2/FiO2", "TEST", 166, 175], ["the convalescent plasma infusion", "TREATMENT", 193, 225], ["worsening", "OBSERVATION_MODIFIER", 107, 116], ["ARDS", "OBSERVATION", 127, 131]]], ["After 500 ml of convalescent plasma infusion each, both critically ill COVID-19 patients improved in terms of symptoms and infection-related markers, with no adverse effects reported.", [["plasma", "ANATOMY", 29, 35], ["critically ill", "DISEASE", 56, 70], ["infection", "DISEASE", 123, 132], ["plasma", "ORGANISM_SUBSTANCE", 29, 35], ["patients", "ORGANISM", 80, 88], ["patients", "SPECIES", 80, 88], ["convalescent plasma infusion each", "TREATMENT", 16, 49], ["critically ill COVID", "TREATMENT", 56, 76], ["symptoms", "PROBLEM", 110, 118], ["infection", "PROBLEM", 123, 132], ["adverse effects", "PROBLEM", 158, 173], ["infection", "OBSERVATION", 123, 132]]], ["Their escalating viral loads prior to the plasma administration started to dramatically fall the next day after the convalescent plasma infusion, while their oxygen demand gradually decreased until they were successfully extubated.", [["plasma", "ANATOMY", 42, 48], ["plasma", "ANATOMY", 129, 135], ["oxygen", "CHEMICAL", 158, 164], ["oxygen", "CHEMICAL", 158, 164], ["plasma", "ORGANISM_SUBSTANCE", 42, 48], ["plasma", "ORGANISM_SUBSTANCE", 129, 135], ["oxygen", "SIMPLE_CHEMICAL", 158, 164], ["Their escalating viral loads", "PROBLEM", 0, 28], ["the plasma administration", "TREATMENT", 38, 63], ["the convalescent plasma infusion", "TREATMENT", 112, 144], ["their oxygen demand", "PROBLEM", 152, 171]]], ["Although the subjects in this study received methylprednisolone within 2 days prior to convalescent plasma infusion, their viral burden decreased afterwards, suggesting the successful neutralization effect of the administered plasma (13) (Table 1).", [["plasma", "ANATOMY", 100, 106], ["plasma", "ANATOMY", 226, 232], ["methylprednisolone", "CHEMICAL", 45, 63], ["methylprednisolone", "CHEMICAL", 45, 63], ["methylprednisolone", "SIMPLE_CHEMICAL", 45, 63], ["convalescent", "ORGANISM", 87, 99], ["plasma", "ORGANISM_SUBSTANCE", 100, 106], ["plasma", "ORGANISM_SUBSTANCE", 226, 232], ["this study", "TEST", 25, 35], ["methylprednisolone", "TREATMENT", 45, 63], ["convalescent plasma infusion", "TREATMENT", 87, 115], ["their viral burden", "PROBLEM", 117, 135], ["successful", "OBSERVATION_MODIFIER", 173, 183], ["neutralization", "OBSERVATION", 184, 198]]], ["A recent study in Wuhan, China, described the efficacy and safety of CPT on six COVID-19 cases (14).", [["CPT", "CHEMICAL", 69, 72], ["CPT", "CHEMICAL", 69, 72], ["CPT", "SIMPLE_CHEMICAL", 69, 72], ["A recent study", "TEST", 0, 14], ["CPT", "TEST", 69, 72], ["six COVID", "TEST", 76, 85]]], ["At least 200 ml of convalescent plasma infusion was administered to six laboratory-confirmed COVID-19 cases, five of whom had lower respiratory tract involvement.", [["plasma", "ANATOMY", 32, 38], ["lower respiratory tract", "ANATOMY", 126, 149], ["lower respiratory tract involvement", "DISEASE", 126, 161], ["convalescent", "ORGANISM", 19, 31], ["plasma", "ORGANISM_SUBSTANCE", 32, 38], ["tract", "ORGANISM_SUBDIVISION", 144, 149], ["convalescent plasma infusion", "TREATMENT", 19, 47], ["COVID", "TEST", 93, 98], ["lower respiratory tract involvement", "PROBLEM", 126, 161], ["lower", "ANATOMY_MODIFIER", 126, 131], ["respiratory tract", "ANATOMY", 132, 149]]], ["All convalescent plasma recipients showed clinical improvement without any adverse effects.", [["plasma", "ANATOMY", 17, 23], ["plasma", "ORGANISM_SUBSTANCE", 17, 23], ["All convalescent plasma recipients", "TEST", 0, 34], ["any adverse effects", "PROBLEM", 71, 90]]], ["Yeh et al. linked CPT in COVID-19 to radiological and serological improvements in terms of resolution of COVID-19-related abnormal radiological findings and mounting numbers of anti-SARS-CoV-2 antibodies, respectively (Table 1).", [["anti-SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 177, 192], ["anti-SARS-CoV-2 antibodies", "PROTEIN", 177, 203], ["CPT in COVID", "TEST", 18, 30], ["COVID", "TEST", 105, 110], ["abnormal radiological findings", "PROBLEM", 122, 152], ["anti-SARS", "TEST", 177, 186], ["CoV", "TEST", 187, 190]]], ["There was evidence of the clinical benefits of convalescent plasma in those running a late course of COVID-19 even after seroconversion exists (14).", [["plasma", "ANATOMY", 60, 66], ["COVID-19", "CHEMICAL", 101, 109], ["COVID-19", "CHEMICAL", 101, 109], ["convalescent", "ORGANISM", 47, 59], ["plasma", "ORGANISM_SUBSTANCE", 60, 66], ["convalescent plasma", "TREATMENT", 47, 66], ["COVID", "TEST", 101, 106]]], ["Hence, the efficacy of convalescent plasma in relation to seroconversion should be rigorously evaluated.", [["plasma", "ANATOMY", 36, 42], ["convalescent", "ORGANISM", 23, 35], ["plasma", "ORGANISM_SUBSTANCE", 36, 42], ["convalescent plasma", "PROBLEM", 23, 42], ["seroconversion", "TREATMENT", 58, 72], ["seroconversion", "OBSERVATION", 58, 72]]], ["CPT succeeded in lowering the SARS-CoV-2 viral burden, although it was administered after steroids (3, 13), contradicting the general notion that steroids have a counteractive effect on CPT (11).", [["CPT", "CHEMICAL", 0, 3], ["steroids", "CHEMICAL", 90, 98], ["steroids", "CHEMICAL", 146, 154], ["CPT", "CHEMICAL", 186, 189], ["CPT", "CHEMICAL", 0, 3], ["steroids", "CHEMICAL", 90, 98], ["steroids", "CHEMICAL", 146, 154], ["CPT", "CHEMICAL", 186, 189], ["CPT", "SIMPLE_CHEMICAL", 0, 3], ["steroids", "SIMPLE_CHEMICAL", 146, 154], ["CPT", "SIMPLE_CHEMICAL", 186, 189], ["CPT", "TREATMENT", 0, 3], ["the SARS", "PROBLEM", 26, 34], ["CoV", "PROBLEM", 35, 38], ["2 viral burden", "PROBLEM", 39, 53], ["steroids", "TREATMENT", 90, 98], ["steroids", "TREATMENT", 146, 154], ["CPT", "TEST", 186, 189]]], ["A thorough assessment of the relationship between steroids and CPT may lead to a more effective therapeutic combination.", [["steroids", "CHEMICAL", 50, 58], ["CPT", "CHEMICAL", 63, 66], ["steroids", "CHEMICAL", 50, 58], ["CPT", "CHEMICAL", 63, 66], ["steroids", "SIMPLE_CHEMICAL", 50, 58], ["CPT", "SIMPLE_CHEMICAL", 63, 66], ["A thorough assessment", "TEST", 0, 21], ["steroids", "TREATMENT", 50, 58], ["CPT", "TREATMENT", 63, 66]]], ["As of this writing, more than 80 clinical trials are aiming to investigate the safety and efficacy of CPT in COVID-19 subjects; however, results have yet to be posted (15).", [["CPT", "CHEMICAL", 102, 105], ["CPT", "CHEMICAL", 102, 105], ["CPT", "SIMPLE_CHEMICAL", 102, 105], ["CPT in COVID", "TEST", 102, 114]]], ["The scarcity of convalescent plasma donors should not be a problem, with millions of fully recovered COVID-19 cases all over the globe.Drawbacks of Using CPTThe drawbacks associated with CPT include adverse effects, such as transfusion transmissible infections (TTIs) and transfusion-related acute lung injury (TRALI) (2, 5).", [["plasma", "ANATOMY", 29, 35], ["lung", "ANATOMY", 298, 302], ["CPT", "CHEMICAL", 187, 190], ["transfusion transmissible infections", "DISEASE", 224, 260], ["TTIs", "DISEASE", 262, 266], ["acute lung injury", "DISEASE", 292, 309], ["TRALI", "DISEASE", 311, 316], ["CPT", "CHEMICAL", 187, 190], ["convalescent", "ORGANISM", 16, 28], ["plasma", "ORGANISM_SUBSTANCE", 29, 35], ["CPT", "SIMPLE_CHEMICAL", 187, 190], ["lung", "ORGAN", 298, 302], ["convalescent plasma donors", "TREATMENT", 16, 42], ["COVID", "TEST", 101, 106], ["CPTThe drawbacks", "TREATMENT", 154, 170], ["CPT", "TREATMENT", 187, 190], ["adverse effects", "PROBLEM", 199, 214], ["transfusion transmissible infections", "PROBLEM", 224, 260], ["TTIs", "TEST", 262, 266], ["transfusion", "TEST", 272, 283], ["acute lung injury", "PROBLEM", 292, 309], ["globe", "ANATOMY", 129, 134], ["acute", "OBSERVATION_MODIFIER", 292, 297], ["lung", "ANATOMY", 298, 302], ["injury", "OBSERVATION", 303, 309], ["TRALI", "OBSERVATION", 311, 316]]], ["In addition, its effectivity depends on the neutralization titer (2, 10).", [["the neutralization titer", "TEST", 40, 64], ["effectivity", "OBSERVATION_MODIFIER", 17, 28]]], ["However, based on available studies, plasma infusion is a safe medical practice, mainly due to advances in blood banking and transfusion, including ABO compatibility checking and TTI screening and monitoring during and after transfusion (2, 5).", [["plasma", "ANATOMY", 37, 43], ["blood", "ANATOMY", 107, 112], ["plasma", "ORGANISM_SUBSTANCE", 37, 43], ["blood", "ORGANISM_SUBSTANCE", 107, 112], ["available studies", "TEST", 18, 35], ["plasma infusion", "TREATMENT", 37, 52], ["a safe medical practice", "TREATMENT", 56, 79], ["blood banking", "TREATMENT", 107, 120], ["transfusion", "TREATMENT", 125, 136], ["ABO compatibility", "TEST", 148, 165], ["TTI screening", "TEST", 179, 192], ["monitoring", "TEST", 197, 207], ["transfusion", "TEST", 225, 236]]], ["Further, in a reported case of TRALI following MERS convalescent plasma infusion, neither anti-human leukocyte antigen nor anti-human neutrophil antigen, both of which are TRALI pathophysiology key players, were detected in the donated plasma (2, 16).", [["plasma", "ANATOMY", 65, 71], ["plasma", "ANATOMY", 236, 242], ["TRALI", "DISEASE", 31, 36], ["TRALI", "DISEASE", 172, 177], ["plasma", "ORGANISM_SUBSTANCE", 65, 71], ["anti-human leukocyte antigen", "GENE_OR_GENE_PRODUCT", 90, 118], ["anti-human neutrophil antigen", "GENE_OR_GENE_PRODUCT", 123, 152], ["plasma", "ORGANISM_SUBSTANCE", 236, 242], ["anti-human leukocyte antigen", "PROTEIN", 90, 118], ["anti-human neutrophil antigen", "PROTEIN", 123, 152], ["TRALI", "PROBLEM", 31, 36], ["MERS convalescent plasma infusion", "TREATMENT", 47, 80], ["neither anti-human leukocyte antigen", "TEST", 82, 118], ["anti-human neutrophil antigen", "TEST", 123, 152], ["TRALI", "OBSERVATION", 31, 36], ["TRALI", "OBSERVATION", 172, 177]]], ["Additionally, neutralization activity could be predicted by ELISA-IgG (10).ConclusionCurrently, no specific antiviral agent has been proven for SARS-CoV-2 infection.", [["SARS-CoV-2 infection", "DISEASE", 144, 164], ["SARS-CoV-2", "ORGANISM", 144, 154], ["IgG", "PROTEIN", 66, 69], ["SARS-CoV-2", "SPECIES", 144, 154], ["ELISA", "TEST", 60, 65], ["specific antiviral agent", "TREATMENT", 99, 123], ["SARS", "PROBLEM", 144, 148], ["CoV", "PROBLEM", 149, 152], ["2 infection", "PROBLEM", 153, 164], ["no", "UNCERTAINTY", 96, 98], ["infection", "OBSERVATION", 155, 164]]], ["However, based on available data, it is plausible to consider CPT as an effective, safe, and feasible therapeutic option for COVID-19.", [["CPT", "CHEMICAL", 62, 65], ["CPT", "CHEMICAL", 62, 65], ["CPT", "SIMPLE_CHEMICAL", 62, 65], ["CPT", "TREATMENT", 62, 65], ["COVID", "TEST", 125, 130]]], ["Determining the effective dose of convalescent plasma infusion is essential, along with other variables such as the neutralization titer.Author ContributionsASA contributed conception of the study and critically revised the manuscript.", [["plasma", "ANATOMY", 47, 53], ["convalescent", "ORGANISM", 34, 46], ["plasma", "ORGANISM_SUBSTANCE", 47, 53], ["convalescent plasma infusion", "TREATMENT", 34, 62], ["the neutralization titer", "TREATMENT", 112, 136], ["ASA", "TREATMENT", 157, 160], ["the study", "TEST", 187, 196]]], ["ANA wrote the first draft of the manuscript.", [["ANA", "PROTEIN", 0, 3]]], ["All authors contributed to manuscript revision, read, and approved the submitted version.Conflict of InterestThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.", [["manuscript revision", "TREATMENT", 27, 46], ["revision", "OBSERVATION", 38, 46]]]], "9f4f9029353504187d404bbc3aaac9cb56acde92": [["Infectious disease is a complex interaction between pathogen, host, and external determinants.", [["Infectious disease", "DISEASE", 0, 18], ["complex", "OBSERVATION_MODIFIER", 24, 31]]], ["It can lead to one of several possible outcomes for a host, such as death, reduction in fitness without death, or recovery without long-lasting impacts on health.", [["death", "DISEASE", 68, 73], ["death", "DISEASE", 104, 109], ["death", "PROBLEM", 68, 73], ["death", "PROBLEM", 104, 109]]], ["Determining the causes and controlling disease is based on understanding these processes that includes intrinsic and extrinsic factors affecting the interaction.", [["controlling disease", "PROBLEM", 27, 46]]], ["However, they are of limited value if used in isolation and if additional work is not undertaken to understand the causal pathway of disease.", [["disease", "PROBLEM", 133, 140], ["disease", "OBSERVATION", 133, 140]]], ["Plowright et al. (2008) suggest a framework using multiple lines of evidence for determining causal inference.", [["multiple lines", "TREATMENT", 50, 64]]], ["A similar framework was used by Skerratt et al. (2007) to show that the spread of chytridiomycosis had caused the greatest loss of vertebrate biodiversity due to disease in recorded history.", [["chytridiomycosis", "DISEASE", 82, 98], ["loss of vertebrate biodiversity", "DISEASE", 123, 154], ["chytridiomycosis", "PROBLEM", 82, 98], ["disease", "PROBLEM", 162, 169], ["chytridiomycosis", "OBSERVATION", 82, 98], ["greatest", "OBSERVATION_MODIFIER", 114, 122], ["vertebrate biodiversity", "OBSERVATION", 131, 154]]], ["Blaustein et al. argue that experiments ''can provide an unambiguous rejection of the null hypothesis that pathogen X is not harmful to its host.''", [["the null hypothesis", "PROBLEM", 82, 101], ["rejection", "OBSERVATION", 69, 78]]], ["However, experimental conditions do not fully encapsulate conditions experienced by the host in the real world, and any experiment is by definition limited in explanatory power.", [["experimental conditions", "PROBLEM", 9, 32]]], ["Changes in abiotic parameters can have strong influences on both pathogen and host physiology and thus virulence and pathogenicity of a disease (Wolinska and King, 2009; Ostfeld, 2009) , and pathogen dynamics can be regulated by host density-or frequency-dependent transmission processes, which are difficult to replicate experimentally (Monello and Gompper, 2009; Sepp\u00e4l\u00e4 et al., 2008; Ryder et al., 2007) .", [["Changes in abiotic parameters", "PROBLEM", 0, 29], ["virulence", "PROBLEM", 103, 112], ["a disease", "PROBLEM", 134, 143], ["dependent transmission processes", "PROBLEM", 255, 287], ["abiotic parameters", "OBSERVATION", 11, 29], ["host density", "OBSERVATION_MODIFIER", 229, 241]]], ["This is certainly the case for the pathogen Batrachochytrium dendrobatidis (Bd)/ amphibian host system, where the outcome of exposure to the pathogen is affected by host species, life stage, age, body condition and behavior, environmental temperature, pathogen strain and infective dose, and habitat (Berger et al., 1998 (Berger et al., , 2004 (Berger et al., , 2005 Berger, 2001; Johnson et al., 2003; Piotrowski et al., 2004; Bosch et al., 2007; Kriger and Hero, 2007; Skerratt et al., 2008; Woodhams et al., 2008; Fisher et al., 2009; Garner et al., 2009; Richards-Zawacki, 2009 ).", [["body", "ANATOMY", 196, 200], ["pathogen", "ORGANISM", 35, 43], ["Batrachochytrium dendrobatidis", "ORGANISM", 44, 74], ["Bd)", "ORGANISM", 76, 79], ["body", "ORGANISM_SUBDIVISION", 196, 200], ["Batrachochytrium dendrobatidis", "SPECIES", 44, 74], ["Batrachochytrium dendrobatidis", "SPECIES", 44, 74], ["the pathogen Batrachochytrium dendrobatidis (Bd)/ amphibian host system", "PROBLEM", 31, 102], ["the pathogen", "PROBLEM", 137, 149], ["body condition", "PROBLEM", 196, 210]]]]}